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Abstract 
Cardiac fatigue is a phenomenon that is characterized by a transient reduction in left 
ventricular contractile and/or relaxation function following acute aerobic exercise. Few studies 
have utilized rodent models to examine possible cellular mechanisms associated with cardiac 
fatigue given the logistical limitations present in human models of cardiac fatigue. Thus, the 
overall objective of this thesis was to determine if oxidative stress, impaired regulation of Ca2+, 
Na+ and K+ or increased proteolytic activity contribute to the development of cardiac fatigue 
using a rat model. 
The aim of the first study in this thesis was to develop an exercise protocol that induced 
cardiac fatigue. Male Sprague-Dawley rats (21-23 weeks) were randomly assigned to either a 
control group (CTL), an acute exercise group (AC) or a group that performed acute exercise and 
were allowed to recover for 24 hours (24H). Animals in the AC and 24H groups performed 
treadmill running (5% grade; 20 m/min) until exhaustion, which occurred after 69 ± 3 and 72 ± 
5 minutes in the AC and 24H groups, respectively. Subsequently, the hearts from anaesthetized 
animals were excised, perfused in a retrograde fashion and instrumented, which permitted the 
assessment of heart rate, hemodynamics and left ventricular contractile and relaxation properties. 
The exhaustive exercise protocol induced cardiac fatigue in the basal state as indicated by a 
respective, 12 and 14% reduction (p<0.05) in LVDP in the AC and 24H groups. In addition, 
there was a trend (p=0.076) for a reduction in the maximal rate of pressure decline (-dP/dt) but 
no significant differences (p>0.05) in the maximal rate of pressure development (+dP/dt) were 
observed. The cardiac fatigue present in the basal state persisted during β-adrenergic stimulation, 
such that LVDP was significantly lower (p<0.05) in the AC and 24H groups and –dP/dt was 
lower (p<0.05) in the AC group during the isoproterenol (ISO) dose response. The cardiac 
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fatigue observed in the basal state and during β-adrenergic stimulation was not due to changes 
in coronary flow or heart rate, which suggests that the mechanisms responsible for cardiac 
fatigue stem from within the cardiomyocyte. 
 The features of cardiac fatigue were reminiscent of myocardial stunning, which directed 
the experiments in Chapter 3 to examine reactive oxygen species (ROS) production, Ca2+ 
homeostasis, proteolytic activity and regulation of Na+ and K+. Left ventricle (LV) homogenates 
were collected for in vitro experiments. Norepinephrine (NE) and epinephrine (Epi) were 
extracted from plasma and the concentrations were determined using a HPLC assay. The 
maximal rates of Ca2+-ATPase activity and Na+/K+-ATPase activity were determined using a 
NADH-enzyme linked spectrophotometric assay. A fluorometric assay and the Ca2+ sensitive 
dye, Indo-1 were used to measure the rates of Ca2+ uptake, leak and release. The production of 
ROS was determined using dihydrodichlorofluorescein-diacetate, which, upon oxidation, yields 
the highly fluorescent dichlorofluorescein. Lipid peroxidation was determined by measuring the 
concentration of malondialdehyde (MDA) in LV homogenates. Western blotting and 
immunoprecipitation were used to assess protein expression and to determine RyR specific 
oxidative post-translational modification.  
Acute exercise resulted in a ~5-fold increase (p<0.05) in plasma Epi concentration, which 
returned to baseline 24 hours post-exercise. There were no differences (p>0.05) in plasma NE 
between the groups. The maximal rates of Ca2+-ATPase activity and Na+/K+-ATPase activity 
were not affected (p>0.05) by exhaustive exercise. In addition, the rates of SR Ca2+ release were 
not significantly different between the three groups. A novel finding was that the rate of SR Ca2+ 
leak increased ~40% in the AC group when compared to the CTL group (p<0.05). These data 
suggest that impaired Ca2+ regulation may have contributed to the cardiac fatigue observed in 
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the AC group. The functional alteration to RyR was associated with a ~15% increase (p<0.05) 
in ROS production in the AC group. However, lipid peroxidation and glutathionylation, nitration 
and carbonylation content on RyR were not significantly different (p>0.05) between the three 
groups. Furthermore, the ratio of phosphorylated RyR (pRyR) to total RyR was not altered by 
acute exercise despite the rise in plasma Epi. The increased SR Ca2+ leak in the AC group likely 
contributed to the increase (p<0.05) in calpain activity observed in the AC group. Taken together, 
an increased rate of SR Ca2+ leak and subsequent calpain activation may contribute 
mechanistically to the cardiac fatigue observed in the AC and 24H group via reduced SR Ca2+ 
load and excitation contraction uncoupling, respectively. 
 The purpose of the experiments presented in Chapter 4 were to examine the hypothesis 
that NADPH oxidase (NOX) inhibition would prevent cardiac fatigue by reducing ROS 
production, reducing SR Ca2+ leak and preventing calpain activation. NOX was inhibited by 
providing 1.5 mM apocynin (APO) in the drinking water of rats for three days prior to the 
exhaustive exercise bout. NOX inhibition prevented exercise-induced cardiac fatigue as LVDP 
and -dP/dt were not significantly different (p>0.05) between the three APO treated groups, 
whether in the basal state or during β-adrenergic stimulation. The production of ROS was similar 
amongst the APO treated groups (p>0.05). The rates of SR Ca2+ leak were not significantly 
different (p>0.05) between the APO treated groups. In association with the reduced rates of SR 
Ca2+ leak, the calpain activity was not significantly different (p>0.05) between the APO groups, 
which likely contributed to the prevention of cardiac fatigue in the APO 24H group. These data 
suggest that improved Ca2+ regulation and reduced proteolytic activity likely contributed to the 
prevention of cardiac fatigue in the APO AC and APO 24H groups. 
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 These studies demonstrate that cardiac fatigue present immediately after exhaustive 
exercise was associated with increased ROS production and increased SR Ca2+ leak and that 
cardiac fatigue present 24 hours post-exercise was associated with enhanced proteolytic activity. 
In the presence of NOX inhibition, cardiac fatigue was prevented and ROS production, SR Ca2+ 
leak and calpain activity were maintained at control levels. Although these results demonstrate 
a strong association between NOX activity and ROS production with SR Ca2+ leak and cardiac 
fatigue, the exact mechanisms that prevent Ca2+ leak remain to be determined. 
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Chapter I: Introduction, review of the literature and statement of problem 
Overview 
The positive effects of regular endurance exercise on cardiovascular health in the general 
population are well recognized (King et al., 1989; Dengel et al., 1998; Andersen et al., 1999; 
Ross et al., 2000). However, prolonged endurance events, such as marathons, triathlons and 
ultramarathons have been shown to have transient, negative effects on LV function (Shave & 
Oxborough, 2012). Mechanistically, it has been demonstrated that prolonged exercise may alter 
ventricular repolarization (Sahlen et al., 2009), LV mechanics (Nottin et al., 2012) and the 
myocardium’s sensitivity to β-adrenergic stimulation (Scott et al., 2007). Animal studies that 
have subjected rats to prolonged aerobic exercise have demonstrated, transient LV fatigue, which 
was associated with increased lipid peroxidation (Wonders et al., 2007) and oxidative stress 
(Vitiello et al., 2011). In addition, rats that swam to exhaustion had significantly lower rates of 
cardiac SR Ca2+-uptake when compared to a control group (Pierce et al., 1984). However, the 
study by Piece and co-workers (1984) did not examine LV function following the exhaustive 
swim bout. Several disease models, which include heart failure, diabetic cardiomyopathy and 
muscular dystrophy cardiomyopathy present with reduced cardiac function in association with 
impaired regulation of intracellular Ca2+. It is possible that LV fatigue following prolonged 
endurance exercise may occur as a result of increased oxidative stress and impaired Ca2+ 
regulation by the sarcoplasmic reticulum, features observed in the stunned myocardium. The 
studies in this thesis will employ a rat model of exhaustive treadmill exercise to determine the 
role of oxidative stress and impaired SR function in exercise-induced cardiac fatigue.  
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Introduction 
Exercise-Induced Cardiac Fatigue in Humans 
 In humans, prolonged endurance events, such as marathons, triathlons and 
ultramarathons have been shown to have transient, negative effects on left ventricular function 
(Shave & Oxborough, 2012). It has been nearly 50 years since Saltin and Stenburg (1964) 
observed a reduction in stroke volume (SV) following three hours of exercise, despite preserved 
blood volume. Since then numerous human studies have demonstrated a reduction in LV 
function in the basal state (i.e. at rest) following an acute bout of prolonged or exhaustive 
exercise. Significant work in this field has been performed by R. Shave’s group at Cardiff 
Metropolitan University, UK (Oxborough et al., 2010a; Shave & Oxborough, 2012)  
 Early human studies utilized two-dimensional M mode echocardiography to measure LV 
cavity dimensions, and pulsed-wave Doppler ultrasound to assess passive filling of the LV in 
early diastole (E) and active filling late in diastole (A), before and after endurance events. 
Douglas and colleagues (1987) monitored 21 athletes competing in an Ironman® Triathlon and 
found significant reductions in LV diastolic dimension, fractional shortening and the ratio of 
early to late (E:A) filling velocities following the race (Douglas et al., 1987). Similarly, George 
and colleagues (2004) observed a reduction in diastolic function as indicated by a reduced E to 
A ratio; however, they did not observe any deficits in LV systolic function following a marathon. 
These authors speculated that the observed changes in diastolic function might be related to a 
disturbance in Ca2+ removal from the cytosol (George et al., 2004). The removal of Ca2+ from 
the cytosol results in myocyte relaxation, which is critical for proper diastolic function (i.e. 
passive filling of the LV). Several human studies have reported impaired systolic and/or diastolic 
function following endurance events that were performed under a variety of conditions (i.e. 
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temperature, humidity, elevation and pace) and did not account for changes in preload (Douglas 
et al., 1987; Whyte et al., 2000; Shave et al., 2004; Dawson et al., 2005). Preload is a major 
determinant of LV contractility and thus, by not controlling the environmental conditions and 
fluid replacement, changes in preload may have contributed to the observed deficits in LV 
function. 
 Researchers have attempted to maintain or manipulate preload in an attempt to more 
accurately compare post-exercise indices of LV function to those recorded pre-exercise. A study 
by Goodman and co-workers (2001) attempted to maintain preload via ad libitum fluid 
consumption and intravenous saline infusion in participants during 150 min of cycling at 70-
74% of HRmax. Despite the intervention used to maintain preload, EDV decreased over the course 
of the 150 minute protocol. Ejection fraction (EF) was not different following the exercise bout; 
however, there was a significant delay in the time to peak filling of the LV, which may be due 
to elevate heart rate post-exercise (Goodman et al., 2001). A delay in the time to peak filling of 
the LV may also be due to lower left atrial pressure, a slower rate of LV pressure decline, 
incomplete LV relaxation or increased LV stiffness (Lew, 1989). A similar study maintained 
central venous pressure (CVP), an indicator of preload, during three hours of cycling by infusing 
saline into the superior vena cava (Dawson et al., 2007). There were no observable changes in 
systolic function following three hours of cycling. However, despite maintenance of CVP, 
diastolic function was reduced, as indicated by a lower E:A ratio. Similarly, a small but 
significant decline in E:A ratio was observed in athletes following an Ironman® triathlon despite 
maintenance of preload and afterload (Hassan et al., 2006). These studies suggest that even when 
preload is maintained there are deficits intrinsic to the cardiomyocyte that contributes to a 
reduction in diastolic function (Hassan et al., 2006). 
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 Advances in imaging techniques and analysis software, namely tissue Doppler imaging 
(TDI) and speckle tracking imaging (STI), have made it possible to examine LV wall motion, 
strain and strain rates in vivo. In simplistic terms, strain is a regional deformation of LV tissue 
and typically is measured as longitudinal, radial, circumferential or rotational movement 
(Gorcsan & Tanaka, 2011). TDI analysis of cardiac function following four consecutive days of 
cycling (3 hours/day) indicated that early diastolic tissue velocity (Eʹ) was decreased and that 
tissue isovolumetric relaxation time (IVRTʹ) was prolonged (Oosthuyse et al., 2012). Two 
separate studies assessed LV function before and after an 89 km and 160 km race using standard 
echocardiography and STI. It was observed that ejection fraction (EF), the E:A ratio, peak strain 
and peak systolic and diastolic strain rates were significantly reduced following the races 
(George et al., 2009; Scott et al., 2009). Furthermore, Oxborough and colleagues (2010b) utilized 
STI analysis and observed a significant reduction in LV filling during early diastole following a 
marathon. These imaging techniques have been described as load-independent (Zhou et al., 
2013), which suggests that the existence of diastolic fatigue following endurance exercise is due 
to intracellular deficits in the cardiomyocyte.  
 Further development of TDI and STI techniques has provided the unique opportunity to 
examine the interval between ventricular excitation and peak tissue velocities as well as rotation 
of the ventricles. A study by Chan-Dewar and co-workers (2010) assessed the time to peak 
systolic and peak diastolic tissue velocity from the onset of the Q wave (normalized to the R-R 
interval) following an 89 km marathon. Immediately following exercise there was a reduction in 
indices of LV function (i.e. reduced EF, E:A and peak tissue velocities), as well as an electro-
mechanical delay indicated by the ~44 ms increase in time from QRS to peak systolic tissue 
velocity. These authors indicated that the electro-mechanical delay was not a result of altered 
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membrane excitability as QRS duration was not affected by exercise. Rather they suggested that 
intrinsic deficits in the cardiomyocyte downstream of excitation are likely candidates and could 
be a combination of either Ca2+ mobilization, Ca2+ sequestration, energy turnover or myofibrillar 
ATPase activity (Chan-Dewar et al., 2010). 
 Left ventricular torsion is the twisting of the ventricle during systole and untwisting prior 
to diastolic filling. Proper LV torsion is essential for ventricle function during rest and exercise 
(Buckberg et al., 2011). Nottin and colleagues (Nottin et al., 2009) evaluated LV torsion via 2D 
ultrasound STI following an Ironman® Triathlon. These authors observed a significant decrease 
and delay in LV twisting during systole, which contributed to the lower ventricular untwisting 
during isovolumetric relaxation (Nottin et al., 2009). These changes in ventricular mechanics 
would likely impact ventricular filling during diastole as the potential energy stored when the 
ventricles twist during systole, is released during diastole and contributes to the untwisting of 
the ventricles, which is vital for the rapid drop in LV pressure (Nottin et al., 2009). A more recent 
study by the same group had participants cycle for two hours, such that their HR was ≥ 150 bpm 
at all times and compared LV strain and twist before and after cycling (Nottin et al., 2012). 
Following exercise, there was a reduction in diastolic function (decreased peak E), which was 
associated with a delay in peak untwisting velocity. Impaired LV untwisting would likely reduce 
LV filling during diastole, which would decrease EDV and reduce contractility. 
  The activation of β-adrenergic receptors and subsequent phosphorylation of target 
proteins by protein kinase A (PKA) is pivotal to the increase in LV contractility observed during 
exercise (discussed below). A reduction in β-adrenergic sensitivity following exhaustive exercise 
could in theory reduce contractility of the heart during a subsequent bout of exercise and may 
represent a form of cardiac fatigue. Indeed, a study by Eysmann and colleagues (1996) had 
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humans cycle at ~60% VO2max until exhaustion (~95 minutes) and demonstrated that following 
a 10 minute post-exercise recovery period, subjects had a reduced EF, E:A ratio and EDV. In 
addition, there was a decrease in the chronotropic (heart rate) response to a given concentration 
of the β-adrenergic agonist, ISO. The results of this study suggest that submaximal exercise to 
the point of exhaustion may blunt the positive chronotropic response to β-adrenergic receptor 
stimulation in pacemaker cells of the sinoatrial (SA) node. Conversely, an acute bout of running 
at ~70% VO2max for one hour did not alter the chronotropic response to ISO in humans (Martin 
et al., 1991). These studies suggest that perhaps there is an interaction between exercise intensity 
and duration with respect to alterations in the heart rate response to β-adrenergic stimulation. 
Work by Welsh and colleagues (2005) examined the end-systolic elastance and the relationship 
between fractional area change and wall stress (i.e. indices of LV contractility) during a 
continuous infusion of the β-adrenergic agonist, dobutamine, following a half-Ironman® 
Triathlon. The LV contractility, HR and systolic blood pressure (SBP) response to dobutamine 
infusion was blunted post-exercise when compared to the pre-exercise dose response. Similar 
findings were observed following four hours of simulated rowing and a half-Ironman Triathlon® 
(Hart et al., 2006; Scott et al., 2007). These data demonstrate that β-adrenergic responsiveness 
in humans is depressed following prolonged exercise, which may limit the capacity of the 
myocardium to attain a desired cardiac output during a subsequent bout of exercise (i.e. cardiac 
fatigue). The evidence in human research suggests that long duration or high intensity exercise 
can have a negative effect on cardiac mechanics at the whole organ level. However, the 
intracellular mechanisms associated with exercise-induced cardiac fatigue remain to be 
elucidated.             
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Exercise-Induced Cardiac Fatigue in Animals 
 The use of animal models has greatly advanced our understanding of cardiac physiology 
in relation to disease and adaptation to exercise. Surprisingly, there are a limited number of 
investigations that have utilized animal models to explore the development of, and mechanisms 
associated with, exercise-induced cardiac fatigue. Grimditch and co-workers (1981) ran 
instrumented dogs at 70% of their maximum heart rate until exhaustion, which occurred on 
average after a duration of 77 minutes. These authors compared SV, cardiac output and ±dP/dt 
at the point of exhaustion to steady state values recorded within the first five minutes of exercise 
and found that upon exhaustion the cardiovascular parameters examined remained unchanged. 
In fact there was an increase in both ±dP/dt (Grimditch et al., 1981). More recent work using 
echocardiography and pressure transducers fed into the LV of anesthetized rats has demonstrated 
that prolonged aerobic exercise resulted in cardiac fatigue (Vitiello et al., 2011; Olah et al., 
2015). Olah and colleagues (2015) assessed EF in anesthetized rats following three hours of 
swim exercise and found that EF was significantly lower in the exercise group when compared 
to the control group. In animals that were forced to run for four hours at 60-65% of their maximal 
heart rate there was approximately a 12% reduction in LVDP (Vitiello et al., 2011). These data 
suggest that the duration of exercise can impact the function of the myocardium following acute 
exercise or perhaps there are species differences in relation to cardiac fatigue.  
The isolated trabeculae and isolated perfused heart techniques permit the evaluation of 
cardiac function in a controlled environment with regard to loading conditions, pH, temperature 
and humoral factors. Early work by Maher and co-workers (1972) measured force production 
from isolated LV trabecular muscles from control rats and rats run to exhaustion on a motorized 
treadmill. These researchers observed an approximate 50% reduction in force from trabeculae of 
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exhausted rats. In a later study, LVDP was assessed using the isolated perfused rat heart 
following four hours of treadmill exercise at 60-65% of maximal heart rate. When compared to 
control hearts, prolonged exercise caused a significant reduction in LVDP (Vitiello et al., 2011). 
A study by Wonders and co-workers (2007) determined the LVDP of isolated rat hearts 
immediately post-exercise and at 24, 48 and 72 hours post-exercise. These authors demonstrated 
that one hour of running at 25 m/min resulted in a transient decline in LVDP that peaked (~25% 
reduction) 48 hours post-exercise and returned to pre-exercise levels at 72 hours post-exercise. 
However, not all studies that have examined cardiac fatigue in rodents have found equivalent 
results. Indices of LV function from hearts excised from rats that ran at 18 m/min and 0% grade 
until exhaustion were not significantly different than hearts from the sedentary control group 
(Seward et al., 1995). Thus, exercise-induced cardiac fatigue has been demonstrated using some, 
but not all exercise protocols.     
The literature regarding β-adrenergic responsiveness following acute exercise in animals 
is more contentious than the evidence in humans. Friedman and colleagues (1987) demonstrated 
a significant desensitization of the β-adrenergic receptors in the canine myocardium following 
60 minutes of treadmill running at a speed and grade that elicited 60-80% of their maximal heart 
rate. Once fully recovered, animals were infused with progressive doses of ISO in order to 
increase heart rate by 25 beats per minute (bpm). The ISO dose required was 3-fold greater post-
exercise when compared to the pre-exercise dose (Friedman et al., 1987). These authors failed 
to assess cardiac function following exercise so it is not certain whether this β-adrenergic 
desensitization occurred in conjunction with LV fatigue. In another study, β-adrenergic 
responsiveness in conjunction with LVDP were assessed using the isolated perfused heart 
technique following four hours of submaximal treadmill exercise in rats (Vitiello et al., 2011). 
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These authors did not observe a significant difference in LVDP between control and exercise 
hearts in response to progressive doses of ISO. These findings are at odds with observations in 
dogs and in previous work performed on humans (Friedman et al., 1987; Welsh et al., 2005; Hart 
et al., 2006; Scott et al., 2007), suggesting that there are perhaps species-dependent changes in 
β-adrenergic signalling following exhaustive exercise. 
Cardiac Excitation-Contraction Coupling 
 In order to discuss potential mechanisms that contribute to the development of exercise-
induced cardiac fatigue it is important to be aware of the processes involved with force 
production and relaxation in the cardiomyocyte. Excitation-contraction (EC) coupling is the term 
given to the molecular events that start with electrical excitation of the cardiomyocyte and 
culminate with myocyte contraction. During diastole, the resting membrane potential of a 
ventricular cardiomyocyte is approximately -90 mV. Slight depolarization of the ventricular 
sarcolemmal membrane, resulting from cation (Na+, Ca2+) influx from adjacent cardiomyocytes 
through gap junctions, activates voltage-gated Na+ channels, which causes rapid Na+ influx 
(inward Na+ current, INa) and contributes to the rapid rise of the cardiac action potential (Phase 
0, see Figure 1.1 and for a detailed review see (Bers et al., 2003)). The membrane potential peaks 
at approximately +25 mV followed by rapid inactivation of Na+ channels that contributes to 
cessation of depolarization. Repolarization and Na+ removal from the cytosol of the 
cardiomyocyte will be discussed below. 
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Figure 1.1. An illustration of the ventricular myocyte action potential. Phase 0: The steep rise 
in membrane potential is due to opening of Na+ channels and rapid Na+ influx. Phase 1: The 
action potential notch occurs as the Na+ channels are inactivated and the transient outward K+ 
channels open. Phase 2: Entry of Ca2+ via the DPHR contributes to the action potential plateau. 
Phase 3: The majority of cardiomyocyte repolarization is due to the delayed, rectifying K+ 
current. Phase 4: The Na+/K+-ATPase restores the electrochemical gradient of Na+ and K+ and 
contributes to repolarization. Adapted from (Bers, 2002). 
 
The wave of depolarization flows to the interior of the cardiomyocyte via the transverse 
tubules (T-tubules) where there are a high density of voltage-dependent Ca2+ channels, known 
as dihydropyridine receptors (DHPR) or L-type calcium channels. DHPRs were first purified 
using skeletal muscle (Curtis & Catterall, 1984) and are heterotetrameric protein complexes 
comprised of α1, α2/δ, β and γ subunits (Hosey et al., 1987; Bodi et al., 2005). Upon 
depolarization, the α1 subunit undergoes a conformational change, which results in opening of 
the pore region and extracellular Ca2+ influx. Movement of Ca2+ across the sarcolemma creates 
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an inward current, termed L-type Ca2+ current (ICa). The Ca2+ entry via ICa contributes to the 
plateau phase of the cardiac action potential (Phase 2, Figure 1.1) and can raise sub-sarcolemmal 
Ca2+ concentration up to 10-20 µM (Figure 1.2) (Bers, 2008). The entry of Ca2+ is often referred 
to as trigger Ca2+ as it initiates Ca2+-induced Ca2+-release (CICR) from the SR through the Ca2+ 
release channel (Fabiato & Fabiato, 1975a). 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. An illustration of a ventricular cardiomyocyte. A single t-tubule and the terminal 
cisterna of the sarcoplasmic reticulum (SR) are in close proximity to each other and form a diad. 
The shaded area between the t-tubule and the SR terminal cisterna is the subsarcolemmal cleft 
region. The dihydropyridine receptor (DHPR) and the ryanodine receptor (RyR) are included for 
reference.   
 
 
 The cardiac isoform of the Ca2+ release channel (Ryanodine Receptor; RyR2) is a 
homotetrameric protein complex with a large cytoplasmic N-terminal domain and a C-terminal 
pore region that spans the SR membrane (Lai et al., 1989; Lehnart et al., 2004a; Ludtke et al., 
2005). The cytoplasmic domain acts as a scaffold for regulatory proteins that modulate RyR 
gating, such as calstabin2 (Brillantes et al., 1994; Timerman et al., 1994), PKA (Marx et al., 
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2000), protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A) (Marx et al., 2001) and 
calmodulin (Fruen et al., 2000; Lehnart et al., 2004a). In vivo, RyR2 gating is modulated by 
Ca2+, Mg2+, ATP (Copello et al., 2002), phosphorylation (Hain et al., 1995) and oxidation 
(Marengo et al., 1998). Entry of trigger Ca2+ raises the subsarcolemmal cleft Ca2+ concentration, 
such that Ca2+ occupies the Ca2+ binding sites on each of the 4 RyR2 subunits. Occupation of the 
Ca2+ binding sites causes a rotation in the RyR2 complex that aligns the central pore and permits 
Ca2+ release from the lumen of the SR (Serysheva et al., 1999). 
 The Ca2+ that is released from the SR rapidly diffuses throughout the cytosol and binds 
to the N-terminal, low affinity Ca2+ binding site on troponin C (TnC). TnC is the 3rd member in 
the troponin complex, which is comprised of troponin I (TnI), the inhibitory subunit, and 
troponin T (TnT), the isoform that anchors the troponin complex to tropomyosin (Fuchs & Smith, 
2001). Tropomyosin (Tm) lies in the groove between actin filaments and regulates the actin-
myosin interaction. When Ca2+ binds to TnC the protein undergoes a conformational change that 
is transmitted through the Tn complex and causes Tm to move to the outer domain of the actin 
filament, which exposes the myosin binding sites on actin (Craig & Lehman, 2001; Kobayashi 
et al., 2008). Thin filament activation permits transition of weakly bound cross-bridges to 
strongly bound cross-bridges and results in shortening of the sarcomere and the development of 
force (McKillop & Geeves, 1993).  
 The degree of developed tension in ventricular myocytes is highly dependent on the 
concentration of cytosolic free calcium ([Ca2+]f). The first recordings of Ca2+ transients in cardiac 
tissue were carried out in atrial trabeculae from frogs using the calcium-sensitive bioluminescent 
protein aequorin (Allen & Blinks, 1978).  These experiments demonstrated that the classical 
inotropic effects of increased stimulation frequency (i.e. increased heart rate), increased 
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extracellular Ca2+ concentration or β-adrenergic stimulation were due to a greater Ca2+ transient 
amplitude. Using aequorin, Yue and co-workers (1986) measured the [Ca2+]f in tetanized 
papillary muscles from ferrets and calculated that maximal Ca2+-activated force occurred at ~1.0 
μM. The evolution of fluorescent Ca2+ indicators improved the resolution of measuring 
intracellular Ca2+ transients. Using fura-2 several groups confirmed the finding of Yue and co-
workers (1986) that maximal Ca2+-activated force occurred at ~1.0 μM (Gao et al., 1994; Backx 
et al., 1995). The relationship between intracellular free Ca2+ concentration ([Ca2+]f) and force 
production is sigmoidal in nature and has a steep linear portion of the curve (Gao et al., 1994; 
Backx et al., 1995) (Figure 1.3). Accordingly, a small change in the [Ca2+]f anywhere along the 
linear portion of the force-Ca2+ curve will result in relatively large changes in force.             
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Figure 1.3. The relationship between intracellular free Ca2+ concentration and force. The 
sigmoidal nature of this curve dictates that small changes in the physiologically relevant range 
of intracellular free Ca2+ (0.1-1.0 μM) results in significant changes in force production. Adapted 
from (Gao et al., 1994). 
 
Repolarization and Restoration of Electrochemical Ion Gradients  
Repolarization of the membrane potential is accomplished primarily by opening of K+ 
channels. In the heart, there are numerous types of K+ channels that have been classified based 
on the duration of their open state, the timing of channel opening and the molecules that activate 
or inactivate the channel (for a comprehensive review see (Nerbonne & Kass, 2005)). As with 
Na+ and Ca2+ channels, flow of K+ through a K+ channel and out of the cell generates an ionic 
current. Transient outward K+ currents (Ito) and delayed, rectifying K+ currents (IK) are the two 
general classes of currents that contribute to cardiomyocyte repolarization (Josephson et al., 
1984; Matsuura et al., 1987). Activation of Ito occurs early in the cardiac action potential as Na+ 
channels are inactivated and contributes to the action potential notch (Figure 1.1). IK currents 
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activate early in the cardiac action potential as well, however, K+ conductance remains 
prominent for the bulk of the action potential duration and provides the majority of the 
repolarizing current (Nerbonne & Kass, 2005). 
 Restoration of diastolic extracellular and intracellular concentrations of Na+ and K+ is 
mediated primarily by the Na+/K+-ATPase (NKA). The NKA transitions between two 
conformations (E1 & E2) and transports Na+ out of the cell and K+ into the cell against a strong 
concentration gradient using energy derived from ATP hydrolysis (Bers et al., 2003). The α 
subunit of the NKA contains one ATP, three Na+ and two K+ binding sites and is modulated by 
several smaller accessory proteins, namely the β subunit and phospholeman (PLM) (Shinoda et 
al., 2009). Based on the stoichiometry of Na+ and K+ transport by the NKA, the NKA also 
contributes to the restoration of sarcolemmal membrane potential. Regulation of NKA activity 
by PLM is analogous to that of SERCA2a regulation by phospholamban (PLN; discussed below). 
PLM appears to modulate NKA activity by decreasing the affinity of NKA for Na+ and K+ 
(Bossuyt et al., 2009; Han et al., 2009). Repolarization of the cardiomyocyte and restoration of 
ion gradients across the sarcolemma permits myocyte relaxation and subsequent depolarizations. 
Cardiomyocyte Relaxation  
In order for relaxation of the cardiomyocyte to occur, the [Ca2+]f must be lowered to ~100 
nM (Lattanzio & Pressman, 1986; Marban et al., 1987). Equally important, the same amount of 
Ca2+ that entered the cell via ICa and amount released from the SR must be extruded to the 
extracellular space or sequestered in the lumen of the SR, respectively. In humans, the relative 
contribution of ICa and SR Ca2+ release to the total rise in [Ca2+]f is approximately 30% and 70%, 
respectively (Bers, 2002). However, in rodents this ratio is shifted in favour of SR Ca2+ release 
and sequestration with ~90% of activating Ca2+ originating from the SR. The primary protein 
 16 
 
responsible for Ca2+ extrusion is the sodium-calcium exchanger (NCX) and the protein 
responsible for pumping Ca2+ into the lumen of the SR is SERCA.   
 The NCX is a unique antiporter, in that it is driven by the concentration gradient of Ca2+ 
and Na+ across the sarcolemma as well as the prevailing membrane potential (Matsuoka & 
Hilgemann, 1992). The NCX is also electrogenic because it transports 3 Na+ for every Ca2+ 
(Bridge & Bassingthwaighte, 1983). Early in the cardiac action potential, subsarcolemmal Na+ 
is high and membrane potential is positive, which drives Na+ extrusion and Ca2+ entry via the 
NCX (reverse mode). Late in the action potential, as repolarization of the ventricular myocyte 
proceeds, the membrane potential is negative and the [Ca2+]f is high, which drives the NCX to 
extrude Ca2+ from the cytosol. During diastole, extracellular Na+ concentration is high, [Ca2+]f 
is low and the membrane potential is negative, which favours Na+ influx and Ca2+ efflux (forward 
mode).  
 SERCA2a is the primary SERCA isoform present in ventricular myocytes and is 
responsible for maintaining low diastolic [Ca2+]f and pumping Ca2+ back into the lumen of the 
SR following systole. Based on the number of Ca2+ and ATP binding sites, the stoichiometry of 
Ca2+ transport via SERCA2a is 2 moles of Ca2+ per mole of ATP hydrolysed (Inesi et al., 1973). 
Activation of SERCA2a can occur directly in a [Ca2+]f dependent manner as Ca2+ interaction 
with binding sites on SERCA2a is a prerequisite for catalytic turnover. Although controversial 
(Odermatt et al., 1996; Rodriguez et al., 2004), SERCA2a may be activated by Ca2+/calmodulin-
dependent protein kinase (CaMKII) phosphorylation at serine 38 (Hawkins et al., 1994; Xu & 
Narayanan, 1999). SERCA2a activity can be augmented by ROS-dependent glutathionylation of 
cysteine 674 (Lancel et al., 2009). Lastly, SERCA2a is regulated by the small integral SR 
membrane protein, phospholamban (PLN). PLN physically interacts with SERCA2a and 
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modulates its activity by lowering the apparent affinity of SERCA2a to Ca2+ (Cantilina et al., 
1993). Acting in unison, NCX and SERCA2a effectively lower [Ca2+]f, which facilitates 
cardiomyocyte relaxation.  
 Enhanced Cardiac Contractility during Exercise 
 During exercise, perfusion of the skeletal muscles must increase several fold in order to 
meet metabolic demand. The heart is finely tuned to match the demand placed upon it during 
exercise by increasing cardiac output. The force-frequency relationship (FFR), frequency-
dependent acceleration of relaxation (FDAR) and the Frank-Starling Law of the heart are 
phenomena intrinsic to the cardiomyocyte that enhance the kinetics and strength of ventricular 
contraction, thus increasing the volume of blood ejected per beat. These phenomena can occur 
independent of β-adrenergic stimulation. A brief outline of the FFR, FDAR and the Frank-
Starling Law is given below. A more in-depth examination of β-adrenergic-induced changes in 
the phosphorylation state of key EC coupling proteins is discussed as these changes can augment 
each of these three phenomena. 
The Force-Frequency Relationship and Frequency-Dependent Acceleration of Relaxation 
 In 1871, Bowditch described the force-frequency relationship, which states that as the 
stimulation frequency of cardiac muscle increases, so too does the strength of contraction 
(Janssen, 2010). It is now recognized that not only does the absolute force of contraction increase 
when stimulation frequency increases, but the rate of contraction and the rate of relaxation 
increase as well (Janssen & Periasamy, 2007). It has been demonstrated that the augmented force 
of contraction observed in the FFR is primarily due to an increase in the Ca2+ transient amplitude 
(Gwathmey et al., 1990; Layland & Kentish, 1999; Miyamoto et al., 1999; Monasky & Janssen, 
2009). The frequency-dependent increase in the Ca2+ transient is due to the temporal effects of 
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increased HR and increased Ca2+ influx via ICa. In a finite period, the cardiomyocyte spends 
more time in the depolarized state, which means that the concentration of Ca2+ entering the 
cardiomyocyte is augmented. Consequently, there is an increased rate of Ca2+ transport into the 
SR lumen via SERCA2a and thus SR Ca2+ load is increased. Greater SR Ca2+ load leads to 
augmented Ca2+ release from the SR, which would result in enhanced force production (Layland 
& Kentish, 1999; Janssen, 2010). Transgenic studies have demonstrated that the FFR was 
blunted in hearts from PLN knockout mice, which implicates PLN as a contributor to the 
augmented SERCA2a activity and thus the FFR (Brittsan et al., 1999; Bluhm et al., 2000). It 
would seem logical that SERCA2a-PLN would also contribute to the FDAR. However, using 
PLN KO mice and CaMKII inhibitors, it was demonstrated that FDAR was not dependent on 
PLN but rather phosphorylation of CaMKII target proteins (DeSantiago et al., 2002; Wu et al., 
2012). CaMKII phosphorylation of sarcomeric proteins, namely, TnI, myosin binding protein-C 
(MyBP-C) and myosin light chain (MLC2) has been demonstrated to enhance the rate of 
relaxation as frequency is increased (Tong et al., 2004; Varian & Janssen, 2007). Interestingly, 
phosphorylation of MyBP-C and TnI enhanced the rate of contraction as well as the rate of 
relaxation, which would support more effective ventricular filling and ejection, given the 
abbreviated cardiac cycle (Tong et al., 2004). Taken together the FFR and FDAR are associated 
with altered SERCA2a-PLN interaction that increase the rate of Ca2+ transport and SR Ca2+ load 
and CaMKII phosphorylation of sarcomeric proteins that augment contraction and relaxation 
kinetics.    
The Frank-Starling Law of the Heart 
 Over a century ago, Otto Frank and Ernest Starling observed that a relationship existed 
between the degree of ventricular filling and the strength of ventricular contraction such that as 
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EDV (i.e. preload) increased so too did the strength of the subsequent heart beat and a greater 
volume of blood was ejected. This is a fundamental property of cardiac muscle and is a result of 
an increase in sarcomere length, which increases the myofilament sensitivity to the [Ca2+]f (de 
Tombe et al., 2010). Early experiments conducted by Fabiato and Fabiato suggested that the 
fraction of Ca2+ released from the SR varied with sarcomere length (Fabiato & Fabiato, 1975b). 
However, this line of evidence has since been disproved using permeabilized fibres (Hibberd & 
Jewell, 1982; Dobesh et al., 2002) and fluorescent dyes sensitive to Ca2+ (Claflin et al., 1998). 
X-ray diffraction experiments demonstrated that an increase in sarcomere length caused a 
decrease in the myofilament lattice spacing, which effectively brings the myosin heads closer to 
actin increasing the probability of strong cross-bridge formation at a given [Ca2+]f (Irving et al., 
2000). Recent experiments using osmotic compression to alter myofilament lattice spacing 
suggests that changes in lattice spacing may not be the primary mechanism responsible for 
myofilament length-dependent activation (Konhilas et al., 2002). Studies that employed 
transgenic mouse models, protein digestion or protein substitution suggest that the cardiac 
isoforms of titin and TnI participate in length-dependent thin filament activation and are critical 
for the classical changes in myofilament Ca2+ sensitivity as a result of increased sarcomere length 
(Cazorla et al., 2001; Konhilas et al., 2003; Tachampa et al., 2007).    
Exercise-Induced Phosphorylation of EC Coupling Proteins 
During exercise NE is released from sympathetic neurons and binds to β1 adrenergic 
receptors on ventricular cardiomyocytes, which activates a cAMP-dependent signalling cascade 
that increases phosphorylation activity of PKA. PKA phosphorylates several EC coupling 
proteins, which results in enhanced lusitropy (relaxation) and inotropy (contractility).  
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Ca2+ Trigger and Ca2+ Release 
 Dihydropyridine receptors are targets of PKA mediated phosphorylation during exercise. 
The use of phospho-specific antibodies suggests that PKA phosphorylates serine 1928 on the α1 
subunit of the DHPR in rat ventricular myocytes (De Jongh et al., 1996; Hulme et al., 2006). 
Phosphorylation of DHPR increases the open probability of the channel, which results in 
enhanced ICa during depolarization (Reuter, 1983; Tsien et al., 1986; Bannister & Ohrtman, 
2009). Therefore, over several beats, more Ca2+ enters the cardiomyocyte and is retained within 
the SR, thus phosphorylation of DHPR is critical to the progressive increase in SR Ca2+ load and 
enhanced inotropy observed during exercise.  
 Sarcoplasmic reticulum Ca2+ release through the RyR is augmented by PKA mediated 
phosphorylation at serine 2809 (Marx et al., 2000; Wehrens et al., 2004). The current 
understanding of the functional effects of serine 2809 phosphorylation of RyR has been well 
documented by Andrew Marks’ group (for review see (Lehnart et al., 2004b)); however, these 
findings are controversial (Kranias & Bers, 2007). The working hypothesis states that in the basal 
state, a small regulatory protein called calstabin is bound to RyR, which stabilizes the tetramer 
and reduces the open probability of the channel. PKA mediated phosphorylation of RyR causes 
calstabin to dissociate from the RyR complex, which destabilizes the complex and increases the 
open probability of the channel. The functional consequence of RyR phosphorylation is an 
increase in the maximal rate of release and faster “turning off” of release (Ginsburg & Bers, 
2004). The importance of exercise-induced phosphorylation of RyR at serine 2808 (PKA target 
in mice) has recently been documented in a study by Shan and colleagues (Shan et al., 2010). 
These authors developed a mouse line that possessed cardiac RyR that could not be 
phosphorylated at serine 2808. In response to ISO, these mice had reduced Ca2+ transients and 
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reduced inotropy as well as impaired exercise tolerance when compared to wild type mice. It 
appears that at least in murine cardiomyocytes, PKA mediated phosphorylation of RyR is 
required for the exercise-induced β-adrenergic response.      
Phosphorylation of Myofibrillar Proteins 
 Phosphorylation of specific myofibrillar proteins can influence force production by 
altering cross-bridge kinetics and/or the sensitivity of the myofilaments to Ca2+. TnI contains 2 
tandem PKA phosphorylation sites at serine 23 and serine 24 (Swiderek et al., 1990). 
Phosphorylation of TnI results in a reduction in the sensitivity of the myofilaments to Ca2+ (Mope 
et al., 1980; Stelzer et al., 2007), which would decrease force on its own; however, the enhanced 
ICa, SR Ca2+ load and SR Ca2+ release offsets the decreased myofibrillar Ca2+ sensitivity during 
β-adrenergic stimulation (Bers, 2002). Transgenic experiments involving substitution of the 
cardiac TnI isoform with the non-phosphorylatable slow-twitch skeletal TnI isoform suggests 
that TnI phosphorylation results in an enhanced rate of relaxation (Kentish et al., 2001). 
Functionally, the effects of TnI phosphorylation would enhance the decline in ventricular tension 
during diastole, which could facilitate ventricular filling.   
 Myosin binding protein C is an ~140 kDa sarcomeric protein that forms transverse fibres 
that connect adjacent thick filaments. MyBP-C binds to both myosin and titin and through this 
interaction is believed to modulate the orientation of myosin heads relative to actin (Colson et 
al., 2010). Phosphorylation of MyBP-C by PKA creates a charge repulsion that drives the myosin 
head away from the thick filament backbone towards actin, thus increasing the probability of 
cross-bridge formation and force generation (Stelzer et al., 2007; Colson et al., 2010). 
Consequently, MyBP-C phosphorylation accelerates the rate of force development (Stelzer et 
al., 2007). Together, phosphorylation of MyBP-C and TnI results in faster rates of contraction 
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and relaxation, respectively, which facilitates ejection during systole and filling during diastole 
when HR is accelerated (Stelzer et al., 2007).  
Ca2+ Removal  
 Phosphorylation of PLN is unique in that it directly increases lusitropy and indirectly 
enhances inotropy (for a comprehensive review see (MacLennan & Kranias, 2003)). As 
previously stated, under resting conditions PLN physically interacts with SERCA2a and lowers 
the apparent affinity of SERCA2a for Ca2+, which reduces SERCA2a activity in the 
physiologically relevant range of 0.1-1.0 µM [Ca2+]f (James et al., 1989; Cantilina et al., 1993). 
Phosphorylation of PLN by PKA at serine 16 causes PLN to dissociate from SERCA2a, thus 
relieving PLN’s inhibitory effect, which increases SERCA2a activity (Lindemann et al., 1983; 
Simmerman et al., 1986; Wegener et al., 1989). The increase in SERCA2a activity results in a 
greater percentage of total [Ca2+]f being sequestered to the SR versus being extruded by the NCX. 
Thus, there is an overall net gain of Ca2+ in the SR, which augments the open probability of RyRs 
and enhances the fraction of Ca2+ released during a subsequent beat. 
 In contrast to the well-defined effects of PLN phosphorylation, there is limited and 
conflicting data regarding β-adrenergic regulation of NCX activity (for a recent review see 
(Zhang & Hancox, 2009)). Studies in mammalian cardiomyocytes have demonstrated that β-
adrenergic mediated activation of PKA significantly increased NCX activity (Perchenet et al., 
2000; Wei et al., 2003). However, Ginsburg and Bers (Ginsburg & Bers, 2005) failed to observe 
any change in NCX activity following ISO treatment in rabbit cardiomyocytes. These conflicting 
reports likely arise due to the complexity of measuring NCX activity and the experimental 
techniques employed. Given the numerous PKA targets associated with EC coupling in the 
mammalian myocardium, it seems plausible that NCX activity may be regulated in some 
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capacity by PKA. The physiological consequence of increased NCX activity due to 
phosphorylation would be an increase in Ca2+ entry early in the cardiac action potential, which 
would amplify the amount of trigger Ca2+. During repolarization, the rate of Ca2+ extrusion 
would be greater if NCX was phosphorylated, which would increase the decay rate of the Ca2+ 
transient and enhance relaxation of the myocyte (Zhang & Hancox, 2009). 
PLM Phosphorylation and NKA Activity 
 NKA activity is dependent on intracellular Na+ and extracellular K+ concentrations. The 
acceleration of heart rate during exercise increases NKA activity due to Na+ accumulation in the 
subsarcolemmal space, which is due to the more frequent opening of Na+ channels in a finite 
period of time (Bers et al., 2003). Activation of the NKA can also be mediated by PKA 
phosphorylation of PLM at serine 68 (Silverman et al., 2005; Cheung et al., 2010). Work by 
Bers’ group using cardiomyocytes isolated from wild type and PLM knock-out mice 
demonstrated that ISO treatment increased PLM phosphorylation in wild type myocytes, which 
enhanced NKA activity by increasing the apparent affinity of NKA to intracellular Na+ without 
effecting the maximal activity of the pump (Despa et al., 2005). Physiologically, an increase in 
NKA activity is important to restore Na+ and K+ gradients because as heart rate increases, the 
number of depolarization events in a finite period of time also increases, which would result in 
an electrochemical imbalance if coordinated augmentation of NKA activity did not occur. 
The cumulative effects of phosphorylation of key EC coupling proteins during exercise 
results in a myocardium that is able to generate more force, at a faster rate and to relax at a faster 
rate. Given the dynamic interplay between the activities of several key EC coupling proteins, a 
deficit in the activity of one or more proteins may contribute to exercise-induced cardiac fatigue.      
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Potential Mechanisms of Exercise-Induced Cardiac Fatigue 
 Despite the evidence of exercise-induced cardiac fatigue in humans and rodents, few 
studies have attempted to examine potential mechanisms that contributed to cardiac fatigue. 
Biochemical analysis of ventricular tissue in humans is problematic logistically; however, two 
studies have examined electrophysiological variables following prolonged exercise to determine 
if altered depolarization-repolarization is associated with exercise-induced cardiac fatigue. A 
study by Whyte and co-workers (2000) monitored 12-lead ECG before and after a half and full 
Ironman® Triathlon. These authors found that there were no significant changes in ST segment 
or T-wave form when compared to pre-race ECG recordings. In a more recent study, 
vectorcardiography was utilized to evaluate ventricular repolarization in seasoned runners (≥55 
yrs) following a 30 km cross-country race (Sahlen et al., 2009). The QT interval normalized to 
heart rate was prolonged immediately after the 30 km race and at 24 hours post-competition. A 
prolonged QT interval is indicative of a delay and/or slowing of ventricular repolarization and 
in pathological circumstances can lead to arrhythmias such as delayed after depolarizations (van 
Noord et al., 2010). Functionally, a slowing of cardiac repolarization would delay ventricular 
relaxation, which may impair ventricular filling during periods when the cardiac cycle is 
shortened (i.e. during exercise). 
  There is substantial evidence that the production of ROS are increased during exercise in 
skeletal muscle and may contribute to the generation of fatigue (Davies et al., 1982; Jackson et 
al., 1985; Diaz et al., 1993; Kobzik et al., 1994). A model of tension versus cellular 
reduction/oxidation (REDOX) state was presented by Reid (2001), which states that in skeletal 
muscle, under basal conditions, small amounts of ROS are constitutively produced and that under 
basal conditions a muscle will generate a given amount of tension (Figure 1.4). An increase in 
exogenous (i.e. in vitro) or endogenous (i.e. during exercise) ROS may act as signalling 
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molecules and modify proteins in a manner that augments force production. During diseased 
states or periods of prolonged exercise, ROS production is exacerbated (i.e. oxidative stress) and 
may have a negative impact on the ability of the muscle to develop tension (Reid, 2001). 
 
 
 
 
 
 
 
 
 
Figure 1.4. A model of the effects of cellular REDOX state on force production. (A) Represents 
the basal or unfatigued state. (B) Application of a reducing agent or antioxidant to an unfatigued 
muscle results in a reduction of force. (C) Exposure to mild levels of ROS augments force 
production. (D) Excessive ROS production or prolonged exposure attenuates force. Adapted 
from (Reid, 2001).  
 
Evidence of increased ROS production and decreased cardiac function following acute 
exercise has recently been demonstrated in the myocardium of rats (Wonders et al., 2007; 
Vitiello et al., 2011; Olah et al., 2015). Indeed, a prolonged bout of swimming in rats has been 
demonstrated to increase dihydroethidium (DHE) fluorescence (a marker of ROS production) in 
cross-sections of LV, which accompanied a significant reduction in ejection fraction (Olah et al., 
2015). Wonders and colleagues (2007) ran rats at 25 m/min and 5% grade for 60 minutes and 
observed a significant reduction in LVDP at 24 and 48 hours post-exercise, which recovered 72 
hours following the acute bout of exercise. Myocardial lipid peroxidation, as indicated by 
 26 
 
malondialdehyde (MDA) and 4-hydroxy-alkenal (4-HAE) content, was increased post-exercise 
and followed a similar recovery time course as that of LVDP. In another study, rats ran for four 
hours at 60-65% of their maximal running speed had a significant reduction in LVDP when 
compared to controls. The exercise-induced cardiac fatigue was associated with a decrease in 
the ratio of reduced glutathione to oxidized glutathione (GSH:GSSG), a marker of oxidative 
stress (Vitiello et al., 2011). These studies suggest a possible role for enhanced ROS production 
and oxidative stress in the development of exercise-induced cardiac fatigue. However, the 
intracellular protein targets of exercise-induced ROS were not examined in these studies. 
Depressed Myocardial and Protein Function in Response to Exogenous ROS 
The isolated perfused heart technique is a powerful model that allows researchers to 
manipulate the constituents of the perfusate and observe the effects on cardiac function in a 
controlled environment. A study by Chen and co-workers (Chen et al., 2002) demonstrated that 
addition of conjugated iron-hydroxyquinoline and 50 μM H2O2 (generates ⋅OH through the 
Fenton reaction) to the cardiac perfusate resulted in an ~50% reduction in LVDP. Following 
ROS exposure the activities of lactate dehydrogenase (LDH) and creatine kinase (CK) in the 
coronary effluent (an indication of sarcolemmal damage to the myocyte) were significantly 
higher when compared to control. In addition, lipid peroxidation was significantly greater in the 
oxidative stress condition compared to control hearts (Chen et al., 2002). These data suggest that 
⋅OH damaged the sarcolemma, which may have contributed to the contractile dysfunction 
following exposure to iron and H2O2. Following exposure of isolated rat hearts to H2O2, there is 
a concentration dependent decrease in LVDP when compared to control hearts (Wang et al., 
1999; Matsumoto et al., 2000). The decrease in LVDP was primarily mediated by a rise in end 
diastolic pressure, which was likely caused by the observed increase in diastolic [Ca2+]f (Wang 
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et al., 1999; Matsumoto et al., 2000). A rise in diastolic [Ca2+]f may be the result of sarcolemmal 
damage, reduced SERCA2a activity, aberrant Ca2+ release or some combination of the three. 
To determine the effects of exogenous ROS on intracellular Ca2+ handling, the use of 
isolated cardiomyocytes loaded with Ca2+ sensitive fluorescent dyes has been readily utilized. 
Incubation of rat cardiomyocytes with 100 μM H2O2 resulted in a significant reduction in 
SERCA2a activity and prolonged rate of Ca2+ removal from the cytosol (Kennedy et al., 2006). 
However, the effects of 100 μM H2O2 on cell contractile function was not assessed in that study. 
In another study, rat cardiomyocytes were incubated with 200 μM H2O2 and significant 
impairments in cell shortening and relaxation were observed (Greensmith et al., 2010). The 
primary mechanism associated with the ROS-induced contractile dysfunction was a reduction in 
SERCA2a activity, which led to a decreased rate of Ca2+ removal, a lower SR Ca2+ load and a 
decrease in the Ca2+ transient amplitude (Greensmith et al., 2010). Similarly, Kuster and co-
workers (Kuster et al., 2010) exposed rat cardiomyocytes to 100 μM H2O2 for 15 minutes and 
observed a reduction in SERCA2a activity, lower Ca2+ transient amplitude and attenuated 
contractile characteristics. These data suggest that ROS-induced contractile dysfunction is 
related in part to decreased SERCA2a activity, which leads to lower SR Ca2+ load and a decrease 
in the Ca2+ transient.    
REDOX Modification of SERCA 
The development of mass spectrometry techniques to detect post-translational 
modifications to proteins has revealed several amino acid residues on SERCA that are sensitive 
to oxidative modification by ROS. The regulation of SERCA2 by REDOX modification appears 
to be biphasic in nature. Activation of SERCA2 is mediated by glutathionylation of a specific 
cysteine residue at position 674 (Adachi et al., 2004; Lancel et al., 2009). A study by Adachi and 
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colleagues (2004) demonstrated that SERCA2b, the SERCA2 splice variant expressed in 
vascular smooth muscle, can be S-glutathiolated at Cys674 by ONOO- (10-50 μM), which 
increased Ca2+ uptake and enhanced relaxation. Importantly, higher concentrations of ONOO- 
(50-250 μM) have been shown to cause irreversible oxidation and inactivation of SERCA2b 
(Grover et al., 2003a; Grover et al., 2003b). A recent study showed an increase in S-
glutathiolated SERCA2a and SERCA2a activity in isolated cardiomyocytes following exposure 
to HNO (Lancel et al., 2009). The importance of the cysteine 674 residue was supported by site 
directed mutagenesis experiments that substituted Cys674 with a serine residue, which prevented 
S-glutathionylation and activation of SERCA2a (Lancel et al., 2009). 
There is ample evidence from in vitro experiments that demonstrate a ROS 
concentration-dependent reduction in SERCA activity (Table 1.1). Indeed, Knyushko and 
colleagues (2005) incubated SR vesicles isolated from rat myocardium with ONOO- and 
measured tyrosine nitration and cysteine oxidation. As the concentration of ONOO- was 
increased, there was a progressive decrease in SERCA2a activity in association with a 
progressive increases in tyrosine nitration and cysteine oxidation. Analysis of tryptic SERCA2a 
fragments using mass spectroscopy revealed two tandem tyrosine residues (Tyr294 & Tyr295) 
that were nitrated by ONOO-. Nitration of these tyrosine residues on SERCA2 have been 
reported in vitro (Knyushko et al., 2005) and in vivo as a result of ageing (Viner et al., 1999; 
Knyushko et al., 2005; Xu et al., 2006) or atherosclerosis (Xu et al., 2006). These tandem tyrosine 
residues are located on the α-helix M4 of SERCA2, which is located at the SR membrane-lumen 
interface (Schoneich & Sharov, 2006). Slight alterations to the orientation of M4 induced by 
nitration may alter SERCA2-Ca2+ interaction or the phosphorylation site (Asp351) of SERCA2, 
which could reduce Ca2+ transport and/or ATPase activity (Schoneich & Sharov, 2006). Equally 
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as important as SERCA2a in the regulation of intracellular Ca2+ is the Ca2+ release channel, 
which is also sensitive to the prevailing REDOX state of the cell. 
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Table 1.1: Effects of ROS on SERCA function. 
 
The table above summarizes the structural and functional effects of incubation of SR samples with several different ROS. Abbreviations: 
human embryonic kidney cells (HEK), sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA), sarcoplasmic reticulum (SR), not assessed 
(N/A), hydrogen peroxide (H2O2), nitric oxide (NO), peroxynitrite (ONOO-), hypochlorus acid (HOCl). 
Isoform Species Tissue Prep ROS Concentration Change in Activity (%) Modification Reference 
SERCA1a; 
SERCA2a Rabbit SR Vesicles 
Fenton 
Reaction N/A ↓60% Protein fragmentation 
Castilho et al., 
1996 
SERCA1a Rabbit SR Vesicles ONOO- 0.1-1.8 mM ↓17-75% Cys oxidation Viner et al., 1996 
SERCA2b HEK-293 cells Microsomes H2O2 30-1000 μM ↓25-75% N/A Grover et al., 1997 
SERCA3 HEK-293 cells Microsomes H2O2 30-1000 μM ↓0-55% N/A Grover et al., 1997 
SERCA1a Rabbit SR Vesicles HOCl 0.1-3 mM ↓35-100% Thiol oxidation Favero et al., 1998 
SERCA2a Rat SR Vesicles ONOO- 50-200 μM ↓5-45% Tyrosine nitration Viner et al., 1999a 
SERCA1a Rabbit SR Vesicles ONOO- 0.1 mM Not stated Oxidation of Cys349 Viner et al., 1999b 
SERCA1a Rabbit SR Vesicles NO 0.1 mM Not stated Cysteine Oxidation Viner et al., 2000 
SERCA2b Pig SR Vesicles ONOO- 25-250 μM ↓10-85% Protein aggregation Grover et al., 2003b 
SERCA2a Rat SR Vesicles FeSO4/EDTA N/A ↓40% Cysteine oxidation, lipid peroxidation Kaplan et al., 2003 
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REDOX Modification of RyR 
The cardiac ryanodine receptor is the focal point of Ca2+ release from the sarcoplasmic 
reticulum. Indeed, a reduction in Ca2+ release would result in a lower Ca2+ transient amplitude, 
which would have a negative impact on force production. Conversely, enhanced Ca2+ release 
from the SR would result in a more forceful contraction. However, if the increased amount of 
Ca2+ released was not sequestered in the SR, but rather extruded from the cell via the NCX, then 
the SR Ca2+ load would decrease. In addition, the total Ca2+ load in the SR can be lowered by 
RyR mediated Ca2+ leak coupled to NCX extrusion of Ca2+ during diastole. Subsequently, the 
reduced SR Ca2+ load would limit the fraction of Ca2+ that could be released during subsequent 
beats and would thus reduce force. It is evident that there is a fine balance between SR Ca2+ 
release, uptake and leak by the SR. 
Ryanodine receptors are sensitive to the REDOX state of the cell. In general, oxidizing 
agents have a stimulatory effect on RyR2 Ca2+ release, whereas reducing agents will inhibit 
RyR2 Ca2+ release (Donoso et al., 2011). Several studies have demonstrated that incubation of 
reconstituted RyR2 in planar lipid bilayers with ROS (i.e. ⋅OH, NO or HNO) increased the open 
probability of the channel, which was likely due to oxidation of sulfhydryl groups since 
incubation with the reducing agent, dithiothreitol (DTT), restored channel competency 
(Stoyanovsky et al., 1997; Anzai et al., 1998; Cheong et al., 2005). An increase in the open 
probability of RyR is associated with increased Ca2+ release (Stoyanovsky et al., 1997; 
Kawakami & Okabe, 1998). Conversely, a study by Zahradnikova and colleagues (1997) found 
that NO decreased the open probability of RyR in a planar lipid bilayer and decreased Ca2+ 
release. Taken together, there is potentially a biphasic effect of ROS on RyR function.  
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Table 1.2: Effects of ROS on RyR function. 
 
The table above summarizes the functional effects of incubation of cardiomyocytes or SR 
samples reconstituted in a planar bilayer with different ROS or NO donors. Abbreviations: not 
assessed (N/A), hydroxyl radical (·OH), nitroxyl (HNO), nitric oxide (NO), hydrogen peroxide 
(H2O2), 4-4’-dithiopyridine (DTDP), open probability (Po).  
Species Tissue Prep ROS Concentration Functional Outcome Reference 
Pig Planar Bilayer ·OH N/A ↑Po Anzai et al., 1998 
Rabbit Planar Bilayer HNO N/A ↑Po; ↑release Cheong et al., 2005 
Rat Cardiomyocyte H2O2 0.1 or 1.0 mM ↑release Suzuki et al., 1998 
Dog Planar Bilayer NO donor N/A ↑Po; ↑release 
Stoyanovsky et al., 
1996 
Rat Cardiomyocyte DTDP 3-100  μM ↓↑ spark frequency Xie & Zhu, 2006 
Dog Planar Bilayer NO donor N/A ↑Po Xu et al., 1998 
Rat  Cardiomyocyte H2O2 50 or 200 μM ↓↑ spark frequency Yan et al., 2008 
Dog Planar Bilayer NO N/A ↓Po; ↓release Zahradnikova et al., 1997 
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The effects of increased oxidant stress on RyR function have been assessed in more intact 
experimental preparations and show similar findings to the aforementioned planar bilayer 
studies. Kawakami & Okabe (1998) isolated heavy SR vesicles from canine LV and incubated 
them with hypoxanthine and xanthine oxidase, a superoxide generating system, and found that 
Ca2+ release was increased. The addition of 0.1 or 1.0 mM H2O2 to the media of isolated 
cardiomyocytes augmented Ca2+-induced Ca2+ release (Suzuki et al., 1998). These studies 
indicate that incubation with oxidants may activate the Ca2+ release channel. However, it appears 
that RyR may respond transiently to ROS in a concentration- and time-dependent manner, where 
low concentrations of ROS or a brief incubation period results in channel activation and 
prolonged exposure or higher ROS concentrations results in inactivation of the channel (Xie & 
Zhu, 2006; Yan et al., 2008). 
A shift in the cellular environment to a more oxidative state may result in enhanced leak 
of Ca2+ through RyRs. Several cardiac injury or pathological models have demonstrated that 
oxidative stress associated with these models resulted in an increased rate of Ca2+ leak from the 
SR. In rat and canine models of heart failure the rate of SR Ca2+ leak was elevated in the failing 
cardiomyocyte, which resulted in a decrease in the SR luminal Ca2+ concentration (Terentyev et 
al., 2008; Gonzalez et al., 2010). It was hypothesized that a reduction in the concentration of 
Ca2+ in the SR would result in a lower Ca2+ transient amplitude and thus force, which likely 
contributed to the decline in cardiac performance observed in heart failure (Terentyev et al., 
2008). A hallmark of heart failure is augmented adrenergic output, which attempts to enhance 
contractile function in the short term, but chronically contributes to the progression of the disease 
(Rundqvist et al., 1997). A study by Bovo and co-workers (2012) incubated isolated rabbit 
cardiomyocytes with ISO and observed that following an initial increase in SR Ca2+ 
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concentration, that there was a progressive decline in SR Ca2+ load that was due to Ca2+ leakage 
from the SR. Lastly, the rate of Ca2+ leak from the SR was exacerbated in cardiomyocytes from 
aged rabbits when compared to young rabbit cardiomyocytes (Cooper et al., 2013). A common 
feature of these Ca2+ leak studies was that ROS production was elevated in the chronic disease 
animals when compared to control animals (Terentyev et al., 2008; Gonzalez et al., 2010; Bovo 
et al., 2012; Cooper et al., 2013). In addition, if the oxidative cellular environment was restored 
to control levels then Ca2+ leak rates were also reversed, which suggests that the modification to 
RyR is reversible.   
Previous studies have demonstrated that altered RyR function can be normalized or 
partially normalized following incubation with a reducing agent. This suggests that modification 
to sulfhydryl groups on RyR contribute to ROS-induced changes in function. Indeed, in vitro 
(Anzai et al., 1998; Cheong et al., 2005) and isolated cardiomyocyte experiments (Suzuki et al., 
1998; Terentyev et al., 2008) have demonstrated that the stimulatory or inhibitory effects of 
exogenous ROS are prevented in the presence of reducing agents. Work by Sanchez and co-
workers (2005), used tachycardia as a preconditioning stimulus to evaluate changes in REDOX 
state as well as RyR function. In SR fractions from the preconditioned group there was an 
elevated rate of Ca2+ release, which coincided with a 1.7-fold increase in RyR S-
glutathionylation (Sanchez et al., 2005). In a follow up study, dogs ran on a treadmill at 6 km/h 
for a total of 25 min using a 5 min on, 5 min off pattern and SR vesicles were isolated from 
myocardium for in vitro analysis of RyR function and post-translational modification (Sanchez 
et al., 2008). Similar to previous findings by this group, exercise augmented S-glutathionylation 
of RyR and SR Ca2+ release. When dogs were administered the NOX inhibitor, APO, prior to 
exercise, there were no significant differences between the control and exercise groups in terms 
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of NOX activity, RyR S-glutathionylation content and Ca2+ release kinetics. These findings 
suggest that mild exercise activates NOX in canine myocardium, which, in the presence of 
glutathione, can augment S-glutathionylation of RyR and increase RyR activity. The effect of 
exhaustive exercise on RyR activity and NOX derived ROS in the rat myocardium has not been 
addressed to date. Furthermore, the effect of exhaustive exercise on RyR structure and function 
is not known 
NADPH Oxidase Derived ROS, and Post-Translational Modification of RyR 
NADPH Oxidases (NOXs) are a family of multi-subunit enzyme complexes that catalyze 
the transfer of an electron from NADPH to O2 and generate superoxide anion (O2-·). In adult 
ventricular cardiomyocytes the primary isoforms expressed are NOX2 and NOX4 (Byrne et al., 
2003; Krijnen et al., 2003). The complete complex is comprised of the membrane bound NOX, 
which is stabilized by the p22phox subunit. Activation of the NOX enzyme occurs following 
translocation and docking of the cytosolic regulatory proteins p40phox, p47phox, p67phox and rac 
(Bedard & Krause, 2007). APO is a NOX inhibitor that acts by preventing the docking of the 
cytosolic regulatory proteins to the NOX complex (Stefanska & Pawliczak, 2008). APO has been 
widely used in in vivo and in vitro experiments that involved skeletal and cardiac muscle 
(Sanchez et al., 2005; Sanchez et al., 2008; Sun et al., 2011; Vitiello et al., 2011). Recent 
evidence suggests that the RyR in skeletal muscle (RyR1) is regulated by NOX4, whereby NOX4 
derived ROS oxidized cysteine residues on RyR1, which led to enhanced Ca2+ release and 
augmented force production (Sun et al., 2011). In canine myocardium, NOX-dependent ROS 
caused S-glutathionylation and activation of RyR2 following pacing-induced tachycardia and 
exercise (Sanchez et al., 2005; Sanchez et al., 2008). In a recent transgenic study, it was 
demonstrated that cardiac specific overexpression of rac1 (a NOX regulatory protein) was 
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associated with an increased rate of SR Ca2+ leak, reduced Ca2+ transient amplitude and lower 
cell shortening in mouse cardiomyocytes (Oberhofer et al., 2013). These studies suggest that 
modest activation of NOX can augment RyR activity and that chronic activation of NOX can 
have deleterious effects on RyR and cardiomyocyte function. 
Exercise-Induced Cardiac Fatigue and NOX Inhibition 
 There is evidence that suggests oxidative stress may play a role in exercise-induced 
cardiac fatigue (Wonders et al., 2007; Vitiello et al., 2011; Olah et al., 2015). However, only one 
study has employed an intervention aimed to prevent oxidative stress and preserve cardiac 
function following prolonged exercise. Vitiello and colleagues (2011) ran rats for four hours and 
observed a significant reduction in cardiac function when assessed in vivo and ex vivo. A key 
finding in this study was that there was no LV fatigue in the hearts of rats that consumed drinking 
water supplemented with APO for three days prior to the exercise bout. The authors concluded 
that NOX inhibition prevented oxidative stress and preserved cardiac function. Unfortunately, 
the intracellular targets of NOX derived superoxide were not examined in the study by Vitiello 
and co-workers (2011). It is possible that exercise-induced NOX mediated oxidative 
modification of proteins are associated with cardiac fatigue. However, no study has concurrently 
examined the relationship between exercise-induced cardiac fatigue and changes in protein 
structure and function. In addition, no study has attempted to determine the mechanisms by 
which NOX inhibition can prevent cardiac fatigue.          
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Thesis Objective 
 The objectives of this thesis were: 1) to determine if exhaustive exercise could induce 
cardiac fatigue in the rat heart; 2) to determine if exhaustive exercise reduced β-adrenergic 
responsiveness of the LV; 3) to determine if reactive oxygen species produced during exhaustive 
exercise reduced the activities of the Na+/K+-ATPase, the Ca2+-ATPase and the Ca2+ release 
channel; and 4) to determine if NADPH oxidase inhibition could prevent exercise-induced 
cardiac fatigue and restore SR Ca2+ leak and calpain activity.  
Study 1: 
The purpose of Study 1 was to determine if:  
1) Cardiac fatigue can be induced using an exhaustive treadmill exercise protocol; 
2) Cardiac function would remain depressed following a 24 hour recovery period; 
3) Exhaustive exercise reduced left ventricular β-adrenergic responsiveness.    
Study 1 Hypotheses: 
1) Exhaustive exercise will result in a significant reduction in LVDP immediately following 
the exercise bout and 24 hour post-exercise; 
2) The left ventricular β-adrenergic response to ISO will be lower following exercise.   
Study 2: 
The purpose of Study 2 was to determine if:  
1) Exhaustive exercise resulted in an increase in ROS production; 
2) Exhaustive exercise impaired the Na+/K+-ATPase activity; 
3) Exhaustive exercise attenuated Ca2+-ATPase activity and RyR gating; 
4) Impaired protein function (above) was due to post-translational oxidative modification; 
5) Reduced Na+ and Ca2+ regulation would activate calpains.   
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Study 2 Hypotheses: 
1) ROS production will be increased immediately following acute, exhaustive exercise; 
2) The maximal rate of Na+/K+-ATPase activity will be reduced immediately post-exercise; 
3) There will be a decrease in Ca2+-ATPase activity and an increase in Ca2+ leak through RyR 
following exhaustive exercise; 
4) There will be an increase in markers of oxidative damage on  the Na+/K+-ATPase, Ca2+-
ATPase and RyR; 
5) Impaired Na+ and Ca+ regulation will result in activation of calpains. 
Study 3: 
The purpose of Study 3 was to determine if: 
1) Inhibition of NADPH oxidase will prevent exercise-induced cardiac fatigue; 
2) Inhibition of NOX would reduce the production of ROS immediately following exhaustive 
exercise; 
3) SR Ca2+ leak will be reduced following exhaustive exercise when NOX is inhibited; 
4) Calpain activation is prevented when NOX is inhibited; 
5) In vitro activation of NOX will increase ROS production and SR Ca2+ leak. 
Study 3 Hypotheses: 
1) Consumption of apocynin and inhibition of NOX will prevent exercise-induced cardiac 
fatigue; 
2) ROS production will be blunted following exhaustive exercise when NOX is inhibited; 
3) SR Ca2+ leak will not be affected by exhaustive exercise when NOX is inhibited; 
4) Calpain activation will not occur following exhaustive exercise in the presence of NOX 
inhibition; 
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5) Activation of NOX in vitro will increase ROS production and SR Ca2+ leak, which will be 
prevented in the presence of apocynin. 
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Chapter II: Cardiac fatigue is present in the basal state and during β-adrenergic 
stimulation in rats following exhaustive exercise 
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Synopsis 
 In humans, prolonged or exhaustive exercise has been shown to result in cardiac fatigue 
and is associated with a reduction in the myocardium’s ability to respond to β-adrenergic 
stimulation. The purpose of this study was to develop an exhaustive treadmill running protocol 
to induce cardiac fatigue in the rat myocardium and to determine if exhaustive exercise reduced 
the myocardial response to β-adrenergic stimulation. Male Sprague-Dawley rats (21-23 weeks) 
were randomly assigned to a CTL group or one of two exercise groups that ran at 20 m/min and 
5% grade until exhaustion and were either sacrificed immediately (AC) or were allowed to 
recover for 24 hours (24H). The hearts were excised and perfused in a retrograde fashion at a 
constant perfusion pressure (~80 mmHg). In the basal state and during adrenergic stimulation, 
there was a significant reduction (p<0.05) in the LVDP of hearts from the AC and 24H groups 
when compared to CTL hearts. Compared to the CTL, there was a trend (p=0.076) for a reduction 
in the –dP/dt in the AC and 24H groups in the basal state. Similarly, the –dP/dt was reduced 
(p<0.05) in the AC group during β-adrenergic stimulation. There were no significant differences 
(p>0.05) in the +dP/dt in the basal state or during β-adrenergic stimulation. The depression in 
LVDP and contractile kinetics were not due to changes in heart rate, coronary vascular resistance 
or coronary flow (p>0.05). This study demonstrated that exhaustive exercise reduced the LVDP 
of the rat myocardium immediately post-exercise and that this depression in LV function 
persisted for up to 24 hours. The β-adrenergic stimulation findings suggest that, potentially, the 
ability of the heart to respond to a subsequent bout of exercise would be impaired, which is 
indicative of cardiac fatigue.   
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Introduction 
 There is a growing body of evidence that suggests that some individuals who partake in 
prolonged endurance competitions experience a decline in cardiac function following the event 
(Douglas et al., 1987; Douglas et al., 1998; Whyte et al., 2000; Shave et al., 2004; George et al., 
2009). Indeed, following a 24 hour endurance race, the ratio of systolic blood pressure to end 
systolic dimension was significantly reduced, which is suggestive of a reduced contractile state 
(Niemela et al., 1984). A study by Douglas and colleagues (1987) observed that for a given 
afterload, the LV fractional shortening was impaired following an Ironman® triathlon. In both of 
these studies the indices of LV systolic function partially or fully recovered within 1-3 days post-
exercise. Given the transient nature of the depressed cardiac function, these studies described 
their findings as “cardiac fatigue” (Niemela et al., 1984; Douglas et al., 1987). Numerous studies 
have documented a reduction in diastolic function and preserved systolic function following a 
relatively shorter distanced marathon (George et al., 2005; George et al., 2004; Hart et al., 2007; 
Neilan et al., 2006). Thus, there appears to be an interaction between event duration and/or 
intensity and the degree of diastolic and systolic fatigue.  
Evidence of exercise-induced cardiac fatigue has been observed in several models of 
prolonged aerobic exercise using rats. In one treadmill study where rats exercised on five 
sequential days and culminated in a final bout to exhaustion, the tetanic force produced in 
trabecular muscles excised from the LV of animals that ran to exhaustion was reduced by ~50% 
when compared to control trabeculae (Maher et al., 1972). More recent studies have 
demonstrated that prolonged swimming (from 3-8 hours) reduced EF and LVDP by 26% and 
30-40%, respectively (Venditti et al., 2001; Olah et al., 2015). Vitiello and co-workers (2011) 
assessed in vivo and ex vivo LVDP in rats following four hours of submaximal treadmill running 
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and noted a ~10 and 20% reduction in LVDP, respectively. Even as little as one hour of treadmill 
running at 25 m/min has been shown to significantly reduce LVDP for up to 48 hours post-
exercise (Wonders et al., 2007). Conversely, Seward and colleagues (1995) failed to observe 
cardiac fatigue in rats following exhaustive treadmill running. In addition, cardiac performance 
in instrumented dogs was not different at the point of exhaustion when compared to five minutes 
into the exercise bout (Grimditch et al., 1981). Thus, prolonged or exhaustive exercise in rodents 
has been shown to induce cardiac fatigue, yet little research has been done using this model to 
investigate the mechanisms associated with cardiac fatigue.  
Research using humans and animals has examined the effects of prolonged and/or 
exhaustive exercise on the chronotropic and inotropic response of the myocardium to β-
adrenergic stimulation. In humans, the chronotropic response to β-adrenergic stimulation is 
reduced following prolonged exercise (Banks et al., 2010), which seems to be more pronounced 
in males compared to females (Scott et al., 2007) and is associated with impaired systolic 
function as opposed to diastolic function (Hart et al., 2006; Welsh et al., 2005). In canines, there 
is a reduction in the chronotropic response to ISO infusion following one hour of running at 60-
80% of maximal heart rate (Friedman et al., 1987). However, changes in the inotropic response 
to ISO infusion were not examined in that study. The inotropic effect of exogenous NE was 
blunted in isolated trabeculae from rats that ran to exhaustion when compared to trabeculae from 
sedentary control hearts (Maher et al., 1972). Conversely, Vitiello and colleagues (2011) found 
no change in the inotropic response to ISO in the isolated perfused rat heart following four hours 
of submaximal running. A reduction in the chronotropic response to β-adrenergic stimulation 
could compromise the contractility of the heart based on the force frequency relationship. If 
reduced chronotropy was coupled with an attenuation of the inotropic effects of β-adrenergic 
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stimulation then in vivo LV ejection would likely be depressed. Thus, exercise-induced 
desensitization to β-adrenergic stimulation represents a form of cardiac fatigue such that the 
heart may not be able to cope with the demands placed upon it by a subsequent bout of exercise.  
In this study, the effect of exhaustive aerobic exercise on LV function was investigated 
ex vivo using the isolated perfused rat heart. It was hypothesized that exhaustive exercise would 
result in left ventricular fatigue and that this fatigue would be present in the basal state and persist 
during β-adrenergic stimulation. It was imperative to establish an exercise protocol that induced 
cardiac fatigue so that subsequent studies in this thesis could utilize this exercise protocol to 
determine the mechanisms associated with cardiac fatigue. 
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Methods 
Animals 
 Adult male Sprague-Dawley rats (21-23 weeks) were used in this study. The 
anthropometric data from these animals is presented in Table 2.1. All animals were obtained 
from the breeding colony at the University of Waterloo. Animals were group housed (4 per cage) 
on a reverse 12 hour light cycle and had free access to food and water. All procedures were 
reviewed and approved by the University of Waterloo Animal Care Committee. 
 
Experimental Design  
There were three groups in this study; a control group (CTL), an acute exercise group 
(AC) whereby animals were sacrificed immediately following exhaustive exercise (see protocol 
below) and a group of animals that were sacrificed 24 hours after exhaustive exercise (24H). 
Animals in all three groups were acclimated to treadmill running for seven days leading up to 
the exhaustive exercise bout. For a detailed description of the acclimation protocol refer to 
Appendix A.  
 The exhaustive exercise bout consisted of a 10 minute warm-up on a motorized rat 
treadmill (Columbus Instruments) set at 5° grade and 10 m/min. Subsequently, the speed was 
Table 2.1: Anthropometric data from animals used in isolated perfused heart experiments
Masses p value
Body Mass (g) 459 ± 6 436 ± 9 447 ± 10 0.16
Heart Mass (g) 1.81 ± 0.04 1.77 ± 0.06 1.83 ± 0.05 0.77
Left Ventricle Mass (g) 1.17 ± 0.02 1.13 ± 0.03 1.17 ± 0.03 0.50
Left Ventricle/Body Mass 0.00255 ± 0.00006 0.00258 ± 0.00007 0.00261 ± 0.00005 0.75
The body mass, heart mass, left ventricle mass and the ratio of left ventricle to body mass data are listed for
the control group (CTL), the group sacrificed immediately after exercise (AC) and the group sacrificed 24
hours-post exercise (24H). Data are presented as means ± SE.
CTL (n=12) AC (n=8) 24H (n=8)
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ramped to 20 m/min and the rats ran until exhaustion, which was deemed to occur when the rats 
could no longer maintain the pace of the treadmill and were in prolonged contact with the 
electrical grid. Upon exhaustion animals were either immediately anaesthetized (35 mg/kg 
sodium pentobarbital; intravenous) for isolated perfused heart experiments or they were returned 
to their cages and allowed to recover for 24 hours. During the exhaustive exercise bouts, animals 
in the CTL group remained in their cages and were anaesthetized just prior to excision of their 
hearts. 
Isolated Perfused Heart  
 The chest cavity of anaesthetized animals was exposed, thus permitting the removal of 
the pericardium and thymus and rapid excision of the heart. Cardioplegia was achieved by 
placing the heart in ice cold Krebs-Henseleit buffer which contained (in mM): 118 NaCl, 4.7 
KCl, 1.2 MgSO4·7H2O, 24 NaHCO3, 1.1 KH2PO4, 1.25 CaCl2·2H2O and 10 glucose, pH 7.4. 
Hearts were mounted on an aortic cannula, secured via 4.0 silk sutures and perfused at a constant 
pressure (~80 mmHg) with Krebs-Henseleit buffer warmed to 37°C and bubbled with 95%O2-
5%CO2. The pressure head was achieved by raising the bubble trap ~1 m (based on 1 cm H2O ≈ 
0.735 mmHg) above the tip of the aortic cannula (Figure 2.1). To measure perfusion pressure, a 
pressure transducer (MLT844, AD Instruments) was connected to the system proximal to the 
aortic cannula. A similar pressure transducer was connected to a balloon tipped catheter and was 
used to measure indices of LV function. The balloon was fed through the left atrium into the left 
ventricle and the volume of the balloon was adjusted to provide a diastolic pressure of ~10 
mmHg. An ultrasonic flow probe (2PXL, Transonic Systems) was placed proximal to the aortic 
cannula, which measured global coronary flow. Following instrumentation, hearts were allowed 
to equilibrate for 30 minutes at which point baseline data were recorded. Subsequently, an ISO 
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dose response was performed using a range of ISO concentrations from 10-11 to 10-7 M. Each 
dose was infused for 2 minutes at a rate equivalent to 1% of the coronary flow using a syringe 
pump (Model 74900, Cole Parmer). Following each dose of ISO the LVDP was allowed to return 
to baseline before the subsequent dose. All data were collected using a Powerlab data acquisition 
system (4/sp, AD Instruments) and were analyzed using Chart software (Ver. 5, AD 
Instruments). After the perfusion experiments were completed, the aorta and any remaining fat 
and connective tissue were removed and the heart was weighed. Subsequently, the atria and right 
ventricle were removed and the left ventricle (plus septum) were weighed. 
Statistics 
 All data are presented as means ± standard error. A one-way ANOVA was used to 
analyze basal measures from isolated perfused hearts. A two-way ANOVA (group x ISO 
concentration) was used to analyze the ISO dose response data. To investigate relationships 
between variables, linear regression analysis was performed using GraphPad Prism 4 software. 
The significance level was set at 0.05, and, when appropriate, a Newman-Keuls post-hoc test 
was used to compare specific means. A trend in the data was considered when the probability 
was between 0.05 and 0.1. 
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Figure 2.1. A schematic of the constant perfusion pressure setup used to assess cardiac function. 
(1) Kreb’s Henseleit buffer was aerated with 95/5% O2/CO2 and (2) warmed to 37°C in a water-
jacketed reservoir. (3) The perfusate was pumped at a high rate to the bubble trap (4), which was 
raised approximately 1 m above the heart such that perfusion pressure was ~80 mmHg. Excess 
perfusate from the bubble trap was returned to the reservoir for re-oxygenation. (5) The hearts 
were mounted to a glass cannula and the left ventricle was instrumented with a pressure 
transducer.    
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Results 
Anthropometric Data and Run Times 
 The anthropometric data of the three groups in this study are presented in Table 2.1. As 
expected, there were no significant differences (p>0.05) between the three groups with respect 
to body mass, heart mass, left ventricle mass and the ratio of left ventricle mass to body mass. 
The animals in the AC group and 24H group ran for durations of 69 ± 3 minutes and 72 ± 5 
minutes, respectively, which did not differ significantly (p>0.05) from each other. 
Basal Cardiac Function and Hemodynamics 
 To examine the effect of acute, exhaustive exercise on cardiac and hemodynamic 
function in the basal state, the isolated perfused heart technique was utilized. Table 2.2 
summarizes the basal cardiac and hemodynamic data. Exhaustive exercise resulted in a 12% 
reduction (p<0.05) in LVDP in the AC group when compared to the CTL group. This cardiac 
impairment persisted for up to 24 hours post-exercise as LVDP was 14% lower (p<0.05) in the 
24H group than the CTL group. There were no significant differences (p>0.05) observed in 
+dP/dt or the time to peak pressure between the three groups. However, there was a trend 
(p=0.076) for a reduction in the –dP/dt in the AC and 24H groups when compared to the CTL 
group.  It is important to note that the impairments in LVDP observed in the AC and 24H groups 
occurred in the absence of any changes in heart rate.  
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This study utilized a constant perfusion pressure setup during isolated perfused heart 
experiments, such that the flow could increase when ATP demand of the heart increased during 
ISO infusion. The perfusion pressure was equal to ~80 mmHg among all three groups (Table 
2.2). Acute exercise did not alter resting levels of global coronary flow nor did exercise alter 
coronary vascular resistance (CVR) when compared to the CTL group (p>0.05) (Table 2.2). 
These data suggest that acute exercise did not alter vascular function in the isolated perfused 
heart model. 
  
Table 2.2: Basal cardiac and hemodynamic measures from isolated perfused heart experiments
Cardiovascular Measure p value
LVDP (mmHg) 133 ± 4 117 ± 7* 114 ± 5* 0.02
+dP/dt (mmHg/s) 4547 ± 326 3747 ± 354 3995 ± 179 0.32
-dP/dt (mmHg/s) -2695 ± 102 -2361 ± 139 -2374 ± 103 0.08
Heart Rate (bpm) 270 ± 8 262 ± 12 281 ± 7 0.53
LVeDP (mmHg) 10.08 ± 1.74 9.83 ± 1.69 10.59 ± 2.18 0.98
Time-to-peak Pressure (ms) 66.8 ± 1.7 66.1 ± 1.4 63.1 ± 1.6 0.24
Perfusion Pressure (mmHg) 80.71 ± 0.38 81.45 ± 0.48 80.80 ± 0.52 0.49
Coronary Flow (mL/min) 21.85 ± 2.25 20.82 ± 1.35 18.04 ± 1.29 0.36
Coronary Vascular Resistance 4.06 ± 0.33 4.04 ± 0.30 4.67 ± 0.39 0.43
(mmHg/mL/min)
Cardiac and hemodynamic summary data recorded in the basal state. Abbreviations: Left ventricular developed pressure
(LVDP); left ventricular end diastolic pressure (LVeDP); maximal rate of pressure development and pressure decline 
(±dP/dt). The number of animals in each group is indicated beside the group label. Data are presented as means ± SE.
There was a trend (p=0.076) for a reduction in -dP/dt in the AC and 24H groups.
* Significantly different (p<0.05) CTL
CTL (n=12) AC (n=8) 24H (n=8)
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Figure 2.2. Isoproterenol dose response curves from the control group (CTL, solid squares), 
acute exercise group (AC, solid circles) and 24 hour post-exercise group (24H, solid triangles). 
The inset indicates the concentration required to increase LVDP by 50% (EC50). Values are 
means ± SE (CTL n=12; AC & 24H n=8). Main effect of exercise (p<0.05), with CTL > AC & 
24H. Main effect of isoproterenol dose (p<0.05). 
 
Cardiac and Hemodynamic Responses to Isoproterenol 
There are conflicting reports regarding the effects of prolonged aerobic exercise and 
desensitization of cardiac β-adrenergic receptors. To examine the exercise-induced changes in 
the chronotropic and inotropic response to β-adrenergic stimulation, an ISO dose response was 
performed. As can be seen in Figure 2.2, the reduced LVDP in the AC and 24H groups observed 
in the basal state (i.e. absence of ISO) persisted throughout the entire ISO dose response. 
Accordingly, there was a main effect of exercise such that the AC and 24H groups response to 
ISO were lower (p<0.05) than the CTL group. There were no significant differences (p>0.05) in 
the concentration required to increase LVDP by 50% (EC50) in either exercise group when 
compared to the CTL group (Figure 2.2 inset). Table 2.3 summarizes the cardiac and 
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hemodynamic effects of the ISO dose response. There were main effects of ISO for each variable 
examined. The heart rate increased progressively throughout the ISO dose response but did not 
differ among the CTL, AC and 24H groups (p>0.05). Importantly, the coronary flow was not 
different between the three groups in the basal state and increased (p<0.05) to the same extent in 
each group during the ISO dose response (peaked at 10-8.3 M). Accordingly, the increase in 
coronary flow resulted from a decrease (p<0.05) in the resistance across the coronary 
vasculature, which also plateaued at an ISO concentration of 10-8.3 M. The +dP/dt increased 
(p<0.05) to similar extents in all three groups during ISO infusion. Progressively increasing the 
concentration of ISO in the perfusate resulted in faster (p<0.05) –dP/dt in all groups. However, 
there was a significant main effect of exercise on the –dP/dt, whereby the AC group relaxed at a 
slower rate (p<0.05) when compared to the CTL and 24H groups during ISO infusion (Table 
2.3).          
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Table 2.3: Cardiac and hemodynamic responses to isoproterenol
Negative log M Isoproterenol Dosage
LVDP (mmHg)
CTL 130 ± 5 129 ± 5 141 ± 5 164 ± 5 211 ± 8 237 ± 9 249 ± 8 276 ± 11 267 ± 11 265 ± 8 0.047
AC 117 ± 8 118 ± 8 127 ± 9 144 ± 11 178 ± 13 206 ± 16 217 ± 17 235 ± 19 242 ± 21 222 ± 18
24H 112 ± 5 112 ± 6 124 ± 5 142 ± 5 178 ± 9 214 ± 14 217 ± 16 240 ± 20 232 ± 20 214 ± 21
+dP/dt (mmHg/s)
CTL 4429 ± 343 4467 ± 352 5038 ± 415 5759 ± 450 7327 ± 607 8610 ± 682 9151 ± 660 11546 ± 742 11666 ± 886 11551 ± 731 0.14
AC 3827 ± 383 3873 ± 397 4355 ± 496 4861 ± 577 5830 ± 712 6928 ± 966 7507 ± 1055 8387 ± 1073 9393 ± 1413 8844 ± 1339
24H 3965 ± 197 4021 ± 232 4519 ± 284 5037 ± 318 6130 ± 513 7585 ± 731 7844 ± 802 9535 ± 1173 9946 ± 1098 9144 ± 1305
-dP/dt (mmHg/s)
CTL -2604 ± 114 -2604 ± 122 -2898 ± 139 -3487 ± 145 -4639 ± 262 -5329 ± 294 -5544 ± 359 -6455 ± 344 -6211 ± 289 -6074 ± 214 0.048
AC -2396 ± 164 -2395 ± 165 -2593 ± 186 -2970 ± 228 -3654 ± 300 -4259 ± 375 -4605 ± 432 -4734 ± 373 -4974 ± 480 -4740 ± 487
24H -2313 ± 117 -2332 ± 132 -2659 ± 135 -3162 ± 154 -4267 ± 260 -5183 ± 406 -5288 ± 481 -5718 ± 545 -5389 ± 470 -5218 ± 503
HR (bpm)
CTL 268 ± 8 271 ± 8 283 ± 7 289 ± 7 299 ± 7 316 ± 7 321 ± 8 337 ± 7 349 ± 8 355 ± 6 0.35
AC 262 ± 11 262 ± 11 275 ± 12 287 ± 12 299 ± 12 308 ± 11 320 ± 9 327 ± 10 338 ± 12 353 ± 8
24H 277 ± 7 278 ± 7 285 ± 7 293 ± 7 315 ± 7 321 ± 7 332 ± 10 348 ± 11 364 ± 15 380 ± 14
Coronary Flow (mL/min)
CTL 21.8 ± 2.5 21.8 ± 2.6 23.0 ± 2.5 24.5 ± 2.5 27.7 ± 2.5 29.8 ± 2.3 29.7 ± 2.3 29.7 ± 2.3 28.2 ± 2.0 29.6 ± 2.7 0.73
AC 19.8 ± 1.2 19.5 ± 1.3 20.3 ± 1.3 21.4 ± 1.4 24.6 ± 1.2 24.7 ± 1.2 25.8 ± 1.3 25.6 ± 1.3 26.1 ± 1.5 27.1 ± 1.6
24H 18.0 ± 1.4 18.1 ± 1.4 19.2 ± 1.5 20.6 ± 1.7 24.8 ± 2.7 25.2 ± 2.7 25.8 ± 2.5 26.0 ± 2.4 26.0 ± 2.5 26.6 ± 2.4
Coronary Vascular Resistance (mmHg/mL/min)
CTL 4.11 ± 0.34 4.16 ± 0.36 3.85 ± 0.31 3.56 ± 0.28 3.10 ± 0.27 2.79 ± 0.21 2.81 ± 0.23 2.80 ± 0.22 2.92 ± 0.23 2.85 ± 0.23 0.71
AC 4.25 ± 0.27 4.33 ± 0.29 4.15 ± 0.28 3.91 ± 0.25 3.31 ± 0.17 3.31 ± 0.18 3.17 ± 0.19 3.19 ± 0.18 3.14 ± 0.21 3.03 ± 0.22
24H 4.71 ± 0.41 4.69 ± 0.44 4.42 ± 0.42 4.13 ± 0.44 3.53 ± 0.49 3.45 ± 0.46 3.30 ± 0.39 3.21 ± 0.33 3.25 ± 0.37 3.13 ± 0.33
Summary of cardiac and hemodynamic response to progressive dosages of isoproterenol. Each negative log molar concentration of isoproterenol is indicated in the first row. The cardiac and hemodynamic variables are indicated in the 
first column. Abbreviations: left ventricular developed pressure (LVDP); rate of pressure development (+dP/dt); rate of pressure decline (-dP/dt); heart rate (HR). The p value corresponds with the main effect of exercise
There was a main effect of exercise for LVDP: CTL > AC, 24H.
There was a main effect of exercise for -dP/dt: AC < CTL, 24H.
There was a main effect of isoproterenol for all variables.
Data are presented as mean ± SE (AC & 24H n=8; CTL n=12).
p value-11 -8.6 -7-7.3-10 -9.5 -9 -8.3 -8 -7.6
 54 
 
Relationships between Cardiac Variables 
 To explore relationships between cardiac, exercise and anthropometric variables in this 
study, linear regression analysis was used. There was no significant relationship between run 
time to exhaustion and body mass (Figure 2.3C). In addition, linear regression analysis of LVDP 
and heart rate revealed that there was not a significant relationship between these two variables 
(Figure 2.3A). Interestingly, there was a significant, positive relationship between LVDP and 
run time to exhaustion, such that hearts from animals that ran longer had a higher LVDP (Figure 
2.3B). 
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Figure 2.3. Linear regression analysis of cardiac, exercise and anthropometric data. Examination 
of the relationship between (A) left ventricular developed pressure (LVDP) and heart rate; (B) 
LVDP and run time and (C) run time and body mass. The strength of each relationship and 
probability values are indicated within each panel. 
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Discussion 
 It is well established that various types of prolonged aerobic exercise in humans can lead 
to a transient decline in cardiac function (Shave et al., 2008). However, there is minimal and 
conflicting evidence regarding the effect of exhaustive exercise on the cardiac function of rats 
and the intracellular mechanisms associated with cardiac fatigue. The aim of this study was to 
develop a model of cardiac fatigue for the subsequent examination of potential intracellular 
mechanisms associated with cardiac fatigue. A secondary aim was to determine if exhaustive 
exercise impaired the ability of the myocardium to respond to β-adrenergic stimulation. To assess 
cardiac performance, the isolated perfused heart technique was employed, which permitted the 
measurement of LVDP, contraction/relaxation kinetics and whole heart hemodynamic measures 
in the basal state and during β-adrenergic stimulation.  
 A significant finding of this study was that acute, exhaustive exercise resulted in a ~12% 
reduction in LVDP immediately following the exercise bout. Furthermore, the exercise-induced 
cardiac fatigue persisted for 24 hours post-exercise. The absolute LVDP observed in the CTL 
group (133±4 mmHg) is in agreement with the LVDP observed in the study by Vitiello and 
colleagues (2011). These authors observed a ~19% reduction in LVDP immediately after a four 
hour submaximal bout of treadmill running, which was greater than the ~12-14% decline in 
LVDP observed in the current study. Another study observed a ~25% reduction in LVDP 
following an hour of running at 25 m/min (Wonders et al., 2007). This speed represents an 
intensity that is 25% greater than that used in the current study. Olah and colleagues (2015) swam 
rats for three hours and observed a ~25% reduction in EF in rats that swam compared to controls 
rats. These data suggest that the duration and intensity of activity may influence the magnitude 
of exercise-induced cardiac fatigue, which has been observed in human studies (Shave et al., 
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2008). However, the regression analysis performed on LVDP and run time in the current study 
suggests the opposite, as there was an increase in LVDP in hearts from animals that ran for a 
longer duration. The reason for this relationship is not currently clear, but is not due to 
differences in the pool from which animals were selected as they were littermates and were 
randomly assigned to either the AC or 24H group. If the reduction in LVDP observed ex vivo 
was present in vivo, then it is possible that animals with the lowest LVDP had lower run times 
due to impaired cardiac output. The reduction in LVDP observed in the basal state was not related 
to changes in heart rate or coronary flow. This is a key observation given that a decrease in 
coronary flow (i.e. ischemia) and an increase in the pacing frequency in the isolated perfused rat 
heart have been demonstrated to reduce LVDP (Simor et al., 1997; Spinder et al., 2004; Dias et 
al., 2006). Taken together, these findings suggest that exhaustive treadmill exercise can induce 
cardiac fatigue in the basal state and that exercise-induced cardiac fatigue may be due to intrinsic 
deficits within the cardiomyocyte. 
 Despite the significant reductions in LVDP observed in this study in the basal state, there 
was no significant change in the +dP/dt or time to peak pressure. Similar observations have been 
made in isolated trabeculae following exhaustive exercise. A study by Maher and colleagues 
(1972) ran rats to exhaustion and observed a ~50% reduction in the tension produced in isolated 
trabeculae when compared to control trabeculae, but there were no significant differences in the 
time to peak tension between the exhaustive exercise group and control group. Conversely, 
studies have demonstrated an exercise-induced reduction in +dP/dt that coincided with a 
reduction in LVDP (Wonders et al., 2007; Vitiello et al., 2011). The experiments by Wonder and 
co-workers (2007) and Vitiello and colleagues (2011) did not address the potential mechanisms 
that contributed to the attenuated +dP/dt. The divergent findings between LVDP and +dP/dt in 
 58 
 
the current study suggest that the ability of the cardiomyocytes to develop tension was 
compromised but the kinetics of contraction were not altered. Exhaustive exercise has been 
demonstrated to reduce the sensitivity of the cardiac myofilaments to Ca2+ (Belcastro & Sopper, 
1984), which may have contributed to the decline in LVDP in the absence of any change in 
+dP/dt.  
There was a trend (p=0.076) for a reduction (~12%) in the –dP/dt in the AC and 24H 
groups when compared to the CTL group. Similarly, hearts from rats that performed 1-4 hours 
of treadmill exercise had a significantly depressed –dP/dt (Wonders et al., 2007; Vitiello et al., 
2011). It was hypothesized that a reduction in SERCA2a activity may have contributed to the 
decreased –dP/dt (Wonders et al., 2007). The implication that SERCA2a activity contributed to 
an exercise-induced reduction in –dP/dt is logical given the role SERCA2a plays in lowering the 
[Ca2+]f in the cardiomyocyte. It has been demonstrated that exhaustive swimming exercise 
resulted in a significant decrease in the rate of SR Ca2+ uptake (Pierce et al., 1984). However, a 
later study did not observe any change in SERCA2a activity following intense, exhaustive 
treadmill running in rats (Delgado et al., 1999). These studies lacked measurements of cardiac 
function; therefore, further examination of the effects of exhaustive exercise on Ca2+ regulation 
in conjunction with cardiac function is warranted. 
The assessment of the cardiac response to a β-adrenergic receptor agonist may provide 
further evidence of exercise-induced cardiac fatigue in the rat myocardium. For example, if the 
chronotropic and inotropic response of the myocardium to β-adrenergic stimulation was blunted 
then the ability to augment cardiac output may be compromised, which would impair 
performance during a subsequent exercise bout. Increasing the ISO dose progressively from 10-
11 M to 10-7 M resulted in a sigmoidal LVDP curve, which is consistent with previous findings 
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(Bilginoglu et al., 2009; Soltysinska et al., 2011; Vitiello et al., 2011). As hypothesized, there 
was a significant main effect of exercise, such that the LVDP of the AC and 24H groups were 
lower during the ISO dose response when compared to the CTL group. A study by Vitiello and 
colleagues (2011) performed a similar ISO dose response on isolated perfused hearts following 
prolonged exercise and did not observe a significant difference in LVDP between the exercise 
and control groups. It is important to note that the LVDP data from the ISO dose response was 
normalized to basal LVDP. It is possible that normalization of LVDP data in the study by Vitiello 
and colleagues (2011) masked an exercise effect, such as the one observed in the current study. 
These data demonstrate that under the experimental conditions utilized in this study, the exercise-
induced cardiac fatigue present in the basal state cannot be overcome by β-adrenergic 
stimulation. 
 The duration of the cardiac cycle is shortened during exercise due to an elevated heart 
rate. This poses a temporal limitation to filling and ejection of the ventricles, which is overcome 
by an enhanced rate of contraction and relaxation of the ventricles. To the author’s knowledge, 
this is the first study to examine the effects of progressive ISO concentrations on cardiac +dP/dt 
and –dP/dt following exhaustive treadmill exercise. The +dP/dt of the LV was not significantly 
different between the three groups in the basal state. Subsequently, a progressive increase in ISO 
concentration added to the perfusate resulted in an increase in the +dP/dt that was similar 
between the CTL, AC and 24H groups. These data suggest that LV contractility during β-
adrenergic stimulation was not altered by exhaustive exercise, which is contrary to previous 
reports in humans (Welch et al., 2005; Scott et al., 2007). Loading conditions are lacking in the 
isolated perfused heart as the LV end diastolic pressure is artificially adjusted and no volume is 
actually ejected from the heart (Liao et al., 2012). Thus, it is possible that changes in loading 
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conditions during β-adrenergic stimulation in human subjects can account for these divergent 
results (Scott et al., 2007). Interestingly, the –dP/dt in the AC group was significantly lower than 
the CTL and 24H groups in response to β-adrenergic stimulation. These results suggest that 
immediately following exhaustive exercise the ability of the heart to relax was compromised. 
During exercise, augmented cardiomyocyte relaxation is largely dependent on PKA mediated 
phosphorylation of PLN and TnI, which results in an increase in SERCA2a activity and a 
decrease in the apparent affinity of TnC for Ca2+, respectively (Odermatt et al., 1996, MacLennan 
& Kranias, 2003; Rao et al., 2014). From a functional perspective impaired relaxation kinetics 
in vivo could reduce filling of the ventricle during diastole, which would lower EDV and thus 
lower SV.  
The persistent depression in LVDP and –dP/dt observed during progressive ISO doses 
was not due to differences in heart rate or coronary flow. The LVDP and –dP/dt increased in an 
ISO-dependent manner and statistically peaked at an ISO concentration of 10-8.3 M and 10-8.0 M, 
respectively. Similarly, the coronary flow rate increased to the same extent in all three groups 
during progressive ISO doses and reached a statistical plateau at 10-8.3 M. These data suggest 
that the reduced LVDP and –dP/dt were not due to coronary flow limitations. It has been 
demonstrated in some (Eysmann et al., 1996; Douglas et al., 1998; Hart et al., 2006; Scott et al., 
2007) but not all human studies (Martin et al., 1991; Banks et al., 2010) that the chronotropic 
effect of a β-adrenergic agonist (i.e. ISO or dobutamine) is blunted following prolonged aerobic 
activity. In an animal model, the ISO dose required to increase heart rate by 25 bpm increased 
3-fold in dogs that ran for an hour at 60-80% of their maximal heart rate (Friedman et al., 1987). 
In the current study, there was no difference in heart rate between the three groups in the basal 
state or at any concentration of ISO, which counters the findings in dogs and the majority of 
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human studies. This observation is important considering the negative inotropic effect an 
increase in heart rate can have on the isolated perfused rat heart (Simor et al., 1997; Lankford et 
al., 1998). Thus, there appears to be experimental (i.e. in vivo versus ex vivo) and species 
differences that may explain the divergent results with respect to the chronotropic response to β-
adrenergic stimulation following prolonged or exhaustive exercise. Taken together, heart rate 
and coronary flow did not contribute to the exercise-induced reduction in LVDP and –dP/dt 
observed during the ISO dose response, which suggests one or more mechanisms intrinsic to the 
cardiomyocyte may contribute to cardiac fatigue. 
 Currently, it is not clear as to the mechanisms associated with exercise-induced 
reductions in LVDP. The decline in cardiac function following exhaustive exercise observed in 
the current study is reminiscent of myocardial stunning. Myocardial stunning is characterized by 
an ischemic-induced reduction in cardiac function, which may last for hours to days (Bolli & 
Marban 1999). Experiments by Heyndrickx and colleagues (1975) were the first to demonstrate 
that following a brief ischemic period there was a transient decline in cardiac contractile function 
despite restoration of normal coronary flow. There are two critical features that accompany 
myocardial stunning; one, is that the ischemic bout did not result in any cardiomyocyte cell death 
and two, the contractile dysfunction is present despite normal or near-normal coronary flow 
(Bolli, 1990). It has been suggested that prolonged aerobic exercise resulting in cardiac fatigue 
may be a form of “pseudo-stunning” brought on by exercise-induced myocardial ischemia (Scott 
et al., 2008). It is well documented in individuals/animals with coronary artery disease, left 
ventricular hypertrophy or artificial stenosis, that acute exercise results in ischemia and 
myocardial stunning (Vatner & Hittinger, 1993; Monnet et al., 2004; Ishii et al., 2009). It is 
impossible to comment on whether there were coronary flow limitations during the exercise 
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bouts in the current study. However, during the isolated perfused heart experiments there was no 
significant difference between the three groups in terms of coronary flow, yet LVDP was reduced 
for up to 24 hours post-exercise. Thus, the reductions in cardiac function observed after 
exhaustive exercise appear to share similar traits as myocardial stunning and accordingly may 
also possess similar mechanisms. Based on the similar physiological features of myocardial 
stunning models and cardiac fatigue models, it seems logical to identify potential mechanisms 
associated with exercise-induced cardiac fatigue from the myocardial stunning literature.  
 In summary, this study developed an exhaustive exercise protocol that effectively 
induced cardiac fatigue in the basal state and during β-adrenergic stimulation. The contractile 
response shared similarities to myocardial stunning, such that cardiac contractile function was 
depressed for up to 24 hours post-exercise, despite normal coronary flow. It can be concluded 
that cardiac fatigue was not due to changes in hemodynamics or heart rate. Thus, cardiac fatigue 
is likely due to impaired function of EC coupling proteins within the ventricular myocyte. 
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Chapter III: Exercise-induced cardiac fatigue is associated with increased ROS 
production, SR Ca2+ leak and calpain activation  
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Synopsis 
 In humans, there is extensive research demonstrating that prolonged or exhaustive 
exercise results in cardiac fatigue. There is a growing body of evidence, which includes 
observations from Chapter 2, that cardiac fatigue can be induced in rats using various exercise 
modalities. However, the intracellular mechanisms that contribute to exercise-induced cardiac 
fatigue in rodents have yet to be determined. Thus, the purpose of this study was to examine the 
effects of exhaustive exercise on in vitro ROS production, Ca2+ regulation, Na+/K+-ATPase 
activity and calpain activation. Adult, male Sprague-Dawley rats (21-23 weeks) were randomly 
assigned to either a CTL, AC or 24H group. Animals in the AC and 24H groups ran at 20 m/min 
and 5% grade until exhaustion, which occurred after 67 ± 3 and 66 ± 3 minutes, respectively. 
The hearts were excised and a portion of the LV was frozen and another homogenized for in 
vitro biochemical analyses. Exhaustive exercise did not alter the maximal rates of Ca2+-ATPase 
activity or Na+/K+-ATPase activity (p>0.05). In addition, the rates of SR Ca2+ release were not 
significantly different (p>0.05) between the three groups. A novel finding in this study was that 
the rate of SR Ca2+ leak increased ~40% (p<0.05) in the AC group when compared to the CTL 
group. Acute exercise resulted in a significant increase in ROS production (p<0.05) and no 
significant change in lipid peroxidation (p>0.05). To determine if ROS production resulted in 
post-translational modification of RyR, immunoprecipitation and Western blotting were 
performed. The degree of glutathionylation, nitration and carbonylation of RyR were not 
different (p>0.05) between the three groups. Furthermore, phosphorylation of serine 2808 on 
RyR was not different (p>0.05) between the CTL, AC and 24H groups, despite a significant 
increase (p<0.05) in the concentration of plasma Epi. Thus, these specific post-translational 
modifications to RyR were not associated with the increased rate of SR Ca2+ leak observed in 
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this study. The reduction in LVDP observed in the 24H group may be associated with the 
significant increase (p<0.05) in calpain activity that was observed in the AC group. Calpain 
activation has been shown to degrade EC coupling related proteins, which would require de novo 
protein synthesis. Taken together, an increased rate of SR Ca2+ leak and subsequent calpain 
activation may have contributed mechanistically to the cardiac fatigue observed in the AC and 
24H groups via reduced SR Ca2+ load and impaired EC coupling, respectively. 
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Introduction 
 Chronic aerobic exercise training has numerous health and cardiovascular benefits, 
which include, but are not limited to, reduced blood pressure, reduced risk of cardiovascular 
disease and prevention of diabetes, cancer and obesity (Warburton et al., 2006). However, a 
single bout of prolonged aerobic exercise has been demonstrated to result in exercise-induced 
cardiac fatigue in humans and other rodent models (Chapter 2 included) when assessed at rest, 
following the exercise bout  (George et al., 2009; Scott et al., 2009; Vitiello et al., 2011; Olah et 
al., 2015). It has been proposed that this phenomenon displays features similar to the stunned 
myocardium (Starnes & Bowles, 1995; Siegel et al., 1997; Scott et al., 2008).  
Research into the molecular mechanisms responsible for myocardial stunning has 
provided two primary hypotheses (for a review see Bolli & Marban, 1999). The first theory 
postulates that ROS production is exacerbated during the ischemic period and the subsequent 
reperfusion period. Oxidative stress can contribute to impaired cardiomyocyte function as a 
result of damage to proteins and/or lipids. Indeed, models of myocardial stunning have 
demonstrated impaired Na+/K+-ATPase activity (Kaplan et al., 2005; Kaplan et al., 2008), 
impaired Ca2+ handling (Kim et al., 2001; Kumar et al., 2009), altered protein phosphorylation 
(Weber et al., 2006) and protein degradation (White et al., 2003). The second theory states that 
myocardial stunning is due to a reduction in the sensitivity of the contractile apparatus to Ca2+, 
a reduction in the regulation of Ca2+ by the SR and/or Ca2+ overload (Bolli and Marban, 1999). 
Although these two theories first evolved separately, there are undoubtedly common threads 
between the two. A ROS-induced reduction in Na+/K+-ATPase activity would result in  Na+ 
accumulation within the cardiomyocyte, this would favour reverse mode Na+/Ca2+ exchange and 
would result in Ca2+ overload (Wei et al., 2007). Calcium overload has been demonstrated to 
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activate calpains, which resulted in myofibrillar protein degradation, a feature associated with 
the first myocardial stunning hypothesis (Gao et al., 1997). Degradation of myofibrillar proteins 
would require de novo protein synthesis to replace the damaged proteins and may explain the 
reduced LVDP observed 24 hours post-exercise. 
In striated muscle, the production of ROS is exacerbated during contractile activity and 
is an established mechanism that contributes to the development of fatigue in skeletal muscle 
(Kobzik et al., 1994; Kolbeck et al., 1997; Lamb & Westerblad, 2011). Previous studies have 
demonstrated that acute exercise resulted in a marked increase in indices of oxidative stress in 
the rat myocardium, which were related to the exercise-induced cardiac fatigue (Wonders et al., 
2007; Vitiello et al., 2011; Olah et al., 2015). Work by Olah and colleagues (2015) demonstrated 
that prolonged swimming caused an increase in leukocyte infiltration and superoxide production 
in the myocardium, which was associated with a significantly lower stroke volume and cardiac 
output when compared to a control group. Wonders and colleagues (2007) ran rats at 25 m/min 
and 5% grade for 60 minutes and observed a significant reduction in LVDP at 24 and 48 hours 
post-exercise, which recovered 72 hours after the acute bout of exercise. Indices of lipid 
peroxidation, namely MDA and 4-HAE content, were increased post-exercise and followed a 
similar recovery time course as that of LVDP. Vitiello and co-workers (2011) showed that 
prolonged treadmill running resulted in a significant decrease in the ratio of reduced glutathione 
to oxidized glutathione (GSH/GSSG; a marker of oxidative stress), which was associated with 
cardiac fatigue. Conversely, Seward and co-workers (1995) ran rats until exhaustion and failed 
to observe any change in cardiac function following exercise despite increased ROS production. 
Nevertheless, there is a strong possibility that ROS produced during acute exercise contributed 
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to the cardiac impairment reported in Chapter 2. Thus, further research is warranted to examine 
the intracellular protein targets of exercise-induced ROS. 
Few studies have attempted to elucidate the intracellular mechanisms that contribute to 
exercise-induced cardiac fatigue. Given the relationship between [Ca2+]f and force, it would seem 
logical that a reduction in contractile function in the heart following acute exercise may be related 
to impaired Ca2+ regulation. A study by Delgado and colleagues (1999) examined the effects of 
exhaustive exercise on maximal Ca2+-ATPase activity. These authors found no significant 
differences in the rates of maximal Ca2+-ATPase activity between sedentary control rats and rats 
that ran to exhaustion. Conversely, an abstract from the 1977 proceedings of the American 
College of Sports Medicine reported that rats run to exhaustion had an approximate 50% 
reduction in the rate of Ca2+ uptake in SR vesicles isolated from the LV (Sembrowich & 
Gollnick, 1977). Similarly, Pierce and colleagues (1984) isolated SR vesicles from rat LV 
following an exhaustive bout of swimming and observed a ~40% reduction in the rate of SR 
Ca2+ uptake. A reduction in Ca2+ uptake would result in less Ca2+ sequestered in the SR after 
each cardiac cycle. Unfortunately, these studies did not investigate the mechanism associated 
with the decreased Ca2+ uptake, nor were the consequences of decreased Ca2+ uptake on cardiac 
contractile function examined. It is possible that production of ROS during exercise caused the 
decrease in SERCA2a activity. Indeed, in pathological models in which ROS production is 
augmented there is a reduction in SERCA2a activity and an increase in SERCA2a nitration 
(Thomas et al., 2011), cysteine oxidation (Qin et al., 2013) and/or carbonylation (Shao et al., 
2011). Taken together, oxidative stress and exhaustive exercise can reduce SERCA2a activity in 
the heart. However, a possible relationship between oxidative stress, SERCA2a activity and 
exercise-induced cardiac fatigue has not been examined to date. 
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The ryanodine receptor in cardiomyocytes is a focal point of Ca2+ homeostasis, whereby 
deficits in RyR function can lead to contractile dysfunction (Bers, 2014). The occurrence of 
aberrant Ca2+ leak during diastole can lead to a reduction in the SR Ca2+ content and the 
amplitude of the Ca2+ transient (Sag et al., 2013). This has been demonstrated in heart failure 
and aging models where the production of ROS is elevated. In a pacing model of canine heart 
failure, there was significant oxidation of free thiols on RyR, which resulted in an increase in 
Ca2+ leak from Ca2+ loaded SR vesicles (Yano et al., 2005; Terentyev et al., 2008). In aged mice 
and rabbits, diastolic Ca2+ leak was elevated in isolated atrial and ventricular myocytes. When 
DTT was incubated with aged myocytes the diastolic Ca2+ leak rate was restored to the level of 
young control myocytes (Cooper et al., 2013; Guo et al., 2014). These studies suggest that 
increased production of ROS resulted in oxidative post-translational modification of RyR, which 
increased Ca2+ leak from the SR. 
Phosphorylation of RyR is an alternative type of post-translational modification that has 
been shown to increase SR Ca2+ leak. In models of heart failure, PKA mediated 
hyperphosphorylation of RyR at serine 2808 has been shown to cause the RyR regulatory 
protein, calstabin2, to dissociate from the RyR tetrameric complex, which resulted in 
destabilization of the channel and increased Ca2+ leak (Marx et al., 2000; Wehrens et al., 2006; 
Marks, 2013). Taken together, post-translational modification (i.e. oxidation and 
phosphorylation) of RyR in pathological models resulted in increased leakage of Ca2+ from the 
SR and impaired cardiac contractility. Thus, it is possible that the decreased LVDP observed in 
Chapter 2 was a result of post-translational modification of RyR, which resulted in an increase 
in the rate of SR Ca2+ leak and consequently a decrease in Ca2+ release.            
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There is minimal work that has investigated the effects of acute exercise on cardiac RyR 
function. A study by Delgado and colleagues (1999) did not observe any differences in the 
amount of [3H]ryanodine bound to RyR in SR vesicles isolated from animals that ran to 
exhaustion when compared to control vesicles. The measure of ryanodine bound to RyR is a 
surrogate measure of the open probability of the channel as ryanodine will only bind to Ca2+ 
release channels that are in the open conformation in response to activating Ca2+ concentrations 
(Delgado et al., 1999). Sanchez and co-workers (2008) isolated SR vesicles from the LV of dogs 
following an intermittent running protocol that consisted of 5 repetitions of 5 minutes on and 5 
minute off. These authors observed a significant increase in the rate of Ca2+ release and a 
decrease in the rate of SR Ca2+ leak, which was associated with S-glutathionylation of the Ca2+ 
release channel. These changes in RyR function would likely augment cardiac function as 
reduced Ca2+ leak during diastole would increase SR Ca2+ load and lead to enhanced fractional 
release during systole (Sanchez et al., 2008). In the studies noted above, the total exercise time 
was ≤ 25 minutes (Delgado et al., 1999; Sanchez et al., 2008). In skeletal muscle, exhaustive or 
prolonged aerobic exercise exceeding 60 minutes has been demonstrated to decrease the rate of 
SR Ca2+ release (Favero et al., 1993; Leppik et al., 2004; Duhamel et al., 2005; Chen et al., 2007 
Green et al., 2011). Therefore, it is possible that exhaustive exercise of a longer duration may 
impair cardiac RyR function and contribute to exercise-induced cardiac fatigue. 
In Chapter 2, cardiac fatigue persisted for up to 24 hours post-exercise and cardiac fatigue 
has been shown to last for 48 hours following an acute bout of treadmill exercise in rats (Wonders 
et al., 2007).  The fact that cardiac fatigue is present for an extended period of time post-exercise 
suggests that the mechanism responsible for the contractile deficit may differ from those 
associated with cardiac fatigue immediately post-exercise. Impaired Ca2+ regulation can result 
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in an elevation in the intracellular Ca2+ concentration (Despa et al., 2014), which would result in 
the activation of calpains (Matsumura et al., 2001). Studies have demonstrated that acute 
treadmill exercise activated calpains in the LV of rat (Raj et al., 1998; Tiidus et al., 2002). 
Activation of calpains has been shown to degrade cardiac Ca2+ regulatory proteins (French et al., 
2006; Pedrozo et al., 2010; Wanichawan et al., 2014) and sarcomeric proteins (Kositprapa et al., 
2000; Ke et al 2008), which may result in contractile dysfunction (van der Laarse, 2002; Ke et 
al., 2008). Degradation of EC coupling proteins would require de novo protein synthesis, which 
may explain the reduction in cardiac contractility observed 24 hours post-exercise in Chapter 2. 
The activity of the Na+/K+-ATPase is an important variable to consider when 
investigating mechanisms associated with exercise-induced cardiac fatigue, as changes in Na+ 
regulation can impair Ca2+ homeostasis and potentially lead to Ca2+ overload in the 
cardiomyocyte (Wei et al., 2007). There is scant research that has investigated the acute effects 
of exhaustive exercise on maximal Na+/K+-ATPase activity in the heart. A study by Pierce and 
colleagues (1984) examined the effects of an exhaustive bout of swimming on maximal Na+/K+-
ATPase activity in sarcolemmal vesicles isolated from the LV of rat. These authors found no 
significant differences in maximal Na+/K+-ATPase activity between sarcolemmal vesicles 
isolated from animals that swam or remained sedentary (i.e. control). No study has examined 
Na+/K+-ATPase activity 24 hours after an exhaustive exercise bout. In skeletal muscle, there are 
conflicting results regarding acute exercise and Na+/K+-ATPase activity, with some evidence 
indicating a decrease (Leppik et al., 2004; Petersen et al., 2005), increase (Juel et al., 2013) or 
no change in Na+/K+-ATPase activity (Green et al., 2007; Green et al., 2011). Therefore, further 
research is warranted to determine the effect of exhaustive exercise on Na+/K+-ATPase activity 
in the LV of rat.     
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In this study, the effect of exhaustive treadmill exercise on the function of Na+/K+-
ATPase, SERCA2a and RyR2 were examined in LV homogenates. It was hypothesized that 
exhaustive exercise would result in an increased production of ROS in the myocardium, which 
would decrease the function of the Ca2+ regulatory proteins SERCA2a and RyR2. It was further 
hypothesized that exhaustive exercise would impair Na+/K+-ATPase activity. The impairment in 
these Na+ and Ca2+ regulatory proteins would likely result in elevated Ca2+ concentration in the 
cleft region of the cardiomyocyte, which would activate calpains. Therefore, it was hypothesized 
that activation of calpains may be associated with the reduction in LV contractile function 24 
hours post-exercise.  
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Methods 
Animals 
 This study used male Sprague-Dawley rats (21-23 weeks) that were obtained from the 
breeding colony at the University of Waterloo. Animals were group housed (4 per cage) on a 
reverse 12 hour light cycle and had access to food and water ad libitum. All procedures were 
reviewed and approved by the University of Waterloo Animal Care Committee. 
Experimental Design  
This study contained two cohorts of animals. The first cohort was used solely for 
collection of tissue and to perform in vitro experiments aimed at identifying mechanisms 
associated with exercise-induced cardiac fatigue. After assessment of Na+/K+-ATPase, 
SERCA2a and RyR2 function, it was determined that an increase in SR Ca2+ leak in the AC 
group was the only significant impairment in in vitro protein function. Subsequently, a second 
cohort of animals were chosen to test whether SR Ca2+ leak remained elevated during isolated 
perfused heart experiments as this would strengthen the observations regarding SR Ca2+ leak 
made in the first cohort (i.e. in vitro analysis only). The hearts from animals in the second cohort 
were excised, instrumented and perfused for 30 minutes prior to collection and homogenization 
of LV. Groups within in the cohort that were only used for in vitro experiments were referred to 
as the in vitro groups and the cohort where hearts were perfused were referred to as the post-
perfusion groups. Within the in vitro groups and the post-perfusion groups there was a control 
group (CTL), an acute exercise group (AC) with animals sacrificed immediately following 
exhaustive exercise and a group of animals that were sacrificed 24 hours after exhaustive 
exercise (24H). The anthropometric data from all animals used in this study are presented in 
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Table 3.1. The identical acclimation and exhaustive exercise protocols that were developed in 
Chapter 2 were employed in this study. 
 
Plasma Collection and Tissue Sampling  
Prior to excision of the heart, blood was drawn from the inferior vena cava into a 1 mL 
syringe containing 25 µL of 0.195 M reduced glutathione and 0.237 M EGTA pH 7.0. Blood 
was gently inverted several times and was centrifuged at 4500 g for 10 min. The plasma was 
collected and stored at -80°C until analyses of NE and Epi concentrations. 
 Hearts from anaesthetized animals were excised and placed in an ice cold homogenizing 
buffer that contained (in mM) 250 sucrose, 5 HEPES pH 7.5, 0.2 phenylmethanesulfonyl fluoride 
and 0.2% NaN3. Next, the aorta was cannulated using a teflon catheter and flushed with 10 mL 
of ice cold homogenization buffer to remove blood (in vitro groups) or perfusate (post-perfusion 
groups) within the coronary vasculature. The hearts were trimmed of atria, the aorta, connective 
tissue and the right ventricle. A piece of LV was frozen and the remaining LV was diluted 
Table 3.1:  Anthropometric data for the in vitro and post-perfusion groups
Masses p values
Body Mass (g) 449 ± 13 466 ± 6 468 ± 8 0.32
Heart Mass (g) 1.43 ± 0.040 1.48 ± 0.029 1.42 ± 0.026 0.43
Left Ventricle Mass (g) 0.99 ± 0.025 1.03 ± 0.021 1.00 ± 0.024 0.51
Left Ventricle/Body Mass 0.0022 ± 0.00010 0.0022 ± 0.00005 0.0021 ± 0.00004 0.67
Body Mass (g) 474 ± 11 443 ± 16 464 ± 13 0.29
Heart Mass (g) 1.86 ± 0.05 1.74 ± 0.075 1.77 ± 0.039 0.31
Left Ventricle Mass (g) 1.21 ± 0.038 1.15 ± 0.058 1.15 ± 0.031 0.50
Left Ventricle/Body Mass 0.0026 ± 0.00005 0.0026 ± 0.00008 0.0025 ± 0.00006 0.48
The in vitro  group was used for all in vitro analyses performed to investigate the mechanisms associated with exercise-induced
cardiac fatigue. The post-perfusion  group consisted of hearts that were perfused for 30 minutes and then LV homogenate  
Data are presented as means ± SE (post-perfusion n=7; in vitro  n=9).
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(wt:vol, 1:10) in homogenization buffer and homogenized using a motorized tissue grinder 
(PT3100, Polytron). The homogenate was aliquoted, frozen in liquid nitrogen and stored along 
with the whole LV pieces at -80°C. 
Ca2+- Dependent Ca2+-ATPase Activity 
Measurements of Ca2+-dependent Ca2+-ATPase activity were made at 37°C using a 
spectrophotometric assay developed by Simonides and Van Hardeveld (Simonides & van 
Hardeveld, 1990), which has since been adapted as a 96-well plate reader assay (Duhamel et al., 
2007). The assay buffer contained (in mM): 20 HEPES pH 7.0, 200 KCl, 15 MgCl2, 1 EGTA, 
10 NaN3, 10 PEP and 5 ATP. For each sample, a cocktail that contained 5 mL assay buffer, 18 
U/mL LDH, 18 U/mL PK, 1 μM Ca2+ ionophore (A23187, Sigma) and 25 μL LV homogenate 
was combined in a test tube on ice. The cocktail was subdivided (300 μL) into 16 microcentrifuge 
tubes with varying concentrations of CaCl2. Next, two 100 μL aliquots from each of the sixteen 
subdivisions was loaded onto a clear bottom 96-well plate. The final step required addition of 
~4 μL of 33 mM NADH to each well. The decrease in NADH absorbance at 340 nm was made 
using a spectrophotometer (SPECTRAmax Plus, Molecular Devices) and represents total 
ATPase activity. To distinguish Ca2+-ATPase activity from total ATPase activity, 240 μM of the 
specific SERCA inhibitor, cyclopiazonic acid (CPA) was used (Seidler et al., 1989). The 
difference between the total ATPase activity and the basal ATPase activity (activity in the 
presence of CPA) represents the Ca2+-ATPase activity. The [Ca2+]f corresponding to each CaCl2 
addition was determined separately by use of dual-wavelength spectrofluorometry and the Ca2+-
fluorescent dye Indo-1. The range of calcium concentrations translated into a pCa range of ~7.0-
5.0. 
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Ca2+ Uptake, Ca2+ Leak and Ca2+ Release 
 Ca2+ uptake, Ca2+ leak and Ca2+ release were measured at 37°C in LV homogenates using 
Indo-1 as previously described (Tupling & Green, 2002). Briefly, a dual-emission wavelength 
spectrofluorometer (Ratiomaster system, Photon Technology International) was used to perform 
fluorescence measurements. The assay buffer contained (in mM): pH 7.0, 200 KCl, 20 HEPES, 
10 NaN3, 0.005 N,N,N′,N′-tetrakis(2-pyridylmethyl) ethylenediamine, 5 oxalate, 15 MgCl2. In a 
4-sided clear cuvette, 1.5 μM Indo-1, ~4.5 μL of 10 mM CaCl2 (corresponded to a [Ca2+]f of 
~3.0-3.5 µM) and ~1.5 mg LV homogenate were brought to a total volume of 2.0 ml with assay 
buffer. The reaction was initiated with the addition of 40 μL of 250 mM ATP. The measurement 
of [Ca2+]f using Indo-1 is based on the difference in the maximal emission wavelengths between 
the Ca2+-bound form of Indo-1 and the Ca2+-free form. The excitation wavelength was 355 nm, 
and the emission maxima were recorded at 485 and 405 nm for the Ca2+-free (G) and Ca2+-bound 
(F) forms of Indo-1, respectively. The [Ca2+]f was calculated using Felix Software (Photon 
Technology International), which utilized the ratio (R) of F to G and the following equation 
(Grynkiewicz et al., 1985): 
[Ca2+]f = Kd × �GmaxGmin� �R − RminRmax − R� 
where Kd is the equilibrium constant for the interaction between Ca2+ and Indo-1, Rmin is the 
minimum value of R following the addition of 338 μM EGTA, Gmax is the maximum value of G 
at the addition of 338 μM EGTA, Gmin is the minimum value of G at the addition of 1.38 mM 
CaCl2, and Rmax is the maximum value of R at the addition of 1.38 mM CaCl2. The Kd value for 
the Ca2+-dye complex is 250 nM for muscle homogenates (Grynkiewicz et al., 1985). The rate 
of Ca2+ uptake (μmol·g protein-1·min-1) was determined at a [Ca2+]f of 2.0, 1.5, 1.0 and 0.5 μM 
by differentiating the [Ca2+]f curve. Ca2+ release and leak were measured in a similar fashion to 
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Ca2+ uptake. The SR of the LV homogenate was actively loaded with Ca2+ using the same method 
as the uptake assay. Once [Ca2+]f plateaued, 5 mM 4-CMC was added to the cuvette to induce 
Ca2+ release. It is important to note that 4-CMC directly activates the RyR to induce Ca2+ release 
(Tupling & Green, 2002). To assess SR Ca2+ leak, a second aliquot of homogenate was used and 
Ca2+ uptake was performed as outlined above; however, 40 µM CPA was added to the cuvette 
once Ca2+ uptake was complete and [Ca2+]f plateaued. The maximal rates of Ca2+ release and 
leak were calculated using the initial fast phase of the [Ca2+]f versus time curve. A graphical 
representation of Ca2+ uptake, release and leak is provided in Figure 3.1. 
 
 
 
 
 
 
 
 
Figure 3.1. An illustration of Ca2+ uptake, release and leak. (A) The addition of ATP initiates 
Ca2+ uptake. Once uptake has reached a minimum, cyclopiazonic acid (CPA) was added to the 
assay. CPA inhibits SERCA2a and permits the assessment of passive Ca2+ leak. (B) Once uptake 
has reached a minimum 4-CMC was added to activate RyR and assess Ca2+ release. 
 
Na+-Dependent Na+/K+-ATPase Activity 
 Measurements of ouabain-sensitive Na+/K+-ATPase activity were made at 37°C using a 
spectrophotometric assay as previously described (Kutchai & Geddis, 2001; Despa et al., 2005), 
but with slight modifications. For each sample, 10 µL of LV homogenate was diluted in 5 mL 
of assay buffer that contained (in mM): pH 7.2, 30 Tris, 20 KCl, 3 MgCl, 1 EDTA, 1.5 PEP, 3 
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ATP, 40 µM CPA, 4.6 U/mL LDH and 3.3 U/mL PK. Then the buffer was subdivided into 16 
microcentrifuge tubes with varying NaCl concentrations (0-120 mM). The decline in NADH 
absorbance was used to calculate Na+/K+-ATPase activity. Background ATPase activity was 
determined in the presence of 10 mM ouabain and subtracted from total ATPase activity to yield 
Na+/K+-ATPase activity. 
Dichlorofluorescein (DCF) Fluorescence and ROS Production 
 ROS production in whole LV homogenate was determined using 2',7'-dichloro-
dihydrofluorescein-diacetate (DCFH-DA) as previously described (Campbell et al., 2015). 
DCFH-DA is hydrolyzed by cellular esterases to form the minimally fluorescent DCFH. The 
oxidation of DCFH by ROS creates the highly fluorescent 2',7'-dichlorofluorescein (DCF). 
Briefly, 20 µL of LV homogenate were incubated at 37oC in the dark with 5 μM DCFH-DA in 
imidazole buffer (20 mM imidazole pH 7.0, 125 mM KCl 10µM CaCl2). DCF fluorescence was 
quantified using a SPECTRAmax Gemini XS 96-well plate spectrofluorometer (Molecular 
Devices) with excitation and emission wavelengths of 490 nm and 525 nm, respectively. The 
fluorescence intensity was normalized to the total protein in each well and was expressed as 
arbitrary units per μg protein (AU/μg protein). 
Malondialdehyde Content 
 MDA content is a marker of lipid peroxidation and was assessed as per the methods of 
Ohkawa and colleagues (1979). Briefly, ~25 mg of frozen LV was homogenized in ten volumes 
of 1.15% KCl using a glass homogenizer (Kontes). In a glass test tube with a crew cap, 50 μL of 
homogenate or MDA standard (Cayman Chemical) were combined with a reaction mixture that 
consisted of: 100 μL 8.1% SDS, 750 μL 20% acetic acid pH 3.5 using NaOH, 750 μL 0.8% 
thiobarbituric acid (TBA) and 350 μL H2O. The standards and samples were incubated in a water 
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bath at 95-100oC for one hour and subsequently cooled for ~10 minutes in an ice-water bath. 
After cooling, 500 μL of H2O and 2.5 mL of a mixture of n-butanol and pyridine (15:1, v/v) were 
added and the tubes were vortexed for 30 seconds. Then the samples were centrifuged at 2000 g 
for 10 minutes, 200 μL of the organic layer from each sample was added to a clear, round bottom 
96-well plate and the absorbance was read at 532 nm (SPECTRAmax Plus, Molecular Devices). 
The concentration of MDA in each sample was calculated using the slope and y-intercept of the 
MDA standard curve and was normalized to protein content in the homogenate. 
Calpain Activity 
 Calpain activity was assessed using a fluorescent assay as described by McMillan and 
Quadrilatero (2011). Briefly, LV homogenates were incubated at 37oC with the non-fluorescent 
calpain substrate, N-Succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin (Suc-LLVY-
AMC) (Enzo Life Sciences) in the presence or absence of the calpain inhibitor, N-
benzyloxycarbonyl-Leu-leucinal (Z-LL-CHO) (Enzo Life Sciences). Cleavage of the Suc-
LLVY-AMC peptide by calpains releases the highly fluorescent AMC molecule. Fluorescence 
was determined using a SPECTRAmax Gemini XS 96-well plate spectrofluorometer (Molecular 
Devices) with excitation and emission wavelengths of 380 nm and 460 nm, respectively. The 
calpain activity was calculated by taking the difference between the fluorescence from 
homogenate incubated without and with the calpain inhibitor. The fluorescence intensity was 
normalized to the total protein in each well and was expressed as arbitrary units per μg protein 
(AU/μg protein). 
Western Blotting 
 The following antibodies were used in this study. The dilution factor of each primary 
antibody is provided in the parentheses: SERCA2a (1:4000), PLN (1:2000), RyR (1:1000) 
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(Pierce Antibodies); p-PLN (1:1000) (Cell Signaling); anti-GSH (1:1000) (Virogen); Ser2808 p-
RyR (1:1000) (Abcam); anti-DNP (1:1000) (Sigma).  
 Western blotting was used to determine the relative expression level and oxidative 
modification of several key cardiac proteins from LV homogenate. Unless described elsewhere, 
all samples were diluted in 1X Sample Buffer that contained 62.5 mM Tris, pH 6.8, 2% SDS, 
5% 2-mercaptoethanol, 10% glycerol and bromophenol blue. Samples were loaded on a 
polyacrylamide gel and separated using standard electrophoresis techniques (Laemmli, 1970). 
In the case of PLN, electrophoresis of proteins was performed using a Tris-Tricine procedure 
developed by Schaggar (2006). The proteins were transferred to a polyvinylidene fluoride 
(PVDF) membrane (BIO-RAD) and blocked for 1 hour at room temperature with a 5% non-fat 
milk suspension in Tris-buffered saline plus Tween (TBST; 20 mM Tris, pH 7.5, 150 mM NaCl, 
0.1% Tween 20). Following a brief wash in TBST, membranes were incubated with the 
appropriate primary antibody, washed, incubated with a horse-radish peroxidise (HRP) 
conjugated secondary antibody and washed a final time. Luminescence was enhanced using 
either ECL Western Blot Substrate (BioVision) or Luminata™ Forte Western HRP Substrate 
(Millipore) and captured using the ChemiGenius2 imaging system and GeneSnap Software 
(SynGene). Optical density of protein bands was quantified using GeneTools Software 
(SynGene).     
Immunoprecipitation 
 Immunoprecipitation was used to measure post-translational modification of RyR. Anti-
RyR antibody was used to immunoprecipitate RyR2 from 200 µg of LV homogenate. The 
homogenate was diluted in 0.2 mL of a modified radioimmunoprecipitation assay (RIPA) buffer 
that contained (in mM): 50 Tris, pH 7.4, 0.9% NaCl, 5.0 NaF, 1.0 Na3VO4, 1% Triton X-100 
and Roche Complete Protease Inhibitors, and mixed with gentle rotation for 1 hour at 4°C with 
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1 µg anti-RyR. The immune complexes were incubated with 30 µL of a 50% protein-A sepharose 
(Sigma) slurry for 1 hour at 4°C. The protein-A sepharose was washed 3 times with RIPA buffer 
for 5 min and then the immunoprecipitated RyR2 was solubilised by adding 5% SDS. The 
purified RyR2 was separated using SDS-PAGE and probed for tyrosine nitration and 
glutathionylation. 
 To determine the reactive carbonyl content of RyR, the immunoprecipitation procedures 
outlined above were used with additional steps following the purification of RyR. Briefly, 5 μL 
of immunoprecipitated RyR was combined with 6 μL of 10 mM 2,4-dinitrophenylhydrazine 
(DNPH) dissolved in 2 M HCl and incubated for 15 minutes at room temperature with gentle 
agitation periodically. Subsequently, 7.5 μL of a 2 M Tris and 30% glycerol solution were added 
to neutralize the mixture followed by the addition of 18 μL 2X Sample Buffer (see Western 
Blotting) and 30 μL 4X Stacking Buffer (0.5 M Tris, pH 6.8 & 0.4% SDS). The samples were 
then loaded on polyacrylamide gels, separated by electrophoresis and Western blotting was 
performed as outlined in Western Blotting. 
Plasma Catecholamine Quantification 
The concentration of plasma NE and Epi was determined as per the methods of Weicker 
and colleagues (1984). Briefly, from 200 µL of plasma catecholamines were adsorbed using 10 
mg Al2O3. Subequently, the conjugated catecholamine-Al2O3 were washed three times with 0.5 
mL of buffer that contained 2.0 M Tris and 2% EDTA pH 8.7. Catecholamines were desorbed 
from Al2O3 by adding 0.1 M HClO4 to the samples. The samples (50 µL) were automatically 
injected into a Waters 2465 HPLC. The samples were separated at a flow rate of 1.2 mL/min 
using a Supelcosil 15cmx4.6mm 5 µm column (58230-U) and a mobile phase that consisted of 
50 mM sodium acetate, 20 mM citric acid, 2 mM sodium octane sulfate, 1 mM di-n-butylamine, 
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100 µM EDTA dissolved in 96:4 volumes of water:methanol pH 3.5. Samples were compared 
to freshly made NE (A9512) and Epi (Sigma; E4375) standards.   
Isolated Perfused Heart  
 In the post-perfusion group of animals (n=7/group), the chest cavity was exposed, thus 
permitting the removal of the pericardium and thymus and rapid excision of the heart. The heart 
was placed in ice cold Krebs-Henseleit buffer which contained (in mM): pH 7.4, 118 NaCl, 4.7 
KCl, 1.2 MgSO4·7H2O, 24 NaHCO3, 1.1 KH2PO4, 1.25 CaCl2·2H2O and 10 glucose. Hearts 
were secured to an aortic cannula via 4.0 silk sutures and perfused at a constant pressure (~80 
mmHg) with Krebs-Henseleit buffer warmed to 37°C and bubbled with 95%O2-5%CO2. To 
measure perfusion pressure a pressure transducer (MLT844, AD Instruments) was connected to 
the system proximal to the aortic cannula. A second pressure transducer was connected to a 
balloon tipped catheter and measured indices of LV contractile function. The balloon was fed 
through the left atria into the left ventricle and the volume of the balloon was adjusted to provide 
a diastolic pressure of ~10 mmHg. An ultrasonic flow probe (2PXL, Transonic Systems) was 
placed proximal to the aortic cannula, which measured global coronary flow. Following 
instrumentation, hearts were allowed to equilibrate for 30 minutes at which point baseline data 
were recorded. All data were collected using a Powerlab data acquisition system (4/sp, AD 
Instruments) and were analyzed using Chart software (Ver. 5, AD Instruments). After the 30 
minute equilibration period hearts were removed from the perfusion apparatus and homogenized 
as per the methods in Blood Collection and Tissue Sampling. These homogenate samples were 
used to confirm if any in vitro changes in protein structure and function persisted throughout the 
perfusion period.  
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Statistics 
 All data are presented as means ± standard error. A one-way ANOVA was used to 
compare group means of the variables outlined above. To investigate relationships between two 
variables, linear regression analysis was performed using GraphPad Prism 4 software. Power 
analysis was performed using G*Power software, which was developed by Heinrich Heine 
University in Dusseldorf, Germany. The significance level was set at 0.05, and, when 
appropriate, a Newman-Keuls post hoc test was used to compare specific means. A trend in the 
data was deemed when the probability was less than or equal to 0.1 and greater than 0.05. In 
some analytical measures there was a high degree of inter-animal variability. Accordingly, if a 
value was greater than 2 standard deviations from the mean that outlying value was removed 
from the data set.  
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Results 
Anthropometric Data and Run Times 
 The anthropometric data of the two cohorts in this study are presented in Table 3.1. In 
the animals used for in vitro analysis and the post-perfusion animals, there were no significant 
differences (p>0.05) between the CTL, AC and 24H groups with respect to body mass, heart 
mass, left ventricle mass and the ratio of left ventricle mass to body mass. The in vitro animals 
in the AC group and 24H group ran for durations of 67 ± 3 and 66 ± 3 minutes, respectively, 
which did not differ from each other (p>0.05). Similarly, there were no significant differences 
(p>0.05) in run times (AC 72 ± 6 min vs. 24H 70 ± 7 min) between the post-perfusion AC and 
24H groups. 
 
  
 
 
 
 
 
 
 
 
Figure 3.2. The plasma concentration of norepinephrine and epinephrine (pg/mL) in the plasma 
from CTL, AC and 24H groups. Catecholamine data in the in vitro and post-perfusion groups 
were pooled and are presented as means ± SE. The number in each bar represents the number of 
samples used for statistical analysis as several outliers were removed. *Significantly different 
(p<0.05) than CTL and 24H. 
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Catecholamines 
 Since all of the animals in the in vitro and post-perfusion groups were handled identically 
up until plasma collection, the catecholamine data were pooled. Immediately following 
exhaustive exercise there was a significant ~5-fold increase (p<0.05) in plasma Epi concentration 
when compared to the CTL group (Figure 3.2). However, there were no significant differences 
(p>0.05) in the concentration of NE in the plasma after the acute exercise bout. The Epi and NE 
concentrations in the 24H group were not different than the CTL group (p>0.05).   
Reactive Oxygen Species Production and Lipid Peroxidation 
 To assess the production of reactive oxygen species, LV homogenate from the in vitro 
group were incubated with DCFH-DA. The fluorescence of DCF was 15% higher (p<0.05) in 
the AC group when compared to the CTL (Figure 3.3A). Lipid peroxidation was determined by 
measuring the concentration of MDA in LV homogenate. There was a ~30% difference in the 
MDA concentration between the AC group and the CTL group; however, the difference between 
groups failed to reach statistical significance (p>0.05) (Figure 3.3B). Power analysis revealed 
that an additional ten animals per group would be required to achieve a statistically significant 
increase in lipid peroxidation in the AC group. 
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Figure 3.3. ROS production and lipid peroxidation. (A) The production of ROS was assessed 
by measuring DCF fluorescence in LV homogenate (n=6). (B) Lipid peroxidation was 
determined by measuring the concentration of malondialdehyde (MDA) in LV homogenates 
(n=8). All values were normalized to total protein and are means ± SE. *Significantly different 
(p<0.05) than CTL and 24H. 
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Maximal Na+/K+-ATPase Activity 
 Ouabain-sensitive, maximal Na+/K+-ATPase activity was determined in LV homogenate 
in the in vitro group using a spectrophotometric assay (Kutchai & Geddis, 2001; Despa et al., 
2005). Contrary to what was hypothesized, there were no differences in maximal Na+/K+-
ATPase activity between CTL, AC and 24H groups (Figure 3.4). 
 
 
 
 
 
 
 
 
Figure 3.4. The ouabain sensitive, maximal rate of Na+/K+-ATPase activity was assessed in LV 
homogenates from CTL, AC and 24H groups using a spectrophotometric assay that measured 
the rate of disappearance of NADH. Values are means ± SE (n=9). 
 
Calcium Regulation 
 To determine if exercise-induced cardiac fatigue was associated with impaired regulation 
of intracellular Ca2+, SERCA2a and RyR2 function were assessed in the in vitro groups. The 
rates of Ca2+-dependent Ca2+-ATPase activity were determined across a ~10-7-10-5 M range of 
[Ca2+]f and the response to increasing [Ca2+]f was sigmoidal in nature (Figure 3.5A). The [Ca2+]f 
required to increase Ca2+-ATPase activity by 50% (pCa50), which represents the apparent Ca2+ 
affinity of SERCA2a, was not significantly different (p>0.05) between the three groups (inset 
Figure 3.5A). The highest Ca2+-ATPase rate that occurred in a pCa range of 5.26 to 4.92 was 
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deemed the maximal Ca2+-ATPase activity. As illustrated in Figure 3.5B, there were no 
significant differences (p>0.05) in maximal Ca2+-ATPase activity between the CTL, AC and 
24H groups. Across all [Ca2+]f examined, there was a non-significant (2.0 µM p=0.24, 1.5 µM 
p=0.25, 1.0 µM p=0.12, 0.5 µM p=0.16) depression in Ca2+ uptake of ~20% in the AC group 
relative to CTL and 24H groups (Figure 3.5C). Since Ca2+-dependent Ca2+-ATPase activity was 
unaltered, the reduction (albeit non-significant) in Ca2+ uptake could reflect a reduced efficiency 
or Ca2+/ATP coupling ratio of SERCA2a or may be due to increases in SR Ca2+ leak. 
 The function of RyR was assessed in two ways. The first was via 4-CMC-induced 
opening of the Ca2+ release channel. The rate of Ca2+ release was not altered (p>0.05) by 
exhaustive exercise when compared to the CTL group (Figure 3.6A). The second assessment of 
RyR function was achieved by adding CPA, a SERCA2a inhibitor, to the assay after the SR was 
loaded with Ca2+. Interestingly, there was a ~40% increase (p<0.05) in the rate of SR Ca2+ leak 
immediately following exhaustive exercise when compared to the CTL group (Figure 3.6B). 
During the 24 hour recovery period SR Ca2+ leak normalized and was not significantly different 
(p>0.05) than CTL values. 
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Figure 3.5. Determination of in vitro SERCA2a function. (A) The rate of Ca2+-dependent Ca2+-
ATPase activity was assessed in LV homogenate from CTL (solid squares), AC (solid circles) 
and 24H groups (solid triangle), over a negative log molar range of ~7-5. The pCa50 for Ca2+-
ATPase activity is displayed in the inset. (B) The maximal rate of Ca2+-ATPase activity. (C) The 
rate of oxalate supported Ca2+ uptake was assessed using Indo-1 and dual emission 
spectrofluorometry. The slope of the Ca2+ uptake curve was determined by differentiating the 
curve at four different free Ca2+ concentrations. Values are means ± SE (n=9). 
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Figure 3.6. Determination of in vitro RyR2 function. (A) The rate of 4-CMC-induced Ca2+ 
release. (B) The rate of Ca2+ leak out of the SR was assessed following the addition of CPA to 
the assay once Ca2+ uptake had reached a minimum (see Methods). Values are means ± SE (n=9). 
*Significantly different (p<0.05) than CTL and 24H groups. 
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SR Protein Content and Phosphorylation Status of SR Proteins 
 To examine any potential exercise-induced changes in protein content or phosphorylation 
state of SR proteins, semiquantitative Western blotting was performed. Exhaustive exercise did 
not alter (p>0.05) the protein content of SERCA2a, PLN and the ratio of phosphorylated PLN 
(pPLN) to PLN (Figure 3.7). PKA phosphorylation of serine 2808 on RyR was assessed and 
normalized to total RyR content. Acute exercise did not alter (p>0.05) the phosphorylation status 
of RyR nor did it alter the total RyR content (p>0.05) in LV homogenate from the CTL, AC or 
24H groups (Figure 3.8).  
 Since phosphorylated RyR content was not altered by acute exercise and given the fact 
that exercise caused an increase in ROS production, it is possible that oxidative modification of 
RyR caused an increase in Ca2+ leak from the SR. To assess oxidative modifications to RyR, 
RyR was immunoprecipitated from LV homogenates and Western blotting was performed on 
purified RyR. The formation of an aldehyde or ketone on an amino acid residue is referred to as 
carbonylation and is a marker of oxidative stress (Dalle-Donne et al., 2003). Protein 
carbonylation was assessed by reacting the immunoprecipitated RyR with 2,4-
dinitrophenylhydrazine, which creates 2,4-dinitrophenylhydrazone adducts on carbonylated 
RyR. There was no significant difference (p>0.05) in carbonyl content on RyR in the AC and 
24H groups when compared to the CTL group (Figure 3.9A). The addition of a –NO2 group to 
tyrosine residues results in the formation of nitrotyrosine and is a marker of oxidative stress 
(Viner et al., 1999; Xu et a., 2006). Western blot analysis demonstrated that exhaustive exercise 
did not alter (p>0.05) the nitrotyrosine content on RyR (Figure 3.9B). Similarly, there were no 
significant differences (p>0.05) in the glutathionylation of RyR between the CTL, AC and 24H 
groups (Figure 3.9C). 
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Figure 3.7. Western blot analysis of SR Ca2+ regulatory proteins from CTL, AC and 24H LV 
homogenate. (A) SERCA2a content, (B) PLN monomer content and (C) the ratio of 
phosphorylated monomeric PLN to monomeric PLN. Equal amounts of protein were loaded in 
each well. A representative blot is displayed in the inset above each graph. The optical densities 
of bands were measured using GeneTools and are presented as means ± SE (n=9). 
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Figure 3.8. Western blot analysis of RyR and phosphorylated RyR from CTL, AC and 24H LV 
homogenate.  (A) Total RyR content and (B) the ratio of phosphorylated RyR to RyR. Equal 
amounts of protein were loaded in each well. A representative blot is displayed in the inset above 
each graph. Values are presented as means ± SE (n=8). 
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Figure 3.9. Oxidative post-translational modifications to RyR2. Immunoprecipitated RyR was 
separated via SDS-PAGE and Western blotting was performed to assess oxidative modifications 
to RyR using antibodies specific for (A) carbonyl content (anti-dinitrophenyl), (B) 3-
nitrotyrosine content and (C) glutathionylation. Representative blots of the RyR pull down via 
immunoprecipitation and the post-translational modification to RyR are provided in each panel. 
Data are ratios of modified RyR to total RyR and are presented as means ± SE (n=8). 
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Calpain Activity 
 The augmented SR Ca2+ leak observed at the AC time point may have contributed to the 
decline in LVDP in the 24H group via activation of calpains due to a rise in the cleft Ca2+ 
concentration. Calpains are cysteine proteases that are activated by elevated cytosolic Ca2+ 
concentrations. Calpain activity was measured in LV homogenates using a minimally fluorescent 
peptide substrate that becomes highly fluorescent once cleaved by calpains. There was a 
significant increase (p<0.05) in calpain activity in the AC group when compared to the CTL 
group (Figure 3.10). 
 
 
 
 
 
 
 
 
Figure 3.10. Calpain activity in LV homogenates were determined by measuring the 
fluorescence of AMC (7-amino-4-methylcoumarin), the cleavage product of Suc-LLVY-AMC. 
Calpain activity was calculated as the difference between AMC fluorescence in the absence or 
presence of a calpain inhibitor (Z-LL-CHO) normalized to total protein. Values are means ± SE 
(n=5). *Significantly different (p<0.05) than CTL and 24H.  
 
Isolated Perfused Heart Function and Post-Perfusion SR Ca2+ Leak 
 To determine if there was an association between enhanced SR Ca2+ leak and reduced 
LVDP, which were observed in the AC groups in the current study and in Chapter 2, respectively, 
LV homogenate was collected from hearts after they were perfused for 30 minutes. Similar to 
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the findings in Chapter 2, there was a significant reduction (p<0.05) in basal LVDP in the AC 
and 24H groups when compared to the CTL group in post-perfusion cohort (Figure 3.11A). In 
addition, there were no significant differences (p>0.05) in ±dP/dt in the basal state from any of 
the three groups (Figures 3.11 B&C). Similar to the in vitro groups, in the post-perfusion AC 
group the rate of SR Ca2+ leak increased (p<0.05) by ~54% when compared to the post-perfusion 
CTL and post-perfusion 24H groups (Figure 3.12). The relationship between LVDP and SR Ca2+ 
leak was assessed using linear regression analysis. When all three groups were included in the 
analysis there was no significant relationship (p>0.05) between LVDP and SR Ca2+ leak. 
However, examination of CTL and AC data resulted in a trend (p=0.09) for an inverse 
relationship between LVDP and SR Ca2+ leak such that as the rate of SR Ca2+ leak increased the 
LVDP decreased (Figure 3.13B). These data suggest that increased SR Ca2+ leak was associated 
with the decline in LVDP observed in the AC group. 
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Figure 3.11. Indices of LV contractility from isolated perfused hearts in the post-perfusion 
group. (A) Left ventricular developed pressure (LVDP) from the CTL, AC and 24H groups. (B) 
The maximal rate of left ventricular pressure development (+dP/dt) and (C) the maximal rate of 
left ventricular pressure decline (-dP/dt). Values are means ± SE (n=7). *Significantly different 
(p<0.05) than CTL. 
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Figure 3.12. Assessment of SR Ca2+ leak following perfusion of isolated hearts. SR Ca2+ leak 
was assessed in LV homogenates from the CTL, AC and 24H groups in the post-perfusion groups 
of animals. Values are means ± SE (n=7). *Significantly different (p<0.05) than CTL and 24H. 
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Discussion 
 Research involving humans and animals has demonstrated the existence of cardiac 
fatigue in the basal state following an acute bout of prolonged or exhaustive exercise. Several 
rat studies have shown that aerobic activity resulted in elevated ROS production (Liu et al., 2000; 
Lin et al., 2006; Wonders et al., 2007). There are surprisingly few animal studies that have 
attempted to elucidate the intracellular mechanisms associated with exercise-induced cardiac 
fatigue, beyond elevated ROS production. The aim of this chapter was to examine the effect of 
exhaustive exercise on ROS production, maximal Ca2+-ATPase and Na+/K+-ATPase activity, 
Ca2+ uptake, Ca2+ release, Ca2+ leak and respective protein modifications when warranted. 
A hallmark of acute aerobic exercise is an increase in circulating plasma NE and Epi 
(Chin & Evonuk, 1971; LeBlanc et al., 1982; Cox et al., 1985; Scheurink et al., 1989). In this 
study, the average run time to exhaustion in the in vitro AC group and the post-perfusion AC 
group were 67 and 72 minutes, respectively. Immediately following exhaustive exercise, there 
was a ~5-fold increase in plasma Epi in the pooled AC group when compared to the CTL group 
(414 ± 93 pg/mL). This resting plasma Epi concentration is in close agreement with some 
(Blizard et al., 1980; Conlee et al., 1991), but not all studies (LeBlance et al., 1982; Cox et al., 
1985). Handling of animals prior to and during administration of anesthesia may explain the 
discrepancy among studies in terms of resting plasma Epi concentration. The magnitude of 
change in plasma Epi in the current study is within what appears to be a broad range (0.5-fold to 
10-fold) that depends on the type (i.e. treadmill versus swimming) and duration of exercise 
(LeBlanc et al., 1982; Cox et al., 1985; Scheurink et al., 1989; Conlee et al., 1991). The resting 
concentration of plasma NE was slightly above values previously reported in the literature 
(LeBlanc et al., 1982; Cox et al., 1985; Scheurink et al., 1989; Conlee et al., 1991). Contrary to 
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previous work, and despite a near doubling of plasma NE in the pooled AC group, there were no 
significant differences in NE concentrations between the AC group and the CTL group. It is 
possible that variability between animals masked an exercise effect. The coefficient of variation 
for the CTL group was ~72% compared to a range of ~34-45% in previously reported control 
groups (Cox et al., 1985; Scheurink et al., 1989; Conlee et al., 1991). The Epi data suggest that 
there was enhanced adrenergic drive during the exhaustive exercise, which may have 
implications for PKA mediated phosphorylation and protein function (to be discussed below).  
Striated muscle produces detectable amounts of ROS in the basal state, which is 
augmented during exercise and contributes to the genesis of fatigue (Reid, 2001; Allen et al., 
2008; Lamb & Westerblad, 2011). Unfortunately, it was not logistically possible to assess ROS 
production in vivo during the exhaustive exercise bout. However, markers of ROS production, 
namely DCF fluorescence and lipid peroxidation, were assessed in LV homogenates and 
represent post-hoc indicators of exercise-induced ROS production. In the AC in vitro group, 
animals that ran to exhaustion had increased ROS production (i.e. DCF fluorescence) when 
compared to the CTL and 24H groups. The elevated ROS in the AC group is in agreement with 
previous studies that have observed increased markers of an oxidative cellular environment 
following acute exercise of various lengths and modalities (Vitiello et al., 2011; Olah et al., 
2015). However, a study reported that following exhaustive treadmill exercise, DCF 
fluorescence in LV homogenate was not significantly different than the sedentary control group 
(Bejma et al., 2000). The amount of lipid peroxidation in the current study was not significantly 
different between the three groups. Similarly, several studies have reported that the amount of 
lipid peroxidation was not altered by exhaustive exercise in whole LV homogenate (Bejma et 
al., 2000; Liu et al., 2000) and post-nuclear homogenate (Gul et al., 2006). Conversely, studies 
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by Wonders and colleagues (2007) and Lin and colleagues (2006) observed a significant increase 
in lipid peroxidation of ~60% and ~40%, respectively, following an acute bout of treadmill 
running. The magnitude of increased lipid peroxidation in those studies is comparable to the non-
significant 30% increase in lipid peroxidation observed in the current study. Power analysis of 
the lipid peroxidation data revealed that to reach significance, an additional ten animals would 
be required in each to group. Taken together, these data suggest that exhaustive treadmill 
exercise increased ROS production, which may be associated with the exercise-induced cardiac 
fatigue observed in Chapter 2 and the current study.  
The increased ROS production observed in this study lends support to the hypothesis that 
cardiac fatigue may share similar mechanisms as myocardial stunning. Another mechanism that 
has been demonstrated to contribute to myocardial stunning is a ROS mediated reduction in 
Na+/K+-ATPase activity (Kaplan et al., 2005). In the current study, maximal Na+/K+-ATPase 
activity was assessed using a spectrophotometric assay in LV homogenate collected from the 
CTL, AC and 24H in vitro groups. When compared to the control group, exhaustive exercise did 
not have an effect on maximal Na+/K+-ATPase activity acutely, or 24 hours post-exercise. To 
the author’s knowledge, only one other study has examined the effects of exhaustive exercise on 
maximal Na+/K+-ATPase activity in the rat myocardium. In the study by Pierce and colleagues 
(1984), sarcolemmal membrane fractions were isolated from the LV of rats that swam with 2% 
of their body weight attached to their tail to the point of exhaustion (~38 minutes). In that study, 
the maximal Na+/K+-ATPase activities were not significantly different between the control group 
and the group that swam to exhaustion (Pierce et al., 1984). These authors did not examine the 
LV function to determine if the exhaustive swim protocol induced cardiac fatigue. Thus, it 
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appears that cardiac fatigue observed in this study was not associated with altered maximal 
Na+/K+-ATPase activity.   
 In cardiomyocytes, SERCA2a is a key regulator of SR Ca2+ content and subsequently 
cardiac contractility (Bers, 2002). Thus, it is possible that reduced SERCA2a function may have 
contributed to the decline in LVDP following acute exercise. The function of SERCA2a was 
assessed by measuring the rate of Ca2+ transport across the SR membrane (i.e. Ca2+ uptake) and 
the maximal Ca2+-ATPase activity. Contrary to what was hypothesized, the rate of Ca2+ uptake 
was not different between the CTL, AC and 24H in vitro groups. When SR Ca2+ uptake was 
calculated at a [Ca2+]f of 1.0 µM, the probability of the AC groups being statistically different 
than the CTL and 24H groups was 0.12. Of the four different [Ca2+]f that were chosen to assess 
the rate of SR Ca2+ uptake, this was the comparison that was closest to achieving significance. 
The rate of SR Ca2+ uptake reported is equal to the total Ca2+ uptake minus Ca2+ leak from the 
SR. As will be discussed below, the rate of Ca2+ leak was increased following exhaustive exercise 
and can account for the apparent decline in Ca2+ uptake in the AC group. Similar to the Ca2+ 
uptake data, the rate of maximal Ca2+-ATPase activity was not significantly different between 
the three groups. Not surprisingly, there were no significant differences in SERCA2a or PLN 
content between the three groups. In support of the Ca2+-ATPase data in the current study, 
Delgado and co-workers (1999) ran rats to exhaustion and found that the rates of maximal Ca2+-
ATPase activity were not significantly different between a control group, a group that completed 
exhaustive exercise and a group that was sacrificed 24 hours post-exercise. In another study, it 
was demonstrated that the rates of Ca2+ uptake were reduced by 40% in isolated SR membrane 
fractions from rats that swam until exhaustion when compared to a control group (Pierce et al., 
1984). The 40% reduction in Ca2+ uptake observed by Pierce and colleagues (1984) is similar in 
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magnitude to the reduction in Ca2+ uptake observed in myocardial stunning (O’Brien et al., 1991; 
Kumar et al., 2009) and would have likely resulted in depressed LV contractility. However, the 
study by Pierce and colleagues (1984) did not assess cardiac function following exhaustive 
exercise. Taken together, this model of exhaustive exercise caused cardiac fatigue, which was 
not associated with any alterations to in vitro SERCA2a function. SERCA2a is only one part of 
the Ca2+ regulatory system in the cardiomyocyte. Thus, regulation of Ca2+ may have been altered 
due to depressed RyR function.  
 The ryanodine receptor is a key regulator of cardiomyocyte function in both health and 
disease (Dulhunty et al., 2012). Accordingly, a reduction in Ca2+ release or increased Ca2+ leak 
would result in a decline in the Ca2+ transient amplitude and attenuated force production. The 
rate of Ca2+ release was assessed in vitro using the specific RyR agonist, 4-CMC (Herrmann-
Frank et al., 1996; Tupling & Green, 2002). The maximal rate of 4-CMC stimulated Ca2+ release 
was not significantly different immediately after exhaustive exercise or 24 hours post-exercise 
when compared to the CTL group. It has been demonstrated in canine LV that the rate of Ca2+ 
release was increased following 25 minutes of intermittent exercise (Sanchez et al., 2008). These 
authors demonstrated that the augmentation of Ca2+ release was dependent on NOX activity and 
glutathionylation of the release channel. It is possible that low to moderate amounts of exercise 
can augment Ca2+ release, whereas exhaustive exercise may result in modifications to RyR that 
nullify the positive effect of brief exercise. Further studies would be required to confirm this 
hypothesis. 
In addition to SR Ca2+ release, the rate of SR Ca2+ leak through the Ca2+ release channel 
was assessed in vitro as described in the methods. When compared to the CTL group, the rates 
of SR Ca2+ leak were significantly increased by ~40% in the AC group. In the 24 hour period 
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following the exhaustive exercise bout the rates of SR Ca2+ leak normalized and were not 
different than the CTL group. Few studies have attempted to examine the effects of acute 
exercise on SR Ca2+ leak in healthy animals. The increased rate of SR Ca2+ leak observed in the 
current study conflicts with previous research that demonstrated a decrease in SR Ca2+ leak 
following 25 minutes of intermittent exercise (Sanchez et al., 2008). These data suggest that brief 
intermittent aerobic activity reduced SR Ca2+ leak, which may augment cardiac function, 
whereas, exhaustive exercise caused an increase in SR Ca2+ leak, which may have impaired 
LVDP.  
To further demonstrate the importance of increased SR Ca2+ leak on LVDP, hearts from 
a second cohort of animals (i.e. post-perfusion groups) were isolated and perfused for 30 minutes 
and then LV homogenates were collected. The rationale for including the post-perfusion 
experiments were to develop an association between exercise-induced impairments in SR Ca2+ 
leak and reduced LVDP. If the increased rate of Ca2+ leak observed in the in vitro AC group was 
indeed associated with reduced LVDP then it would be expected that following isolated heart 
experiments that SR Ca2+ leak would also be increased. Similar to Chapter 2, exhaustive exercise 
resulted in a significant reduction in LVDP in the AC and 24H groups when compared to the 
CTL group. Importantly, there was a significant increase in SR Ca2+ leak in the post-perfusion 
AC group when compared to the post-perfusion CTL group. Regression analysis using the post-
perfusion CTL and AC data revealed a trend (p=0.09) towards an inverse relationship between 
LVDP and the rate of SR Ca2+ leak, such that as the SR Ca2+ leak rate increased, the LVDP 
decreased. As this is the first study to demonstrate this relationship following exhaustive 
exercise, insight into the mechanisms associated with increased SR Ca2+ leak and impaired 
cardiac contractile function may be drawn from chronic disease models. 
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A link between aberrant SR Ca2+ leak and depressed cardiac function has been 
demonstrated in studies using models of heart failure (Terentyev et al., 2008; Gonzalez et al., 
2010; Bers, 2014). Research by Andrew Marks’ group from Columbia University has resulted 
in the development of a RyR Ca2+ leak model of heart failure (for review see Marks, 2013). The 
model states that heart failure results in chronically elevated circulating catecholamines (i.e. NE 
and Epi), which leads to augmented PKA activity. The enhanced PKA activity results in 
hyperphosphorylation of RyR, which causes the accessory protein, calstabin2 to dissociate from 
RyR. Under normal conditions calstabin2 stabilizes the RyR macromolecular complex, but upon 
dissociation, the RyR complex destabilizes and becomes “leaky”. Persistent leakage of Ca2+ from 
the SR results in a decline in the total SR Ca2+ content, a reduction in the amplitude of subsequent 
Ca2+ transients and a decline in force production. It is possible that elevated catecholamines, 
specifically Epi, observed in the current study resulted in PKA activation and phosphorylation 
of RyR, which subsequently augmented SR Ca2+ leak. However, contrary to observations in 
heart failure studies, acute exercise did not alter the ratio of phosphorylated RyR to RyR in any 
of the three groups. Acute exercise has been demonstrated to increase phosphorylation of RyR1 
and RyR2 (Bellinger et al., 2008; Gehlert et al., 2012; Wehrens et al., 2003). The discrepancy 
between the current study and previous exercise studies in terms of RyR phosphorylation may 
be related to the temporal effects of LV collection and homogenization. These steps were 
performed as quickly as possible, but several minutes elapsed from the time of exercise cessation 
to LV homogenization, which may have resulted in dephosphorylation of RyR. Indeed, in order 
to observe increased RyR phosphorylation in the isolated perfused heart following ISO infusion 
(i.e. simulated exercise), a mild protein phosphatase inhibitor was required in the perfusate 
(Reiken et al., 2003). Thus, it is possible that high phosphatase activity post-exercise limited the 
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ability to detect changes in phosphorylated RyR in the current study. In addition, studies have 
challenged the Marks group model regarding the functional consequences of RyR 
phosphorylation in the healthy and failing myocardium (MacDonnell et al., 2008; Zhang et al., 
2012). Taken together, the increased SR Ca2+ leak through the RyR observed in the current 
chapter may not be related to changes in phosphorylation state, which suggests that alternative 
RyR post-translational modification may have occurred during acute exercise. 
Acute exercise and disease models can alter the function of RyRs via ROS dependent 
post-translational modification (Sanchez et al., 2008; Bellinger et al., 2009; Andersson et al., 
2011a). To determine if oxidative modification of RyR contributed to the increased rate of SR 
Ca2+ leak observed in the current study, RyR was immunoprecipitated and Western blot analyses 
were performed to probe for oxidative modifications to purified RyR. Exhaustive exercise did 
not alter the carbonyl content on RyR acutely or 24 hours post-exercise. Acute exercise has been 
shown to increase carbonyl content in whole LV homogenate and in post-nuclear homogenate 
(Perez et al., 2003; Aydin et al., 2007). In support of the current findings, Liu and co-workers 
(2000) did not observe a change in carbonyl content in LV homogenate from rats run to 
exhaustion. Unfortunately assessment of carbonylation using any type of homogenate 
preparation does not provide an indication of specific proteins that were carbonylated. In chronic 
disease models such as diabetes, muscular dystrophy and aging, immunoprecipitation of RyR 
has been used to demonstrate that RyR specific carbonylation and Ca2+ leak is increased in these 
models when compared to healthy control groups (Andersson et al., 2011a; Andersson et al., 
2011b; Shao et al., 2012). In the current study we demonstrated a rise in ROS production, 
increased SR Ca2+ leak and no change in carbonylation in the AC group. These data suggest that 
carbonylation of RyR did not contribute to the increased rate of SR Ca2+ leak following 
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exhaustive exercise or that the techniques employed were not sensitive enough to detect 
differences in carbonylation. It is possible that alternative redox modifications to RyR may have 
taken place during exhaustive exercise, which contributed to the increased rate of Ca2+ leak. 
The production of nitric oxide (NO) and superoxide results in increased nitration of 
cardiac proteins in models such as aging and cardiovascular disease (Viner et al., 1999; Xu et a., 
2006). The accumulation of nitrotyrosine residues on SR proteins has been demonstrated to have 
a negative impact on the protein function (Viner et al., 1999; Knyushko et al., 2005; Lokuta et 
al., 2005; Tang et al., 2010). Given that NO and superoxide production is augmented during 
exercise in the heart (Bo et al., 2008; Roof et al., 2013), it is possible that the increased SR Ca2+ 
leak was a result of tyrosine nitration of RyR. Surprisingly, Western blot analysis failed to detect 
differences in nitrotyrosine content between the three groups. However, several studies have 
demonstrated in disease models where ROS production is chronically augmented, that there is 
an increase in nitration of RyR (Kanski et al., 2005; Jain et al., 2014; Yamada et al., 2014). These 
data suggest that perhaps chronic exposure to elevated ROS is required to nitrate RyR and alter 
channel function, compared to the acute period of increased ROS production observed in the 
current study.    
The addition of glutathione (GSH) to a free thiol (-SH) containing cysteine residue on a 
protein is referred to as S-glutathionylation and is an important physiological regulator of protein 
function in both health and disease (Ghezzi, 2013). To determine if S-glutathionylation of RyR 
contributed to the increase in SR Ca2+ leak, S-glutathionylation content was assessed via Western 
blotting of immunoprecipitated RyR from the CTL, AC and 24H groups. Exhaustive exercise 
did not alter S-glutathione content on RyR. These findings are at odds with a previous study that 
found acute exercise increased S-glutathione content on RyR, which resulted in an increase in 
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SR Ca2+ release and an attenuation of SR Ca2+ leak (Sanchez et al., 2008). The exercise protocol 
employed by Sanchez and colleagues (2008) was brief in duration and of a moderate intensity, 
thus the exhaustive nature of the exercise protocol used in the current study may have prevented 
or reversed any S-glutathionylation of RyR. Indeed, under more extreme models of cardiac 
stress, namely ischemia and reperfusion, the amount of S-glutathionylated RyR was reduced, 
which was associated with attenuated SR Ca2+ release (Tang et al., 2010; Wang et al., 2013). 
These previous studies demonstrate that RyR function can be regulated via S-glutathionylation. 
However, it appears likely that S-glutathionylation of RyR did not contribute to the increased 
leak through the Ca2+ release channel observed in the present study.     
The increased rate of Ca2+ leak from the SR may have contributed to the reduced LVDP 
observed in the AC group and it may also explain the reduction in LVDP observed 24 hours 
post-exercise. An elevated rate of SR Ca2+ leak would likely increase the Ca2+ concentration in 
the cleft region of the cardiomyocyte. Calpains are Ca2+ activated cysteine proteases, which are 
activated by nM to µM concentrations of Ca2+ (Matsumura et al., 2001). Acute exercise increased 
the calpain activity immediately after exercise when compared to the CTL and 24H groups. 
These findings are similar to previous studies that ran rats for one hour at 25 m/min and 8% 
grade or 21 m/min and 12% grade and found that calpain activity in the LV was increased by 
46% and ~1.8-fold, respectively (Raj et al., 1998; Tiidus et al., 2002). Activation of calpains has 
been demonstrated to participate in myocardial stunning (Matsumura et al., 1993; Matsumura et 
al., 1996). In addition, calpains have been demonstrated to cleave Na+/K+-ATPase, troponins, 
NCX and RyR (Zeitz et al., 2002; Inserte et al., 2005; Pedrozo et al., 2010; Wanichawan et al., 
2014). Thus it is possible that activation of calpains and degradation of one or more of these 
proteins may have impaired EC coupling and contributed to the cardiac fatigue observed in the 
 109 
 
24H group. Unfortunately, assessment of EC coupling cannot be performed by an in vitro assay. 
Therefore, further research is warranted to examine this hypothesis.  
 This study demonstrated that exhaustive exercise resulted in an increased rate of SR Ca2+ 
leak, which was observed in the in vitro and post-perfusion groups. These data suggest that the 
cardiac fatigue observed in the AC groups in Chapter 2 and the current study were associated 
with increased SR Ca2+ leak. Exhaustive exercise resulted in an increase in ROS production and 
a robust increase in plasma Epi concentration. However, our results indicate that carbonylation, 
nitration, glutathionylation and phosphorylation of RyR do not appear to be linked 
mechanistically to the observed increase in SR Ca2+ leak. It is possible that the Western blot 
techniques employed in this study were not sensitive enough to detect exercise-induced post-
translational modifications to RyR. Acute exercise activated the protease, calpain, which has 
been implicated in myocardial stunning. Calpain activation may explain the prolonged (up to 24 
hours) depression in LVDP observed in the current study as cleavage of EC coupling proteins 
would require de novo protein synthesis. Thus, an increase in SR Ca2+ leak resulted in cardiac 
fatigue acutely and 24 hours post-exercise, likely via changes in SR Ca2+ load and calpain 
mediated impairment of EC coupling. 
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Chapter IV: Inhibition of NADPH oxidase prevents exercise-induced cardiac fatigue by 
preventing SR Ca2+ leak and calpain activation 
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Synopsis 
 Previous studies and the findings from Chapter 3 suggest that ROS production is 
augmented following prolonged or exhaustive exercise, which may be associated with cardiac 
fatigue. However, only one study has utilized an intervention to reduce ROS production and 
prevent cardiac fatigue. Thus, the purpose of this study was to determine if NOX inhibition 
would prevent cardiac fatigue and to determine the mechanisms associated with preservation of 
cardiac contractility. Three groups of adult, male Sprague-Dawley rats (21-23 weeks) were 
provided 1.5 mM APO in their drinking water for three days and assigned to a control group 
(APO CTL), a group that was sacrificed following the exhaustive exercise bout (APO AC) or a 
group that was sacrificed 24 hours post-exercise (APO 24H). One cohort of animals were used 
for isolated perfused heart experiments while another was used for in vitro experiments. The 
LVDP and ±dP/dt were not significantly different between the three APO groups in the basal 
state or during β-adrenergic stimulation, which suggests that inhibition of NOX prevented 
exercise-induced cardiac fatigue. There were no significant differences in ROS production or 
lipid peroxidation between the APO treated groups. Additionally, the level of ROS production 
was significantly lower in the APO treated groups when compared to the non-APO treated 
groups in Chapter 3. The rates of SR Ca2+ leak were not significantly different between the APO 
treated groups. Furthermore, APO treated groups had reduced rates of SR Ca2+ leak when 
compared to non-APO treated groups in Chapter 3. NOX inhibition further augmented RyR 
function in terms of Ca2+ release, whereby Ca2+ release was higher in APO treated groups when 
compared to non-APO treated groups. Within the APO treated groups there were no significant 
differences in RyR nitration, carbonylation, glutathionylation or phosphorylation, which 
suggests that these post-translational modifications were not associated with the reduction in SR 
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Ca2+ leak in the APO AC group. The maximal Ca2+-ATPase activities were not different between 
the three APO treated groups. There was a main effect of NOX inhibition such that maximal 
Ca2+-ATPase activity was lower in APO treated groups when compared to non-APO treated 
groups. Consequently, there was a significant increase in the coupling ratio (Ca2+ uptake/Ca2+-
ATPase activity) in the APO treated groups, which was due in part to the reduction in SR Ca2+ 
leak. NOX inhibition resulted in a significant increase in the apparent Ca2+ affinity of SERCA2a 
in APO treated groups, which was likely due to increased phosphorylation of PLN. These data 
suggest that the function of SERCA2a and RyR were augmented when NOX was inhibited, 
which mechanistically may explain the prevention of cardiac fatigue observed in APO AC and 
APO 24H groups. Lastly, there were no significant differences in calpain activity in the APO 
treated groups and overall calpain activity was lower in these groups when compared to non-
APO treated groups. Taken together, NOX inhibition prevented cardiac fatigue and the 
associated mechanisms were a reduction in ROS production, improved Ca2+ regulation and an 
attenuation in calpain activity. 
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Introduction 
Several studies have observed cardiac fatigue in rats following one to four hours of 
aerobic exercise, which was associated with an increase in ROS production (Wonders et al., 
2007; Vitiello et al., 2011; Olah et al., 2015). In the previous chapter it was observed that 
exhaustive exercise resulted in a significant increase in ROS production as measured in LV 
homogenates. Interestingly, a study by Vitiello and colleagues (2011) found that animals 
provided with the NADPH oxidase inhibitor, apocynin, prior to the acute exercise bout did not 
experience cardiac fatigue or oxidative stress. Their results suggest that activation of NADPH 
oxidases during exercise resulted in increased ROS production, which contributed to cardiac 
fatigue. However, the downstream effects of NOX activation were not investigated in that study. 
NADPH oxidases (NOXs) are a multi-subunit enzyme complex that catalyzes the 
following reaction: 
NADPH + 2O2 NADPH oxidase�⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯� 2O2− + NADP+ + H+    
The activation of NOXs are important under physiological and pathological conditions (Bedard 
& Krause, 2007). There are five NOX isoforms (NOX1-5), with NOX2 and NOX4 being the 
two predominant isoforms expressed in the myocardium (Bendall et al., 2002; Li et al., 2006; 
Akki et al., 2009). NOXs are transmembrane proteins that require interaction with one or more 
regulatory proteins to confer activity. In cardiomyocytes, NOX2 and NOX4 associate with the 
regulatory protein, p22phox, which acts to stabilize the enzyme. Activation of NOX2 requires 
translocation of the cytosolic proteins p40phox, p47phox, p67phox and rac to the nascent NOX2 and 
p22phox complex. NOX4 only requires p22phox in order to be activated, and thus is constitutively 
active at a low level in the basal state (Matsushima et al., 2014).  
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 In Chapter 3 it was demonstrated that exhaustive exercise resulted in an increase in ROS 
production, which was associated with a ~40% increase in the rate of SR Ca2+ leak and reduced 
cardiac contractility. Currently it is not clear what the source of ROS production was in Chapter 
3. It is possible that the increased rate of SR Ca2+ leak was mediated by NOX dependent ROS 
production. Acute activation of NOX has been shown to regulate RyR1 and RyR2 function via 
ROS-induced post-translational modification (Sanchez et al., 2008; Sun et al., 2011). An in vitro 
study incubated skeletal muscle SR membrane fractions under varying partial pressures of 
oxygen (1, 5 and 20% PO2) and observed a progressive increase in ROS production as PO2 
increased (Sun et al., 2011). It was determined that NOX4 dependent ROS production oxidized 
a small number of cysteine residues on RyR1 and increased the open probability of the Ca2+ 
channel. Another study incubated triads (a t-tubule flanked by two SR terminal cisternae) 
isolated from skeletal muscle with NADPH in order to activate NOX, and observed an increase 
in the open probability and S-glutathionylation of RyR (Hidalgo et al., 2006). An increase in the 
open probability of RyR results in an increase in the leak rate through the channel (Williams et 
al., 2011; Wang et al., 2014). Conversely, a study by Sanchez and co-workers (2008) ran dogs 
intermittently for 25 minutes, which resulted in S-glutathionylation of RyR2 and a decrease in 
the rate of Ca2+ leak. Interestingly, inhibition of NOX with APO prevented structural and 
functional modifications to RyR, in these previous studies. The SR Ca2+ leak data from the study 
by Sanchez and colleagues (2008) is opposite to the SR Ca2+ leak data from Chapter 3 and may 
be related to the exhaustive nature of the exercise protocol used in the current thesis. Perhaps the 
effects of exhaustive exercise on NOX activation and SR Ca2+ leak in association with cardiac 
fatigue are more analogous to models of severe stress rather than brief, low intensity exercise.  
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In pathological models such as heart failure, diabetes and atherosclerosis there is an 
increase in NOX dependent ROS production (Liu et al., 2010; Maalouf et al., 2012; Kinkade et 
al., 2013). When NOX was inhibited in these disease models the progression and/or severity of 
the disease was reduced (Liu et al., 2010; Roe et al., 2011; Kinkade et al., 2013). The 
improvement in health of these animals when NOX was inhibited may have been due to 
improved Ca2+ regulation. Indeed, in a mouse model of dystrophic cardiomyopathy, it was 
demonstrated that dystrophic hearts had a 5-fold increase in NOX2 expression and a decrease in 
contractility, which was associated with an increased rate of SR Ca2+ leak (Gonzalez et al., 2014). 
Incubation of cardiomyocytes with APO partially restored contractility and fully restored SR 
Ca2+ regulation. In a transgenic mouse line that expressed constitutively active Rac1 it was 
demonstrated that RyR2 function was impaired as indicated by a significant reduction in the 
fractional release of Ca2+ from the SR and an increase in the rate of SR Ca2+ leak (Oberhofer et 
al., 2013). Taken together, chronic activation of NOX is associated with increased SR Ca2+ leak, 
which may contribute to impaired contractile function. Thus, it is possible that the exhaustive 
exercise protocol employed in Chapter 3 resulted in activation of NOX and ROS production, 
which contributed to the genesis of cardiac fatigue. 
There appears to be a link between activation of NOX and calpains in the myocardium 
in response to physiological stress. In isolated cardiomyocytes, incubation with NE significantly 
increased NOX activity and activated calpains, which lead to apoptosis of cardiomyocytes (Li et 
al., 2009a). Induction of cardiomyocyte apoptosis was prevented when cells were treated with 
APO prior to application of NE. In a separate study, rat cardiomyocytes were incubated with 
high concentrations of glucose, which resulted in calpain activation and subsequently lead to cell 
death (Li et al., 2009b). The effects of hyperglycemic stress were prevented when a NOX 
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inhibitor or a RyR antagonist were incubated with the cardiomyocytes. These data suggest that 
there may be an interaction between activation of NOX, altered RyR function and calpain 
activation. 
In Chapter 2 and Chapter 3, exhaustive exercise caused a reduction in LVDP, which 
persisted for 24 hours post-exercise. It has been hypothesized that exercise-induced cardiac 
fatigue is a form of pseudo-myocardial stunning (Starnes & Bowles, 1995; Siegel et al., 1997; 
Scott et al., 2008) and perhaps may share common mechanisms. It has been demonstrated that 
exposure of skinned trabeculae to calpains recapitulated the decreased myofilament sensitivity 
to Ca2+ and decreased maximal Ca2+ activated force present in trabeculae from stunned 
myocardium (Gao et al., 1996). Furthermore, myocardial stunning was prevented in hearts that 
were provided leupeptin, a calpain inhibitor, prior to ischemia and reperfusion (Matsumura et 
al., 1993; Matsumura et al., 1996). Activation of calpains in cardiomyocytes has been shown to 
cleave troponins, NCX, RyR, desmin, actin, myosin and junctophilin (Zeitz et al., 2002; Blunt 
et al., 2007; Ke et al., 2008; Pedrozo et al., 2010; Celes et al., 2013; Murphy et al., 2013; 
Wanichawan et al., 2014). In Chapter 3, there was an increase in calpain activity immediately 
after exhaustive exercise. Therefore, it is possible that activation of calpains resulted in 
degradation of one or more EC coupling related proteins, which impaired EC coupling and 
contributed to the cardiac fatigue observed 24 hours post-exercise. 
Inhibition of NOX has been shown to prevent exercise-induced cardiac fatigue (Vitiello 
et al., 2011). It is possible that the increased rate of SR Ca2+ leak observed in Chapter 3 was 
mediated by NOX activation and contributed to the development of cardiac fatigue via two 
distinct mechanisms. The first mechanism would be a reduction in the amount of stored Ca2+ in 
the SR due to increased Ca2+ leak, which would lower the fractional release of Ca2+ and the 
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developed tension in cardiomyocytes. The second mechanism is related to augmented SR Ca2+ 
leak and an elevation in the intracellular Ca2+ concentration, which likely activated calpains. 
Accordingly, the purpose of this study was to supplement rats with APO prior to an exhaustive 
exercise bout to examine the hypotheses that NOX inhibition would prevent the exercise-induced 
cardiac fatigue by preventing ROS production, increased SR Ca2+ leak and activation of calpains.            
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Methods 
Animals 
 Adult male Sprague-Dawley rats (21-23 weeks) were used in this study. All animals were 
obtained from the breeding colony at the University of Waterloo. Animals were housed four per 
cage, were placed on a reverse 12 hour light cycle and had free access to food and water. All 
procedures were reviewed and approved by the University of Waterloo Animal Care Committee. 
Experimental Design  
A pharmacological intervention was employed in this study in an attempt to prevent 
exercise-induced cardiac fatigue. Rats were provided drinking water supplemented with 1.5 mM 
APO for 3 days prior to the exhaustive exercise bout. Pilot studies demonstrated that there were 
no significant differences in the amount of water consumed in the absence or presence of APO 
and that daily consumption of APO averaged ~19 mg/kg body wt/day. The concentration of APO 
in the drinking water and consumption rate are well within previously reported concentrations 
(1.5-12 mM) and consumption rates (4-100 mg/kg/day) (Sanchez et al., 2008; Roe et al., 2011; 
Vitiello et al., 2011; Castro et al., 2012; Dal-Ros et al., 2012; El-Sawalhi & Ahmed, 2014; 
Winiarska et al., 2014). The APO supplementation regime used in the current study was selected 
based off of work by Vitiello and colleagues (2011), who demonstrated that this concentration 
prevented exercise-induced cardiac fatigue.   
Two cohorts of animals were used in this study, the first was used solely for isolated 
perfused heart experiments and the second was used for in vitro experiments (described below). 
There were three groups in each cohort; a control group (APO CTL), an acute exercise group 
(APO AC) that was sacrificed immediately following exhaustive exercise and a group that was 
sacrificed 24 hours after exhaustive exercise (APO 24H). The anthropometric data for all of these 
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groups are presented in Table 4.1. Animals in all groups were acclimated to treadmill running 
for 7 days prior to the exhaustive exercise bout. The exhaustive exercise bout utilized was 
identical to that described in Chapters 2 and 3. 
 
Isolated Perfused Heart  
 A detailed description of the isolated perfused heart experiments were presented in 
Chapters 2 and 3. Briefly, animals were anesthetized via a tail vein injection of sodium 
pentobarbital (35 mg/kg) prior to excision of the heart. Hearts were mounted to an aortic cannula 
and perfused in a retrograde fashion at a constant pressure (~80 mmHg) with Krebs-Henseleit 
buffer warmed to 37°C and bubbled with 95%O2-5%CO2. The LV was instrumented with a 
balloon tipped catheter and the volume of the balloon was adjusted to provide a diastolic pressure 
of ~10 mmHg. Pressure transducers (MLT844, AD Instruments) were connected to the system 
proximal to the aortic cannula and to the balloon tipped catheter for determination of perfusion 
pressure and LV pressure, respectively. An ultrasonic flow probe (2PXL, Transonic Systems) 
Table 4.1:  Anthropometric data from the APO treated in vitro and isolated perfused heart groups
Masses p values
Body Mass (g) 471 ± 14 464 ± 8 466 ± 7 0.89
Heart Mass (g) 1.53 ± 0.031 1.51 ± 0.038 1.50 ± 0.060 0.87
Left Ventricle Mass (g) 1.07 ± 0.026 1.03 ± 0.018 1.04 ± 0.039 0.62
Left Ventricle/Body Mass 0.00229 ± 0.00010 0.00222 ± 0.00005 0.00223 ± 0.00006 0.81
Body Mass (g) 473 ± 9 484 ± 10 474 ± 12 0.73
Heart Mass (g) 1.73 ± 0.030 1.83 ± 0.029 1.76 ± 0.044 0.11
Left Ventricle Mass (g) 1.14 ± 0.021 1.21 ± 0.019 # 1.18 ± 0.027 0.04
Left Ventricle/Body Mass 0.0024 ± 0.00002* 0.00251 ± 0.00003 0.0025 ± 0.00003 0.01
Anthropometric data from apocynin supplemented animals that were used for isolated perfused heart experiments and in vitro  experiments.
The number of animals in each group is indicated beside the group label. Data are presented as means ± SE.
# Significantly different (p<0.05) than CTL
* Significantly different (p<0.05) AC & 24H
APO CTL (n=8) APO AC (n=8) APO 24H (n=8)
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APO CTL (n=17) APO AC (n=12) APO 24H (n=11)
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was placed proximal to the aortic cannula, which measured global coronary flow. Following 
instrumentation, hearts were allowed to equilibrate for 30 minutes at which point baseline data 
were recorded. On a subset of hearts (n=6/group) an ISO dose response was performed using a 
range of ISO concentrations from 10-11 to 10-7 M. All data were collected using a Powerlab data 
acquisition system (4/sp, AD Instruments) and were analyzed using Chart software (Ver. 5, AD 
Instruments). 
Plasma Collection and Tissue Sampling  
Prior to excision of the heart, blood was drawn from the inferior vena cava into a 1 mL 
syringe containing 25 µL of 0.195 M reduced glutathione and 0.237 M EGTA pH 7.0. Blood 
was gently inverted several times and was centrifuged at 4500 g for 10 min. The plasma was 
collected and stored at -80°C until analysis of NE and Epi concentrations. 
 In the cohort of animals used for in vitro experiments, the hearts from anaesthetized 
animals (n=8/group) were excised and placed in ice cold homogenizing buffer. Subsequently, 
the aorta was cannulated using a teflon catheter and flushed with 10 mL of ice cold 
homogenization buffer to remove blood from the coronary vasculature. The heart was trimmed 
of atria, the aorta, connective tissue and the right ventricle. A piece of LV was frozen and the 
remaining LV was diluted (wt:vol, 1:10) in homogenization buffer and homogenized using a 
motorized tissue grinder (PT3100, Polytron). The piece of LV and homogenate were frozen and 
stored at -80°C. 
DCF fluorescence and ROS Production 
 ROS production in LV homogenate was determined using DCFH-DA as previously 
described (Campbell et al., 2014). Briefly, LV homogenates were incubated at 37oC in the dark 
with 5 μM DCFH-DA in imidazole buffer and DCF fluorescence was quantified using a 96-well 
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plate spectrofluorometer (SPECTRAmax Gemini XS, Molecular Devices) with excitation and 
emission wavelengths of 490 nm and 525 nm, respectively. The fluorescence intensity was 
normalized to the total protein in each well and was expressed as arbitrary units per μg protein 
(AU/μg protein).  
Malondialdehyde Content 
 MDA content was assessed in fresh LV homogenate following the methods of Ohkawa 
and colleagues (1979). Briefly, ~25 mg of frozen LV was homogenized in ten volumes of 1.15% 
KCl using a glass homogenizer (Kontes). LV homogenate samples and MDA standards were 
reacted with acidic TBA for an hour at 95-100oC and subsequently cooled. After cooling, 500 
μL of H2O and 2.5 mL of a mixture of n-butanol and pyridine (15:1, v/v) were added and the 
samples were vortexed for 30 seconds. Then the samples were centrifuged at 2000 g for 10 
minutes, 200 μL of the organic layer from each sample was added to a clear, round bottom 96-
well plate and the absorbance was read at 532 nm (SPECTRAmax Plus, Molecular Devices). 
The MDA concentration in each sample was calculated using the slope and y-intercept of the 
MDA standard curve and was normalized to protein content in the homogenate. 
Ca2+- Dependent Ca2+-ATPase Activity 
The assay used to measure Ca2+-dependent Ca2+-ATPase activity was described in detail 
in Chapter 3 and was adapted from a cuvette based spectrophotometric assay to a 96-well plate 
reader assay (Simonides & van Hardeveld, 1990; Duhamel et al., 2007). Each LV homogenate 
sample was added to a cocktail that contained 5 mL assay buffer, 18 U/mL LDH, 18 U/mL PK 
and 1 μM Ca2+ ionophore (A23187, Sigma). Subsequently, the cocktail was subdivided into 16 
microcentrifuge tubes with varying concentrations of CaCl2. Next, two aliquots from each of the 
sixteen subdivisions was loaded onto a clear bottom 96-well plate and then NADH was added to 
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each well. The decrease in NADH absorbance at 340 nm represents total ATPase activity 
(SPECTRAmax Plus, Molecular Devices). The difference between the total ATPase activity and 
the basal ATPase activity (i.e. activity in the presence of CPA) represents the Ca2+-ATPase 
activity.  
Ca2+ Uptake, Ca2+ Leak and Ca2+ Release 
 Ca2+ uptake, Ca2+ leak and Ca2+ release were measured at 37°C in LV homogenates using 
Indo-1 as previously described in Chapter 3 and by Tupling & Green (2002). The assay buffer 
contained (in mM): 200 KCl, 20 HEPES pH7.0, 10 NaN3, 0.005 N,N,N′,N′-tetrakis(2-
pyridylmethyl) ethylenediamine, 5 oxalate, 15 MgCl2. In a 4-sided clear cuvette, 1.5 μM Indo-
1, ~4.5 μL of 10 mM CaCl2 and ~1.5 mg LV homogenate were brought to a total volume of 2.0 
mL with assay buffer. The reaction was initiated with the addition of 40 μL of 250 mM ATP. 
The rate of Ca2+ uptake (μmol·g protein-1·min-1) was determined at a [Ca2+]f of 2.0, 1.5, 1.0 and 
0.5 μM by differentiating the [Ca2+]f versus time curve. Ca2+ release and Ca2+ leak were induced 
using 4-CMC and CPA, respectively, once Ca2+ uptake reached a minimum.  
In Vitro Activation of NOX, ROS Production and Ca2+ Leak 
 In the previous chapter, it was demonstrated that exhaustive exercise increased ROS 
production, which was associated with increased SR Ca2+ leak and cardiac fatigue. In this study, 
it was hypothesized that in vivo inhibition of NOX would ameliorate exercise-induced ROS 
production and SR Ca2+ leak, which would prevent cardiac fatigue. In an attempt to further 
confirm this hypothesis several in vitro experiments were performed. Previous in vitro studies 
demonstrated that PO2 manipulation or exogenous NADPH activated NOX, which augmented 
ROS production and increased RyR open probability (Hidalgo et al., 2006; Sun et al., 2011). 
Therefore, the aim of the first experiment was to determine if endogenous NOX in LV 
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homogenate could be activated using exogenous NADPH as a substrate. ROS production, as 
indicated by DCF fluorescence, was assessed in LV homogenate alone, LV homogenate plus 1 
mM NADPH and in LV homogenate with 1 mM NADPH and 30 μM APO. Once, it was 
established that exogenous NADPH could activate NOX and increase ROS production, these 
incubation conditions (i.e. LV incubation in the presence and absence of APO and NADPH) 
were performed in LV homogenate subsequent to measurement of SR Ca2+ leak. 
Calpain Activity 
 Calpain activity was assessed using a fluorescent assay as described by (McMillan and 
a, 2011). Briefly, LV homogenates were incubated at 37oC with the non-fluorescent calpain 
substrate, Suc-LLVY-AMC (Enzo Life Sciences) in the presence or absence of the calpain 
inhibitor, Z-LL-CHO (Enzo Life Sciences). Calpain activity was calculated as the difference 
between AMC fluorescence from LV homogenate incubated with and without the calpain 
inhibitor. The fluorescence intensity was normalized to the total protein in each well and was 
expressed as arbitrary units per μg protein (AU/μg protein).  
Western Blotting 
The following antibodies were used in this study. The dilution factor of each primary 
antibody is provided in the parentheses: SERCA2a (1:4000), PLN (1:2000), RyR (1:1000), 
NOX4 (1:1000) (Pierce Antibodies); p-PLN (1:1000) (Cell Signaling); anti-GSH (1:1000) 
(Virogen); Ser2808 p-RyR (1:1000) (Abcam); anti-DNP (1:1000) (Sigma). 
The Western blotting protocol used in this study was described in further detail in Chapter 
3. Unless described elsewhere, all samples were diluted in 1X Sample Buffer under reducing 
conditions. Samples were loaded on a polyacrylamide gel and separated using standard 
electrophoresis techniques (Laemmli, 1970), or in the case of PLN, proteins were separated using 
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a Tris-Tricine gel (Schaggar, 2006). Once proteins were transferred to a PVDF membrane, the 
membrane was blocked for 1 hour at room temperature using 5% non-fat milk in TBST. 
Membranes were washed with TBST and then incubated with the appropriate primary antibody. 
The membranes were then washed, incubated with secondary antibody and washed a final time. 
Signals were detected using enhanced chemiluminescence and the ChemiGenius2 imaging 
system and GeneSnap Software (SynGene). The optical density of protein bands were quantified 
using GeneTools Software (SynGene). 
Immunoprecipitation 
 Immunoprecipitation was used to measure post-translational modification of RyR. Anti-
RyR antibody was used to immunoprecipitate RyR2 from 200 µg of LV homogenate. The 
homogenate was diluted in 0.2 mL of a modified radioimmunoprecipitation assay (RIPA) buffer 
that contained (in mM): 50 Tris pH 7.4, 0.9% NaCl, 5.0 NaF, 1.0 Na3VO4, 1% Triton X-100 and 
Roche Complete Protease Inhibitors and mixed with gentle rotation for 1 hour at 4°C with 1 µg 
anti-RyR. The immune complexes were incubated with 30 µL of a 50% protein-A sepharose 
(Sigma) slurry for 1 hour at 4°C. The protein-A sepharose was washed 3 times with RIPA buffer 
for 5 min and then the immunoprecipitated RyR2 was solubilised by adding 5% SDS. The 
purified RyR2 was separated using SDS-PAGE and probed for nitration and glutathionylation. 
 To determine the reactive carbonyl content of RyR the immunoprecipitation procedures 
outlined above were used with additional steps following the purification of RyR. Briefly, 
immunoprecipitated RyR was derivatized for 15 minutes at room temperature with 10 mM 2,4-
DNPH dissolved in 2 M HCl. Subsequently, the samples were neutralized, loaded on 
polyacrylamide gels, separated by electrophoresis and Western blotting was performed as 
outlined in Western Blotting. 
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Plasma Catecholamine Quantification 
The concentration of plasma NE and Epi was determined as described in Chapter 3 and 
by Weicker and colleagues (1984) using high-performance liquid chromatography and 
electrochemical detection.    
Statistics 
All data are presented as means ± standard error. A one-way ANOVA was used to 
compare group means of the variables outlined above. A two-way ANOVA was used to compare 
group by ISO data. A two-way ANOVA was also used to make comparisons between results 
from this study and previous chapters. To investigate key relationships, linear regression analysis 
was performed using GraphPad Prism 4 software. The significance level was set at 0.05, and, 
when appropriate, a Newman-Keuls post hoc test was used to compare specific means. If a value 
was greater than 2 standard deviations from the mean that outlying value was removed from the 
data set. 
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Results 
Anthropometric Data and Run Times  
The anthropometric data from the animals used in isolated perfused heart and in vitro 
experiments are presented in Table 4.1. There were no significant differences (p>0.05) in any 
anthropometric measures between the in vitro APO CTL, APO AC and APO 24H groups. 
Similarly, body mass and heart mass were not significantly different (p>0.05) in the groups used 
for isolated perfused heart experiments. However, the LV mass from perfused hearts in the APO 
AC group was significantly larger (p<0.05) than the APO CTL group. In addition, the LV/body 
mass ratio was significantly lower (p<0.05) in the perfused heart APO CTL group compared to 
the APO AC and APO 24H groups. 
Cardiovascular Indices in the Basal State 
The results of the isolated perfused heart experiments from animals that were 
supplemented with 1.5 mM APO in their drinking water are presented in Table 4.2. As 
hypothesized, APO treatment prevented exercise-induced cardiac fatigue in the basal state, such 
that there were no significant differences (p>0.05) in LVDP between any of the groups (Table 
4.2). The LVDP was similar between the three groups, despite the fact that heart rate in the APO 
AC and APO 24H groups increased (p<0.05) by 7.4% and 10.7%, respectively. Importantly, the 
regression analysis between LVDP and HR did not reveal a significant relationship (p>0.05) 
between these two variables in the current study (Appendix B). In addition to LVDP, the time-
to-peak pressure and ±dP/dt were not different between the APO treated groups (p>0.05). In the 
basal state, there was a trend for increased perfusion pressure in the APO AC. Importantly, there 
were no significant differences (p>0.05) in coronary flow or CVR between the APO CTL, APO 
AC and APO 24H groups. However, the coronary flow and CVR means in the APO treated 
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groups appeared to differ from the coronary flow and CVR means in the non-APO treated 
animals from Chapter 2 (See Table 2.2). Therefore, a two-way ANOVA was performed to 
examine a potential main effect of APO treatment on variables assessed in this Chapter. 
Unfortunately, a non-APO CTL group was not run concurrently with the APO treated groups, 
which is major limitation to this study and as such these comparisons and subsequent discussions 
must be taken with a degree of caution. Interestingly, there were main effects of APO treatment 
with respect to coronary flow and CVR, such that hearts from animals treated with APO had 
lower coronary flow and higher CVR (p<0.05).  
 
Cardiovascular Indices During β-Adrenergic Stimulation 
The cardiac and hemodynamic responses to progressive doses of ISO were assessed on 
a subset of APO CTL, APO AC and APO 24H hearts and the data are presented in Table 4.3. 
Table 4.2: Basal cardiac and hemodynamic measures in APO groups
Cardiac Measure p values
LVDP (mmHg) 135 ± 2.7 135 ± 4.1 126 ± 2.4 0.19
LVeDP (mmHg) 8.0 ± 1.20 8.3 ± 1.74 10.1 ± 1.61 0.59
+dP/dt (mmHg/s) 4122 ± 236 4396 ± 235 3943 ± 245 0.47
-dP/dt (mmHg/s) -2525 ± 91 -2796 ± 157 -2415 ± 96 0.11
Time-to-peak Pressure (ms) 69.2 ± 2.1 67.9 ± 2.5 65.1 ± 2.3 0.46
Heart Rate (bpm) 272 ± 3.5 292 ± 7.8* 301 ± 8.6* 0.01
Perfusion Pressure (mmHg) 79.8 ± 0.25 80.8 ± 0.28 80.0 ± 0.37 0.06
Coronary Flow (mL/min) 16.97 ± 0.81 16.47 ± 0.37 17.57 ± 1.22 0.70
Coronary Vascular Resistance 4.86 ± 0.21 4.93 ± 0.11 4.79 ± 0.35 0.93
(mmHg/mL/min)
Summary cardiac and hemodynamic data in the basal state. Abbreviations: Left ventricular developed pressure (LVDP); 
left ventricular end diastolic pressure (LVeDP); maximal rate of pressure development and pressure decline (±dP/dt).
The number of animals in each group is indicated beside the group label. Data are presented as means ± SE.
* Significantly different (p<0.05) CTL
APO CTL (n=17) APO AC (n=12) APO 24H (n=11)
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There were significant main effects of ISO for all recorded variables. Progressively increasing 
the concentration of ISO (10-11 – 10-7 M) infused into the perfusate resulted in an increase in 
LVDP, ±dP/dt, HR and coronary flow and a decrease in perfusion pressure and CVR (Table 4.3). 
There were no significant differences (p>0.05) in the ISO concentration required to increase 
LVDP by 50% (in log M: APO CTL -8.59 ± 0.05 vs. APO AC -8.70 ± 0.11 vs. APO 24H -8.56 
± 0.05). In addition, there was no significant effect (p>0.05) of exhaustive exercise with respect 
to any cardiovascular variable.   
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Table 4.3: Cardiac and hemodynamic responses to isoproterenol
Negative log M Isoproterenol Dosage
LVDP (mmHg)
CTL 128 ± 4 129 ± 4 137 ± 4 154 ± 6 194 ± 11 212 ± 20 230 ± 13 246 ± 22 265 ± 41 244 ± 15 0.83
AC 130 ± 4 130 ± 4 144 ± 6 160 ± 8 212 ± 11 215 ± 28 234 ± 12 240 ± 19 264 ± 16 250 ± 10
24H 134 ± 6 134 ± 6 145 ± 6 164 ± 7 203 ± 16 227 ± 33 244 ± 19 269 ± 22 265 ± 37 234 ± 20
+dP/dt (mmHg/s)
CTL 4181 ± 252 4253 ± 278 4609 ± 340 5275 ± 478 6646 ± 670 7246 ± 1165 8292 ± 757 9631 ± 1390 11715 ± 2357 10239 ± 1084 0.85
AC 4419 ± 167 4388 ± 183 4743 ± 299 5124 ± 363 6640 ± 538 7122 ± 1271 8098 ± 495 8570 ± 1242 10109 ± 1511 8976 ± 842
24H 4453 ± 281 4482 ± 301 4929 ± 388 5497 ± 509 6701 ± 912 7610 ± 1782 8337 ± 878 9846 ± 1331 10396 ± 1759 8985 ± 1179
-dP/dt (mmHg/s)
CTL -2702 ± 64 -2714 ± 76 -2946 ± 139 -3421 ± 201 -4462 ± 339 -4776 ± 418 -5367 ± 269 -5542 ± 403 -5838 ± 162 -5516 ± 302 0.93
AC -2652 ± 89 -2665 ± 110 -3002 ± 160 -3506 ± 244 -4725 ± 386 -5229 ± 739 -5559 ± 462 -6130 ± 579 -5838 ± 834 -5604 ± 402
24H -2862 ± 152 -2865 ± 170 -3098 ± 201 -3605 ± 238 -4593 ± 456 -5000 ± 922 -5622 ± 491 -6101 ± 570 -5709 ± 679 -5223 ± 431
HR (bpm)
CTL 275 ± 16 276 ± 16 285 ± 15 296 ± 15 309 ± 14 313 ± 23 320 ± 9 335 ± 16 316 ± 20 332 ± 19 0.90
AC 265 ± 8 266 ± 9 276 ± 10 290 ± 9 304 ± 12 305 ± 10 317 ± 14 341 ± 22 320 ± 21 349 ± 22
24H 277 ± 7 278 ± 7 281 ± 6 283 ± 7 294 ± 8 296 ± 9 308 ± 3 321 ± 7 338 ± 10 352 ± 14
Coronary Flow (mL/min)
CTL 18.0 ± 1.5 17.9 ± 1.5 18.8 ± 1.6 20.4 ± 1.4 24.2 ± 1.5 23.7 ± 2.4 22.7 ± 1.5 23.2 ± 2.0 23.7 ± 4.3 24.9 ± 1.9 0.43
AC 15.2 ± 1.4 15.4 ± 1.5 16.6 ± 1.5 18.3 ± 1.6 23.1 ± 1.6 22.6 ± 1.1 25.4 ± 0.9 24.6 ± 3.4 24.8 ± 1.5 22.6 ± 1.9
24H 18.7 ± 2.0 18.7 ± 2.0 19.8 ± 2.1 20.8 ± 2.1 25.2 ± 2.4 26.5 ± 3.0 27.5 ± 1.6 26.0 ± 2.0 27.6 ± 1.5 26.2 ± 1.9
Coronary Vascular Resistance (mmHg/mL/min)
CTL 4.60 ± 0.40 4.63 ± 0.41 4.39 ± 0.38 3.96 ± 0.28 3.27 ± 0.21 3.40 ± 0.46 3.52 ± 0.25 3.47 ± 0.34 3.46 ± 0.67 3.22 ± 0.30 0.51
AC 5.56 ± 0.53 5.56 ± 0.56 5.10 ± 0.49 4.58 ± 0.43 3.49 ± 0.28 3.53 ± 0.20 3.07 ± 0.12 3.37 ± 0.58 3.15 ± 0.17 3.57 ± 0.34
24H 4.59 ± 0.55 4.58 ± 0.53 4.32 ± 0.51 4.06 ± 0.44 3.26 ± 0.33 3.10 ± 0.38 2.86 ± 0.16 3.11 ± 0.27 2.85 ± 0.19 3.08 ± 0.32
Summary of cardiac and hemodynamic response to progressive dosages of isoproterenol. Each negative log molar concentration of isoproterenol is indicated in the first row. The cardiac and hemodynamic variables are indicated in the first 
column. Abbreviations: left ventricular developed pressure (LVDP); rate of pressure development (+dP/dt); rate of pressure decline (-dP/dt); heart rate (HR). The p value corresponds with the main effect of exercise.
Data are presented as mean ± SE (n=6).
There were no interaction effects for any variable analyzed.
There was a main effect of isoproterenol for all variables.
p values-8 -7.6 -7.3 -7-11 -10 -9.5 -9 -8.6 -8.3
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Catecholamines 
 The concentration of plasma Epi and NE were assessed using HPLC. Similar to Chapter 
3, there were no significant differences (p>0.05) in plasma NE concentration among the three 
APO treated groups. Interestingly, there were no differences (p>0.05) in the concentration of Epi 
between the APO groups (Figure 4.1). Comparison of these data to the Epi and NE data from 
Chapter 3 revealed a main effect of APO, whereby plasma Epi concentration was lower (p<0.05) 
in APO treated animals when compared to the non-APO treated groups. There was no main 
effect of APO treatment on plasma NE concentration (p>0.05). 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. The concentration of norepinephrine and epinephrine (pg/mL) in the plasma from 
the APO CTL, APO AC and APO 24H groups. The number in each bar represents the number 
of samples used for statistical analysis as several outliers were removed. Values are means ± SE. 
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Reactive Oxygen Species Production and Lipid Peroxidation 
 Homogenates isolated from the LV of animals treated with APO were incubated with 
DCFH-DA to measure the production of ROS. As hypothesized, there were no significant 
differences (p>0.05) in fluorescent intensity of DCF between the three APO treated groups 
(Figure 4.2A). Furthermore, when compared to the DCF fluorescence data from Chapter 3, the 
ROS production in the APO treated groups were lower (p<0.05) than the non-APO treated 
groups. The MDA concentration (i.e. lipid peroxidation) in LV homogenates from the APO 
treated groups were not significantly different from each other (p>0.05) (Figure 4.2B). 
Furthermore, there was no main effect (p>0.05) of APO treatment on lipid peroxidation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. ROS production and lipid peroxidation in APO treated groups. (A) The production 
of ROS was assessed by measuring DCF fluorescence in LV homogenate (n=6). (B) Lipid 
peroxidation was determined by measuring the concentration malondialdehyde (MDA) in LV 
homogenate (n=8). All values were normalized to total protein and are presented as means ± SE.  
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SERCA2a Function 
 The maximal rate of Ca2+-ATPase activity and the rate of Ca2+ uptake were not different 
between the three APO treated groups in this study (Figure 4.3B & C). However, several main 
effects of APO treatment have revealed some interesting findings regarding SERCA2a function. 
On average, the apparent Ca2+ affinity of SERCA2a (i.e. pCa50) was greater (p<0.05) in the APO 
treated groups when compared to the non-APO treated groups. This can be illustrated by 
examining the Ca2+-dependent Ca2+-ATPase activity of the CTL and APO CTL groups (Figure 
4.4A). Additionally, there were main effects of APO on maximal Ca2+-ATPase activity and Ca2+ 
uptake, such that Ca2+-ATPase activity was lower and Ca2+ uptake was higher in the APO treated 
groups (p<0.05). This observation lead to an examination of the coupling ratio, which provides 
a measure of the transport efficiency of SERCA2a (i.e. the moles of Ca2+ transport per mole ATP 
hydrolyzed) and is calculated by dividing the rate of Ca2+ uptake at 2.0 µM by the maximal Ca2+-
ATPase activity. The coupling ratios were significantly higher (p<0.05) across groups that were 
provided APO in their drinking water when compared to non-APO treated groups (Figure 4.4B).   
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Figure 4.3. SERCA2a function in APO treated groups. (A) The rate of Ca2+-dependent Ca2+-
ATPase activity was assessed in left ventricle homogenate from APO CTL (solid squares), APO 
AC (solid circles) and APO 24H groups (solid triangle), over a negative log molar range of ~7-
5. The pCa50 for Ca2+-ATPase activity is displayed in the inset. (B) The maximal rate of Ca2+-
dependent Ca2+-ATPase activity. (C) The rate of oxalate supported Ca2+ uptake was assessed in 
LV homogenates using Indo-1 and dual emission spectrofluorometry. The slope of the Ca2+ 
uptake curve was determined by differentiating the curve at four different free Ca2+ 
concentrations. Values are means ± SE (n=8). 
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Figure 4.4. Comparison of the coupling ratios and Ca2+-dependent Ca2+-ATPase activity 
between Chapter 3 and Chapter 4. (A) The rate of Ca2+-dependent Ca2+-ATPase activity 
normalized to the maximal Ca2+-ATPase activity in the CTL group from Chapter 3 (solid 
squares) and the APO CTL group from the current study (solid triangles). (B) The coupling ratio 
was calculated by dividing the rate of Ca2+ uptake at 2.0 µM by the maximal Ca2+-ATPase 
activity. Solid bars represent the coupling ratios from Chapter 3 and open bars are the coupling 
ratios from the current study. Values are means ± SE. There were a main effects of APO such 
that pCa50 and coupling ratios were higher in APO treated groups.   
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RyR Function 
The function of the Ca2+ release channel was assessed by determining the rates of SR 
Ca2+ release and the rates of SR Ca2+ leak. The rates of 4-CMC-induced Ca2+ release were not 
significantly different (p>0.05) between the three APO groups (Figure 4.5A). However, there 
was a main effect of APO treatment on the rates of Ca2+ release whereby the APO treated groups 
had higher (p<0.05) rates of Ca2+ release when compared to the non-APO treated groups. As 
hypothesized, APO treatment preserved SR Ca2+ leak, such that leak was not significantly 
different (p>0.05) between the APO CTL, APO AC and APO 24H groups (Figure 4.5B). In 
addition, a main effect of APO was observed between groups in Chapter 3 and the current study, 
with SR Ca2+ leak being lower (p<0.05) in the APO treated animals. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. RyR function in APO treated groups. (A) The rates of 4-CMC-induced Ca2+ release 
in the APO treated groups. (B) The rates of Ca2+ leak out of the SR was assessed following the 
addition of CPA to the assay once Ca2+ uptake reached a minimum (see Methods). Values are 
means ± SE (n=8). 
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Calpain Activity 
 The calpain activity was assessed by incubating LV homogenate with the minimally 
fluorescent calpain substrate, Suc-LLVY-AMC, and monitoring the fluorescence in the presence 
or absence of Z-LL-CHO, a calpain inhibitor. It was hypothesized that NOX inhibition would 
prevent calpain activation following exhaustive exercise. As illustrated in Figure 4.6, calpain 
activity was not altered by exhaustive exercise in animals that were given APO (p>0.05).   
 
 
 
 
 
 
 
 
Figure 4.6. Calpain activity in APO treated groups. Calpain activity was determined in LV 
homogenates by measuring the fluorescence of AMC (7-amino-4-methylcoumarin), the cleavage 
product of Suc-LLVY-AMC. Calpain activity was calculated as the difference between AMC 
fluorescence in the absence or presence of a calpain inhibitor (Z-LL-CHO) normalized to total 
protein. Values are means ± SE (n=5). 
 
Western Blotting 
 Western blotting was performed to determine the content of proteins and their 
phosphorylation status. Three days of APO consumption did not alter (p>0.05) the expression of 
NOX4 in the LV of rats from the APO CTL, APO AC and APO 24H groups (Figure 4.7C). There 
were no differences (p>0.05) between the three APO treated groups in relation to SERCA2a 
content, PLN content or phosphorylation of PLN (Figure 4.7). In addition, there were no 
 137 
 
significant differences (p>0.05) in total RyR or the ratio of pRyR to RyR between the three APO 
treated groups (Figure 4.8). Interestingly, the pRyR to RyR ratio was higher (p<0.05) in APO 
treated animals when compared to non-APO treated counterparts. Consistent with the findings 
from Chapter 3, there were no significant (p>0.05) oxidative modifications to RyR in the APO 
AC and APO 24H groups when compared to the APO CTL group (Figure 4.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Western blot analysis of whole LV homogenates from APO treated groups. The inset 
in each panel is a representative blot, which was loaded in the same sequence as displayed on 
the bar graphs. (A) SERCA2a protein content. (B) Protein content of the PLN monomer. (C) 
NOX4 content. (D) The ratio of phosphorylated monomeric PLN to monomeric PLN; the inset 
blot is pPLN. Values are means ± SE (n=8). 
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Figure 4.8. Western blot analysis of RyR2 from APO treated groups. The inset in each panel is 
a representative blot, which was loaded in the same sequence as the data displayed on the bar 
graphs. (A) Total RyR protein content. (B) The ratio of phosphorylated RyR to RyR; the inset 
blot is pRyR. Values are means ± SE (n=8). 
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Figure 4.9. Oxidative modification of RyR was assessed using immunoprecipitation and 
Western blotting techniques. RyR was probed for (A) carbonyl content as indicated using anti-
DNP antibody, (B) 3-nitrotyrosine and (C) glutathionylation. Representative blots of the RyR 
pull down via immunoprecipitation and the post-translational modification to RyR are provided 
in each panel. Samples were loaded in the same order as the data presented in the bar graphs. 
Data are ratios of modified RyR to total RyR and are presented as means ± SE (n=8). 
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In Vitro Activation of NOX, ROS Production and SR Ca2+ Leak 
 To support the hypotheses that exercise-induced NOX activation increased SR Ca2+ leak 
and that NOX inhibition contributed to the reduction of SR Ca2+ leak observed in the current 
study, in vitro experiments were performed to activate NOX and assess ROS production and SR 
Ca2+ leak. Incubation of LV homogenates with 1 mM NADPH increased (p<0.05) ROS 
production by ~30% when compared to LV homogenates alone (Figure 4.10A). The addition of 
30 µM APO to LV homogenates incubated with 1 mM NADPH prevented the increase in ROS 
production. These experiments were repeated, but instead of measuring ROS production, 
samples were assayed for SR Ca2+ leak. In the presence of 1 mM NADPH there was a significant 
increase (p<0.05) in SR Ca2+ leak, which was prevented in the presence of APO (Figure 4.10B). 
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Figure 4.10. In vitro activation of NOX and assessment of ROS production and SR Ca2+ leak. 
(A) ROS production assessed by measuring DCF fluorescence. LV homogenates were incubated 
with 1 mM NADPH to activate NOX and in some experiments 30 µM APO were added to inhibit 
NOX. The presence or absence of a chemical is indicated by a “+” or “-“, respectively. (B) LV 
homogenates were exposed to the same concentrations of NADPH or APO and SR Ca2+ leak 
was assessed using Indo-1 and dual emission fluorometry. Values are means ± SE (n=8). * 
Significantly different (p<0.05) than the other groups. 
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Discussion 
 This study produced several novel findings regarding acute exercise and cardiac function. 
The first was that APO supplementation and inhibition of NOX prior to exhaustive exercise 
prevented exercise-induced cardiac fatigue. The second was that NOX inhibition resulted in 
improved Ca2+ regulation in the form of a reduction in SR Ca2+ leak, an increase in the coupling 
ratio and an increase in the apparent Ca2+ affinity of SERCA2a. The third exciting finding was 
that NOX inhibition prevented activation of calpains immediately following exhaustive exercise. 
Lastly, it was demonstrated that activation of NOX in vitro in LV homogenates can regulate 
RyR2 function, which resulted in an increase in the rate of SR Ca2+ leak. 
A key finding in this study was that NOX inhibition prevented exercise-induced cardiac 
fatigue in the basal state. This is primarily evident in the LVDP data, which demonstrated that 
NOX inhibition prevented an exercise-induced decline in LVDP. These findings are in support 
of a previous study that inhibited NOX using APO prior to a prolonged, submaximal exercise 
bout (Vitiello et al., 2011). In that study, acute exercise resulted in a significant decline in LVDP 
in the absence of NOX inhibition. However, inhibition of NOX maintained LVDP following the 
prolonged exercise bout (Vitiello et al., 2011). In the current study, the ±dP/dt were not 
significant different between the APO CTL, APO AC and APO 24H groups. Similarly, the study 
by Vitiello and colleagues (2011) found that ±dP/dt was not different between control and 
exercise groups that consumed APO. These data suggest that by inhibiting NOX activity, the 
contractile function of the myocardium is maintained following exhaustive exercise.  
The protective effects of NOX inhibition observed in the basal state carried forward 
during β-adrenergic stimulation of the isolated perfused hearts. A novel finding in this study was 
that LVDP was not significantly different between the three APO groups during infusion of 
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progressively higher concentrations of ISO. This is in contrast to the results of Chapter 2, which 
demonstrated that cardiac fatigue (i.e. depressed LVDP) persisted throughout the ISO dose 
response. In addition, there were no significant differences in the ±dP/dt of isolated perfused 
hearts when NOX was inhibited. Unfortunately, the ±dP/dt during β-adrenergic stimulation were 
not reported by Vitiello and co-workers (2011). In Chapter 2, there was a significant reduction 
in the –dP/dt during β-adrenergic stimulation in the AC group. It is possible that improved Ca2+ 
regulation, namely decreased SR Ca2+ leak, increased apparent affinity of SERCA2a for Ca2+ 
and the coupling ratios (discussed below), contributed to the maintenance of –dP/dt in the APO 
AC group in the current study. These data suggest that the mechanism responsible for the cardiac 
fatigue present during β-adrenergic stimulation in Chapter 2 was mitigated by NOX inhibition.  
The basal LVDP in the APO AC and APO 24H groups were similar to the LVDP in the 
APO CTL group despite a significant 7.4% and 10.7% increase in heart rate in the APO AC and 
APO 24H groups, respectively. Linear regression analysis of LVDP and heart rate produced a 
negative, non-significant correlation coefficient, which suggests that an increase in heart rate 
was not related to a decrease in LVDP. However, the force frequency relationship in isolated 
perfused rodent hearts has been shown to be negative (Simor et al., 1997; Lankford et al., 1998; 
Dias et al., 2006). In the isolated perfused mouse heart, an increase in the stimulation frequency 
from 300 to 600 bpm resulted in a progressive reduction in LVDP (Dias et al., 2006). Another 
study perfused rat hearts at a constant pressure and paced the hearts from 250 to 500 bpm and 
monitored changes in LVDP (Simor et al., 1997). When the stimulation frequency was increased 
from 250 to 300 bpm the LVDP declined by ~33%. A similar study observed a modest reduction 
of ~8% in LVDP when stimulation frequency was increased from 250 to 300 bpm (Lankford et 
al., 1998). The increase in heart rate between the APO AC group and APO CTL group was 20 
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bpm and between the APO 24H group and APO CTL group was 29 bpm. If the changes in heart 
rate in the current study were extrapolated to the trends observed in the studies by Simor and co-
workers (1997) and Lankford and colleagues (1998), it would be expected that the increased 
heart rate could have resulted in a ~4-16% reduction in LVDP. These data suggest that, the 
LVDP in the APO AC and APO 24H groups could possibly have been higher, had heart rate not 
been elevated in these groups. 
Coronary flow was not affected by the combination of NOX inhibition and exhaustive 
exercise, suggesting that changes in coronary flow were not responsible for the preserved LVDP 
observed in the current study. However, APO treatment resulted in significantly lower coronary 
flow across all three APO groups when compared to the coronary flow data from Chapter 2. 
Attenuated delivery of oxygen (i.e. ischemia) would result in a reduction in LVDP (Hamilton et 
al., 2003; Cai et al., 2003). APO has been shown to have no effect on basal coronary flow in the 
isolated perfused mouse heart and the conscious instrumented dog (Zhang et al., 2009; El-Awady 
et al., 2013). In aortic rings, APO has been shown to have vasodilatory effects in healthy animals 
and in animals with endothelial dysfunction (i.e. hypertension, genetic knockouts) (Oelze et al., 
2006; Baumer et al., 2007; Unger & Patil, 2009; Senejoux et al., 2011). These findings would 
suggest that consumption of APO would have resulted in vasodilation and increased coronary 
flow. However, this hypothesis was not supported when the CVR and coronary flow data from 
the current study were compared to the hemodynamic data from Chapter 2. Thus, the mechanism 
responsible for the reduced coronary flow in the current study may not reside in the coronary 
vasculature, but rather the ventricular myocyte. A major determinant of coronary flow is the 
metabolic demand of the myocardium (Duncker & Bache, 2008). The metabolic demand in the 
myocardium may have been reduced in APO treated animals. The coupling ratio was 
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significantly higher in APO treated animals, which means that the ATP cost to transport a given 
amount of Ca2+ across the SR membrane was reduced. Furthermore, the rate of SR Ca2+ leak 
across the three APO treated groups was lower than the non-APO treated groups. Lower Ca2+ 
leak would lead to less Ca2+-ATPase activity during diastole, which would potentially lower 
ATP demand even further. Although speculative, this improved Ca2+ transport efficiency and 
lower Ca2+ leak may have lowered ATP demand in the LV and thus lowered LV oxygen demand, 
which resulted in reduced coronary flow. 
 The intracellular mechanisms associated with NOX inhibition and prevention of cardiac 
fatigue were evaluated using LV homogenates from a second cohort of animals treated with 
APO. Several studies have demonstrated an increased production of ROS and increased lipid 
peroxidation in LV from animals that exhibited exercise-induced cardiac fatigue (Wonders et 
al., 2007; Vitiello et al., 2011; Olah et al., 2015). In Chapter 3, it was demonstrated that 
exhaustive exercise resulted in a significant increase in ROS production, which was associated 
with a reduction in LVDP. To determine if ROS generated during exhaustive exercise were due 
to activation of NOX, 1.5 mM APO was supplemented in the drinking water of rats for three 
days prior to the exercise bout. In the current study, inhibition of NOX prevented the increase in 
ROS production in LV homogenates collected immediately after the exhaustive exercise bout. 
Furthermore, there was significantly lower ROS production in each group in the presence of 
NOX inhibition (i.e. the current study) when compared to groups in the absence of NOX 
inhibition (i.e. Chapter 3). These findings are supported by a study by Vitiello and colleagues 
(2011), who provided APO in the drinking water of rats and subjected them to prolonged 
treadmill running. Following prolonged exercise the ratios of GSH to GSSH were not 
significantly different between the APO treated group and the control group (Vitiello et al., 
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2011). In the current study, the concentrations of MDA in LV homogenates were not 
significantly different between the APO treated groups. Visually, when the lipid peroxidation 
data from Chapter 3 and the current study were compared there appeared to be an effect of acute 
exercise on non-APO treated animals. However, analysis of both these data sets did not reveal a 
significant interaction or main effect of APO treatment. These findings suggest that lipid 
peroxidation may not factor into the development of cardiac fatigue, which is opposite to a 
previous study (Wonders et al., 2007). By inhibiting NOX, ROS production was blunted, which 
suggests that NOX is activated during acute exercise and is likely a main source of ROS 
production in the rat myocardium during exercise. 
 The reduced ROS production observed in the present study may have been mediated in 
part by the reduction in plasma Epi concentration following acute exercise. It has been 
demonstrated that stimulation of β-adrenergic receptors results in elevated ROS production 
within cardiomyocytes (Zhang et al., 2005; Andersson et al., 2011a; Bovo et al., 2012). Indeed, 
incubation of isolated rat cardiomyocytes with Epi has been demonstrated to increase production 
of ROS (Costa et al., 2009). A novel finding in this study was that the concentration of plasma 
Epi in the APO AC group was not significantly different than the APO CTL and APO 24H 
groups. As a result, the plasma Epi concentration was lower in APO treated groups when 
compared to non-APO treated groups. The mechanism by which NOX inhibition prevented the 
rise in circulating Epi is not immediately clear in this study. Epi is secreted from chromaffin cells 
in the adrenal medulla. One study demonstrated that intermittent hypoxia augmented Epi 
secretion from chromaffin cells. If cells were incubated with inhibitors of NOX or RyR prior to 
hypoxia, then Epi secretion was reduced (Souvannakitti et al., 2010). Perhaps APO prevented 
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activation of NOX in the adrenal medulla during exhaustive exercise, which reduced the 
secretion of Epi. 
  The prevention of exercise-induced cardiac fatigue may have been mediated by changes 
in SERCA2a Ca2+ transport efficiency. When compared to the APO CTL group, exhaustive 
exercise did not alter the maximal Ca2+-ATPase activity or the rate of Ca2+ uptake in the APO 
AC or APO 24H groups. However, maximal Ca2+-ATPase activity and Ca2+ uptake were lower 
and higher, respectively, in all APO treated groups when compared to the non-APO treated 
groups in Chapter 3. These differences in Ca2+-ATPase activity and Ca2+ uptake resulted in a 
significantly higher coupling ratio in APO treated groups. An increased coupling ratio indicates 
that there is greater net Ca2+ accumulation in the SR for a given amount of ATP hydrolysis (de 
Meis, 2002). The increased coupling ratio was likely mediated by an increase in the apparent 
Ca2+ affinity of SERCA2a and lower rates of SR Ca2+ leak in the APO treated groups 
(Chamberlain et al., 1984; Beeler & Gable, 1994; Frank et al., 2000). In the current study, there 
were no significant differences in the expression of SERCA2a or the phosphorylation status of 
PLN between the APO treated groups. However, the ratio of pPLN to PLN was greater in APO 
treated groups compared to non-APO treated groups, which would have increased the apparent 
Ca2+ affinity of SERCA2a. A study by Frank and colleagues (2000) observed a leftward shift in 
the Ca2+-dependent Ca2+-ATPase curve and an increase in the coupling ratio in the LV of PLN 
knockout mice. These findings were replicated in LV of wild type mice when PLN was 
phosphorylated via the addition of active PKA, which is in support of the observations in the 
current study. The increased phosphorylation of PLN observed in the current study cannot be 
accounted for by the NE and Epi data. Indeed, there was a main effect of Epi, such that the 
plasma concentrations were lower in the APO treated groups. Intuitively, this would result in a 
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reduction in PLN phosphorylation. It is possible that NOX inhibition contributed to the enhanced 
phosphorylation of PLN. However, there are conflicting reports in the literature regarding 
activation and inhibition of NOX and the phosphorylation status of PLN. In a MDX model of 
cardiomyopathy, inhibition of NOX resulted in a significant increase in pPLN. However, NOX 
inhibition had no effect on pPLN content in cardiomyocytes from wild type mice (Gonzalez et 
al., 2014). In another study, perfusion of isolated rat hearts with APO alone had no effect on 
pPLN content, but when APO and dobutamine were combined there was greater pPLN content 
compared to dobutamine alone (Kubin et al., 2011). Lastly, studies using isolated 
cardiomyocytes have demonstrated that activation of NOX via angiotensin II augmented pPLN 
content (Jin et al., 2012; Zhang et al., 2015). Thus, the mechanism by which NOX inhibition 
increased pPLN content in the current study is not clear. Regardless, the functional consequence 
of increased pPLN content, coupling ratio and the apparent affinity of SERCA2a for Ca2+ would 
result in enhanced Ca2+ sequestration at low [Ca2+]f (i.e. during diastole) (Frank et al., 2000). 
This would increase SR Ca2+ load and augment the fractional release of Ca2+, which would result 
in a more forceful contraction. This may account for the protection against exercise-induced 
cardiac fatigue afforded by NOX inhibition.    
Another novel finding regarding Ca2+ regulation was that NOX inhibition enhanced RyR 
function when assessed in vitro. The rates of SR Ca2+ leak were not significantly different in the 
APO AC group when compared to the APO CTL group. In addition, the rate of SR Ca2+ leak in 
Chapter 3 was significantly elevated in the AC group, which was associated with a reduction in 
LVDP. On average, the rates of SR Ca2+ leak were lower in the APO treated groups when 
compared to the non-APO treated groups. These data suggest that NOX inhibition prevented 
aberrant SR Ca2+ leak and may have contributed to the prevention of exercise-induced cardiac 
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fatigue. These findings are opposite to a study by Sanchez and co-workers (2008), who 
demonstrated that NOX activation and augmented RyR glutathionylation decreased the rate of 
SR Ca2+ leak following a brief bout of aerobic exercise. Unfortunately, these authors did not 
investigate the effects of NOX inhibition on SR Ca2+ leak following acute exercise. In the current 
study there was a main effect of APO for RyR glutathionylation, such that APO treated groups 
had lower glutathionylated RyR content when compared to non-APO treated groups. Given the 
observations by Sanchez and colleagues (2008), a reduction in glutathionylated RyR would be 
expected to increase SR Ca2 leak. Similarly, there was significantly greater pRyR content in 
APO treated groups when compared to non-APO groups, which would be expected to increase 
SR Ca2+ leak (Wehrens et al., 2007). Thus, the mechanisms associated with the protective effects 
of NOX inhibition on SR Ca2+ leak remain to be determined.      
The function of RyR was also determined by measuring the rate of 4-CMC-induced Ca2+ 
release. In the current study, there were no significant differences in the rates of Ca2+ release 
between the APO CTL, APO AC and APO 24H groups. However, the rate of Ca2+ release was 
significantly higher in the APO treated groups when compared to the non-APO treated groups. 
These findings are paradoxical as activation of NOX has been demonstrated to increase Ca2+ 
release in skeletal and cardiac muscle preparations (Hidalgo et al., 2006; Sanchez et al., 2008; 
Donoso et al., 2014). Therefore, inactivation of NOX would be expected to reduce the rate of 
SR Ca2+ release. In addition, exogenous ROS have been demonstrated to increase the rate of SR 
Ca2+ release (Stoyanovsky et al., 1997; Cheong et al., 2005). ROS production was lower in the 
APO treated groups, which would be expected to cause a reduction in SR Ca2+ release. The 
reduction in SR Ca2+ leak and the leftward shift in the Ca2+-ATPase activity curve in the current 
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study would result in augmented SR Ca2+ load and greater fractional Ca2+ release in vivo. These 
factors may have contributed to the greater rate of Ca2+ release in the APO treated animals. 
 To demonstrate that NOX can regulate RyR, in vitro experiments were employed in an 
attempt to activate NOX and subsequently assess SR Ca2+ leak. Incubation of LV homogenates 
with exogenous NADPH significantly increased NOX dependent ROS production, which was 
prevented when APO was incubated in combination with NADPH. When LV homogenates were 
incubated with NADPH there was an increase in the rate of SR Ca2+ leak, which was prevented 
by the addition of APO to the assay. Similar in vitro findings have been observed using skeletal 
muscle samples. Sun and co-workers (2011) incubated SR vesicles isolated from rabbit hindlimb 
muscles with 1 mM NADPH and observed a significant increase in NOX mediated ROS 
production and an increase in the open probability of RyR1. A similar study reported that 0.1-
0.5 mM NADPH incubated with isolated triads caused an increase in the open probability of 
RyR1 (Hidalgo et al., 2006). Taken together, these studies and the current study demonstrate that 
in vitro activation of NOX can regulate RyR function. This is an important finding as it supports 
the hypothesis that exhaustive exercise activated NOX in vivo, which was associated with an 
increased rate of SR Ca2+ leak and cardiac fatigue.  
 In Chapter 3 it was observed that calpain activity was increased in the AC group when 
compared to the CTL group. In this study, inhibition of NOX prevented exercise-induced 
activation of calpains as there were no significant differences between the APO treated groups. 
Activation of calpains in isolated cardiomyocytes has been shown using high glucose or NE as 
a stressor, which resulted in apoptosis (Li et al., 2009a; Li et al., 2009b). Cell death and calpain 
activation were prevented when cardiomyocytes were incubated with either a NOX or RyR 
inhibitor prior to the lethal stress. The fact that calpains were not activated during exhaustive 
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exercise may have contributed to the preservation of LVDP in the APO 24H group. Once 
activated, calpains can degrade a host of EC coupling related proteins, which include, but are not 
limited to troponins, NCX, RyR, desmin, actin, myosin and junctophilin (Zeitz et al., 2002; Blunt 
et al., 2007; Ke et al., 2008; Pedrozo et al., 2010; Celes et al., 2013; Murphy et al., 2013; 
Wanichawan et al., 2014). These studies suggest that there is a potential interaction between 
NOX activation, RyR dysfunction, increased cytosolic Ca2+ concentration, activation of calpains 
and excitation-contraction uncoupling. Inhibition of this pathway may explain the protective 
effects of APO on LVDP observed in the current study.   
 To summarize, this study used a pharmacological intervention, namely APO treatment 
for 3 days, to inhibit NADPH oxidase. It was demonstrated that NOX inhibition prevented 
exercise-induced cardiac fatigue observed immediately following and 24 hours after the exercise 
bout. In addition, the production of ROS in the APO AC group was not different than the APO 
CTL group and on average, the APO treated groups had lower ROS production than the non-
APO treated groups. The mechanisms responsible for the APO mediated preservation of LVDP 
in hearts from animals that ran to exhaustion appear to be due to improved Ca2+ regulation, which 
was associated with preserved calpain activity. In Chapter 3 it was demonstrated that acute, 
exhaustive exercise increased SR Ca2+ leak and calpain activity. Inhibition of NOX maintained 
the rate of SR Ca2+ leak in the APO AC group, such that it was not different than the APO CTL 
group. The altered RyR function was not mediated by phosphorylation or post-translational 
oxidative modification. To confirm the relationship between NOX and RyR, NOX was activated 
in vitro, which increased ROS production and resulted in RyR mediated SR Ca2+ leak. When 
these in vitro experiments were repeated in the presence of APO, ROS production and SR Ca2+ 
leak were blunted. The reduction in SR Ca2+ leak observed immediately following exhaustive 
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exercise likely contributed to the prevention of calpain activation. Calpains can target and 
degrade EC coupling proteins and by preventing calpain activation, NOX inhibition may have 
prevented sarcomeric damage and cardiac fatigue in the APO 24H group. These findings suggest 
a possible connection between exercise-induced activation of NOX and the subsequent increase 
in SR Ca2+ leak, which may have two functional consequences. The first being that Ca2+ leakage 
from the SR reduces the SR Ca2+load and results in a lower Ca2+ transient amplitude and thus 
force production. The second is that SR Ca2+ leak in the cleft region may raise cleft Ca2+ 
concentration sufficiently to activate calpains, which may contribute to prolonged cardiac fatigue 
due to EC coupling failure. 
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Chapter V: General discussion, conclusions, perspective and future directions 
General Discussion 
 The purpose of this thesis was to develop an exhaustive exercise model that induced 
cardiac fatigue and to determine the mechanisms associated with exercise-induced cardiac 
fatigue. The literature suggests that exhaustive exercise increases ROS production in the LV and 
that ROS production is associated with cardiac fatigue. These observations were replicated in 
the current thesis and it was further demonstrated that by inhibiting NOX activity during 
exhaustive exercise, ROS production was blunted and cardiac fatigue was abolished. A major 
finding in this thesis was that SR Ca2+ leak was increased following exhaustive exercise in the 
absence of NOX inhibition, but that inhibition of NOX prior to exhaustive exercise prevented 
exercise-induced SR Ca2+ leak. Evidence for an interaction between NOX activation and RyR2 
was further demonstrated by assessing ROS production and SR Ca2+ leak in the presence and 
absence of APO. These findings provide clear support for the hypothesis that impaired Ca2+ 
regulation would be mechanistically associated with cardiac fatigue. The fact that ROS 
production and SR Ca2+ leak returned to control levels 24 hours post-exercise suggests that 
alternate mechanism(s) are responsible for cardiac fatigue present 24 hours post-exercise. The 
activation of calpains was a likely consequence of increased SR Ca2+ leak following exhaustive 
exercise and may have contributed to EC uncoupling and cardiac fatigue 24 hours after the 
exercise bout. An important observation was that by inhibiting NOX and preserving Ca2+ 
regulation, calpains were not activated following exhaustive exercise and cardiac fatigue was 
not observed 24 hour post-exercise. 
For these collective studies to be successful, it was necessary to develop an exhaustive 
exercise protocol that could be used to induce cardiac fatigue. Evidence from several studies 
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performed on rats suggest that exhaustive or prolonged aerobic exercise results in cardiac fatigue. 
Therefore, it was hypothesized that the exhaustive exercise protocol used in this thesis would 
result in a reduction in LVDP, which was confirmed in Chapter 2. Seward and co-workers (1995) 
did not detect cardiac fatigue in rat hearts following an exhaustive exercise protocol (18 m/min, 
0% grade) that was very similar to the protocol used in this thesis. The discrepancy between this 
thesis and the results of Seward and colleagues (1995) may be due to the fact that the Langendorff 
technique was employed in this thesis whereas, the working heart technique was utilized in the 
previous study. The working heart technique more closely mimics the in situ effects of preload 
and afterload on pump function of the heart (i.e. perfusate is pumped from the left atria into the 
left ventricle and from there out the aorta). The Langendorff technique lacks preload and 
afterload and there is no fluid ejected from the heart. However, there is evidence that cardiac 
fatigue is present in vivo under conditions where preload and afterload would influence cardiac 
function (Vitiello et al., 2011; Olah et al., 2015). Taken together, the isolated perfused heart 
technique is a suitable method for the investigation of cardiac fatigue in rat. 
A novel observation in this thesis was that cardiac fatigue was present during periods of 
β-adrenergic stimulation. This was evident as the LVDP was significantly lower in the AC and 
24H groups during progressive doses of ISO. These findings differ from a previous study that 
performed an ISO dose response on isolated perfused hearts and did not observe any differences 
in LVDP between a control group and a group that performed prolonged exercise (Vitiello et al., 
2011). The data presented in the study by Vitiello and colleagues (2011) was normalized, such 
that the maximal response was set at 100%, which makes comparison to the current study 
difficult as the maximal LVDP responses to ISO were lower in the AC and 24H groups when 
compared to the CTL group. It is possible that the maximal LVDP observed in the study by 
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Vitiello and co-workers (2011) were not different between the control and exercise groups. An 
important observation in this thesis, was that cardiac fatigue in the basal state and during β-
adrenergic stimulation were not due to differences in heart rate or coronary flow. It is possible 
that metabolite accumulation occurred in the cardiomyocyte during exhaustive exercise, which 
contributed to cardiac fatigue. However, the contractile function of hearts were assessed under 
optimal ex vivo conditions (i.e. pH, electrolyte concentration, temperature) following 30 minutes 
of perfusion, which should have been ample time to restore metabolite concentrations 
(Humphrey et al., 1985). These data suggest that cardiac fatigue is due to a deficit within the 
cardiomyocyte and reinforces the importance of the in vitro findings within this thesis.   
The production of ROS is a well-defined mechanism associated with myocardial 
stunning and skeletal muscle fatigue (Reid et al., 1992; Kolbeck et al., 1997; Kaplan et al., 2002; 
Kaplan et al., 2005; Moopanar and Allen, 2005; Tatarkova et al., 2005; Moopanar and Allen, 
2006; Zweier & Talukder, 2006; Bruton et al., 2008). The exhaustive exercise protocol utilized 
in this thesis resulted in a significant increase in ROS production and cardiac fatigue in the AC 
group. These data are consistent with the study by Olah and co-workers (2015), who used the 
ROS sensitive dye, DHE to demonstrate that ROS production was elevated following three hours 
of swimming. In this thesis, there were no significant differences in lipid peroxidation in LV 
homogenates despite there being a mean difference of 30% between the CTL and AC groups. 
These data are opposite of several studies that reported increased lipid peroxidation following 
exhaustive or prolonged exercise (Lin et al., 2006; Aydin et al., 2007; Wonders et al., 2007; 
Huang et al., 2008). Although speculative, it may be possible that ROS produced during acute 
exercise caused lipid peroxidation in certain membrane fractions (i.e. the SR membrane) and not 
others (i.e. the sarcolemma), which may have been masked by measuring lipid peroxidation in 
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whole homogenate. Indeed, a study exposed hearts to ischemia-reperfusion and assessed MDA 
content in various subcellular fractions and observed an increase of ~50% in homogenate, a near 
doubling in mitochondrial membranes and no change in the microsomal or cytosolic fractions 
(Ambrosio et al., 1991). Such varied subcellular distributions of lipid peroxidation have been 
demonstrated in other tissues and models of stress (Aguilar-Delfin et al., 1996; Oztezcan et al., 
2000; Luna-Moreno et al., 2007). In Chapter 4, inhibition of NOX prevented the exercise-
induced increase in ROS production that was observed in Chapter 3. Furthermore, there was no 
evidence of cardiac fatigue in hearts in the presence of NOX inhibition. Taken together, cardiac 
fatigue is associated with NOX-dependent production of ROS. 
 There is evidence suggesting that exogenous and endogenous ROS has deleterious effects 
on the maximal Na+/K+-ATPase activity in LV homogenate and LV sarcolemmal vesicles 
(Vinnikova et al., 1992; Kaplan et al., 2005; Kaplan et al., 2008; Singh et al., 2012). To determine 
if production of ROS during exhaustive exercise impaired Na+/K+ pump function, maximal 
Na+/K+-ATPase activity was assessed using a spectrophotometric assay in LV homogenates. 
When compared to the CTL group, exhaustive exercise did not affect maximal Na+/K+-ATPase 
activity in the AC or 24H groups. This is the first study to examine the effects of exhaustive 
exercise on maximal rates of Na+/K+-ATPase activity in a 24 hour post-exercise group. Pierce 
and colleagues (1984) swam rats to exhaustion and isolated sarcolemmal membrane fractions 
from the LV immediately following the exercise bout. In that study, there were no significant 
differences in maximal Na+/K+-ATPase activities between the exercise group and the control 
group. The in vitro analyses of Na+/K+-ATPase activity in this thesis were performed under 
optimal conditions, which means that a reduction in maximal Na+/K+-ATPase activity would be 
indicative of structural damage to the pump. Exhaustive exercise has be shown to reduce 
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glycogen content in the LV (Pierce et al., 1984; Seward et al., 1995). Furthermore, glycogen has 
been demonstrated to be the preferential source of glucose for glycolytic ATP provision for the 
Na+/K+-ATPase (James et al., 1999; Dutka & Lamb, 2007). Therefore, metabolic inhibition of 
Na+/K+-ATPase activity may have occurred in vivo; however, our in vitro analyses are not able 
to determine whether that occurred or not. Taken together, exhaustive exercise did not alter the 
structure or function of the Na+/K+-ATPase. 
In the myocardium SERCA2a and RyR2 are the main regulators of intracellular Ca2+, SR 
Ca2+ load and the Ca2+ transient. The increased production of ROS during exhaustive exercise 
may have altered the structure and function of SERCA2a and contributed to cardiac fatigue. 
Thus, it was hypothesized that exhaustive exercise would result in a reduction in maximal Ca2+-
ATPase activity and Ca2+ uptake. Contrary to these hypotheses, the rates of maximal Ca2+-
ATPase activity and Ca2+ uptake were not significantly different between the CTL, AC and 24H 
groups. These data suggest that the structure of SERCA2a was not altered by exhaustive exercise, 
as these analyses were performed under optimal in vitro conditions. However, it is possible that 
metabolic inhibition of SERCA2a occurred in vivo, which contributed to Ca2+ overload and 
activation of calpains. Indeed, exhaustive exercise results in a reduction in the concentration of 
ATP and accumulation of AMP and ADP in rat myocardium (Weicker et al., 1990). Furthermore, 
studies have reported that by increasing the concentration of inorganic phosphate that the decay 
phase of the Ca2+ transient was prolonged and Ca2+ loading of the SR was impaired (i.e. reduced 
SERCA2a function) (Smith & Steele, 1992; Xiang & Kentish, 1995; Yang & Steele, 2002). The 
Ca2+ uptake data in this thesis differs from two previously reported studies that found a reduction 
in Ca2+ uptake following exhaustive exercise (Sembrowich & Gollinick, 1977; Pierce et al., 
1984). These disparate results may be related to the sample preparation and assays used to assess 
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Ca2+ uptake. In the current study, whole homogenate and the Ca2+ sensitive dye, Indo-1 were 
used to measure Ca2+ uptake. The studies by Sembrowich & Gollinick (1977) and Pierce and co-
workers (1984) performed Ca2+ uptake analyses using purified SR vesicles. The SR yield using 
differential centrifugation is reduced compared to whole homogenate (Chin & Green, 1996) and 
thus may not accurately represent the function of the entire population of Ca2+ pumps. In 
addition, exercise has been shown to differentially alter Ca2+ uptake when assessed in skeletal 
muscle homogenate and SR vesicles (Byrd et al., 1989). Sembrowich & Gollinick (1977) and 
Pierce and co-workers (1984) assessed Ca2+ uptake using a 45Ca2+ assay, which contained 50 µM 
45Ca2+ and 5 mM oxalate in the assay medium. These conditions make it difficult to determine 
the free Ca2+ concentration in the assay. The use of Indo-1 and dual emission fluorometry in the 
current thesis allowed for precise control of the free Ca2+ concentration in the assay medium. 
However, a limitation to the Indo-1 Ca2+ uptake assay is that the free Ca2+ concentration in the 
assay medium was not maximal (i.e. ~10 µM) and thus maximal Ca2+ uptake could not be 
assessed. If the free Ca2+ concentration was indeed maximal in the studies by Sembrowich & 
Gollinick (1977) and Pierce and co-workers (1984), then it is difficult to compare Ca2+ uptake 
data in these studies to data in this thesis. In the studies by Sembrowich & Gollinick (1977) and 
Pierce and co-workers (1984), Ca2+ uptake was reduced by ~40-50%, which is comparable to 
the relative reduction in Ca2+ uptake in patients and animals with heart failure (i.e. models with 
pronounced LV contractile deficits) (O’Brien et al., 1991; Schwinger et al., 1995; Shao et al., 
2005). Unfortunately, the former studies did not assess LV contractile properties following 
exhaustive exercise, and thus, it is not clear if the reduction in Ca2+ uptake had any effect on LV 
contractility. Taken together, exhaustive exercise did not alter the structure and function of 
SERCA2a as determined by the in vitro analyses used in this thesis. However, it cannot be ruled 
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out that maximal Ca2+ uptake was altered by exhaustive exercise or that metabolic inhibition of 
SERCA2a occurred in vivo.  
The ryanodine receptor is emerging as a key regulator of cardiomyocyte function in both 
health and disease (Dulhunty et al., 2012). Accordingly, a reduction in SR Ca2+ release or 
increased SR Ca2+ leak would result in a decline in the Ca2+ transient and attenuated force 
production. In Chapter 3, the rates of maximal SR Ca2+ release were not significantly different 
between the CTL, AC and 24H groups. To the author’s knowledge only one study has assessed 
the rate of SR Ca2+ release in the LV following an acute bout of aerobic exercise. In that study, 
dogs were subjected to an intermittent exercise protocol, which consisted of five bouts of running 
at 6 km/h for five minutes followed by five minutes of rest. It was found that intermittent exercise 
resulted in an increase in the rates of Ca2+-induced Ca2+ release, which was associated with 
NOX-dependent ROS production and glutathionylation of RyR (Sanchez et al., 2008). These 
divergent results may stem from species and methodological differences in the two studies. It 
has been shown that there are ultrastructural, functional and Ca2+-induced Ca2+ release 
differences between rats and dogs (Fabiato and Fabiato, 1978; Fabiato, 1982; Schaper et al., 
1985; Bouchard and Bose, 1989). The exercise protocol employed in this thesis was continuous 
and exhaustive in nature, whereas the protocol used by Sanchez and colleagues (2008) was 
intermittent and did not result in exhaustion. Perhaps there is a relationship between SR Ca2+ 
release and the duration or intensity of exercise, such that brief periods of exercise can augment 
RyR function, which results in optimal SR Ca2+ release and exhaustive exercise results in a 
progressive decline in the rate of Ca2+ release. This hypothesis is analogous to the inverted “U” 
model of muscle force versus cellular REDOX state (refer to Figure 1.4 and Ried, 2001). A more 
likely explanation is derived from the method employed to induce Ca2+ release. In the current 
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thesis, 4-CMC was used to induced Ca2+ release, which directly binds to and activates RyR 
(Jacobson et al., 2006), whereas, the study by Sanchez and colleagues (2008) utilized a buffered 
solution with a free Ca2+ concentration of 1 µM to induce Ca2+ release. Previous studies have 
shown that maximal Ca2+ release or RyR open probability occurred at a free Ca2+ concentration 
of ~10 µM (Rousseau et al., 1986; Meissner and Henderson, 1987; Copello et al., 1997). It is 
possible that the Ca2+ release conditions utilized in the study by Sanchez and co-workers (2008) 
were submaximal and represent an exercise-induced increase in the affinity of RyR to 
submaximal trigger Ca2+ as opposed to an increase in the maximal rate of Ca2+ release. Currently, 
it is not clear what affect exhaustive exercise had on Ca2+-induced Ca2+ release. However, it can 
be concluded that exhaustive exercise did not alter 4-CMC-induced conductance of Ca2+ through 
the Ca2+ release channel.    
The rate of Ca2+ leak from the SR is equally as important as the rate of SR Ca2+ release 
with respect to cardiomyocyte function. In aging and heart failure there is increased oxidative 
stress in the cardiomyocyte, which is associated with an increased rate of SR Ca2+ leak and 
impaired contractile function (Cooper et al., 2013; Umanskaya et al., 2014; Kobayashi et al., 
2015). In this thesis, the rate of SR Ca2+ leak was increased by ~40% immediately following 
exhaustive exercise when compared to the CTL and 24H groups. Few studies have examined the 
effects of acute exercise on SR Ca2+ leak in healthy myocardium. One study found a decrease in 
SR Ca2+ leak following 25 minutes of intermittent exercise (Sanchez et al., 2008). The 
assessment of SR Ca2+ leak in this thesis and the study by Sanchez and colleagues (2008) were 
performed in a similar manner. Ca2+ uptake was monitored using fluorescence spectroscopy and 
when Ca2+ uptake had reached a minimum a SERCA inhibitor (CPA in the current thesis and 
thapsigargin in Sanchez et al., 2008) was added to the assay and passive Ca2+ efflux was 
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recorded. Despite these similarities, there were differences in assay temperature (37oC versus 
30oC), sample preparation (homogenate versus SR membrane isolation), exercise protocols and 
species that may account for the divergent results with respect to SR Ca2+ leak. Regardless of 
the methodological differences between these studies, these data can be interpreted that brief 
intermittent aerobic activity reduced SR Ca2+ leak, which would likely augment cardiac function, 
whereas, exhaustive exercise caused an increase in SR Ca2+ leak, which was associated with a 
reduction in LVDP.  
The putative post-translational modifications to RyR that are associated with increased 
SR Ca2+ leak are elevated PKA mediated phosphorylation and oxidative modification to the 
channel (Marx et al., 2000; Wehrens et al., 2006; Bellinger et al., 2008; Bellinger et al., 2009; 
Andersson et al., 2011b). Despite a significant increase in circulating Epi in the AC group, PKA 
mediated phosphorylation of RyR was not altered in this group. These findings conflict with 
previous studies that found increased pRyR content following acute exercise (Wehrens et al., 
2003; Gelhert et al., 2012). The discrepancy in pRyR2 from LV following acute exercise may 
be related to tissue collection and processing. The study by Wehrens and co-workers (2003) flash 
froze the LV immediately after exercise ceased. In this thesis, the collection and homogenization 
of LV was performed as quickly as possible, but it is possible that dephosphorylation of RyR 
occurred in the time period from exercise cessation to freezing of LV homogenates. The 
significance of PKA mediated phosphorylation of RyR2 and the subsequent impact on cardiac 
function has been challenged (MacDonnell et al., 2008; Zhang et al., 2012). The results from this 
thesis indicate that exercise-induced SR Ca2+ leak was not associated with changes in PKA 
mediated phosphorylation of RyR, which suggests a different mechanism was responsible for 
increasing SR Ca2+ leak. 
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To determine if oxidative post-translational modification of RyR contributed to the 
increase in SR Ca2+ leak, nitration, carbonylation and glutathionylation of RyR were assessed 
using immunoprecipitation and Western blotting techniques. Despite an increase in ROS 
production following exhaustive exercise, there were no significant differences between the 
CTL, AC and 24H groups with respect to glutathionylation, nitration or carbonylation of RyR. 
Using immunohistochemistry it has been demonstrated that acute exercise increased the 
nitrotyrosine content of cardiac cross-sections (Olah et al., 2015). Unfortunately, the 
immunohistochemistry technique does not permit the evaluation of specific proteins that are 
nitrated. To the author’s knowledge, this thesis is the first study to assess nitration of RyR2 
following an acute bout of exhaustive exercise. Taken together nitration of proteins may increase 
in the LV following acute exercise (Olah et al., 2015); however, RyR does not appear to be the 
target of tyrosine nitration. The protocol that was used to measure carbonylation of RyR was 
very similar to previous studies that demonstrated group differences in RyR carbonylation 
(Andersson et al., 2011a; Andersson et al., 2012; Umanskaya et al., 2014). Those studies used 
chronic models of oxidative stress compared to the acute increase in ROS production observed 
in this thesis. Perhaps a persistent increase in ROS production, as seen in aging and muscular 
dystrophy, is required to carbonylate RyR and have functional effects. The interaction of ROS 
with amino acids is quite complex and can result in a wide range of oxidative modifications to 
amino acids (Stadtman & Levine, 2003). It is possible that the ROS produced during exercise 
modified RyR2 in a manner not assessed in this thesis. For example RyR2 can be S-nitrosylated 
(the addition of NO to the thiol moiety of cysteine) in exercise, aging and disease models 
(Bellinger et al., 2008; Bellinger et al., 2009; Andersson et al., 2011a). An alternate explanation 
is that the immunoprecipitation and Western blot techniques utilized in this thesis were not 
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sensitive enough to detect differences between groups or that specific amino acids were 
modified, which cannot be determined using these techniques. Indeed, mass spectroscopy studies 
indicate that tyrosine nitration of RyR from skeletal muscle and the cerebellum is increased with 
aging (Kanski et al., 2005; Gokulrangan et al., 2007). Furthermore, mass spectroscopy analysis 
revealed that of the 100 cysteine residues on RyR1, 13 or fewer cysteine residues are sensitive 
to redox regulation (Voss et al., 2004; Aracena-Parks et al., 2006). Taken together, exhaustive 
exercise did not alter the post-translational oxidative modifications assessed in this thesis; 
however, it is possible that different modifications to RyR occurred or more sensitive methods 
were required to detect structural modifications to RyR.  
An interesting finding in his thesis was that LVDP remained depressed 24 hours post-
exercise despite the fact that ROS production and SR Ca2+ leak had normalized, which suggests 
an alternate mechanism was responsible for the cardiac fatigue present in the 24H group. It was 
hypothesized that the increased SR Ca2+ leak observed in vitro resulted in an increase in cytosolic 
[Ca2+]f in vivo, which activated calpains. Indeed, calpain activity was significantly increased 
immediately following exhaustive exercise, which is consistent with previous reports (Raj et al., 
1998; Tiidus et al., 2002). Activation of calpains has been demonstrated to degrade a host of EC 
coupling proteins (Matsumura et al., 1993; Matsumura et al., 1996; Zeitz et al., 2002; Inserte et 
al., 2005; Pedrozo et al., 2010; Wanichawan et al., 2014). Degradation of EC coupling proteins 
would result in EC uncoupling and would require de novo synthesis of proteins in order to replace 
the degraded proteins. It can be concluded that calpains did not target Na+/K+-ATPase, 
SERCA2a or RyR2 since the assay conditions used to determine the function of these proteins 
were optimal and thus, degradation would have resulted in a decrease in activity measured in 
vitro. Therefore, calpain mediated degradation of proteins such as NCX, TnI, TnT, desmin, α-
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actinin, spectrin or junctophilin may have occurred, which contributed to EC uncoupling in the 
24H group (Matsumura et al., 1996; Goa et al., 1997; Zeitz et al., 2002; Murphy et al., 2013; 
Wanichawan et al., 2014). Toxicological and disease models have implicated activation of 
calpains as a contributing factor to impaired cardiac contractile function (French et al., 2006; 
Campos et al., 2011; Celes et al., 2013). Interestingly, when animals were provided a RyR 
antagonist prior to toxicological stress, there was a reduction in calpain activity and cardiac 
contractile function was preserved (Campos et al., 2011; Celes et al., 2013). These data support 
the hypothesis that exhaustive exercise increased ROS production, which resulted in an increased 
rate of SR Ca2+ leak and activation of calpains. The latter two mechanisms likely contributed to 
the depression in LVDP in the AC and 24H groups via a reduction in SR Ca2+ load and EC 
uncoupling, respectively. 
Once potential mechanisms associated with exercise-induced cardiac fatigue were 
determined, a pharmacological intervention was sought in an attempt to prevent cardiac fatigue. 
The NADPH oxidase inhibitor, apocynin was supplemented in the drinking water of rats for 
three days leading up to the exhaustive exercise bout. Inhibition of NOX prevented exercise-
induced cardiac fatigue, as there were no significant differences in LVDP and ±dP/dt between 
the APO treated groups in the basal state. These findings are in agreement with a work by Vitiello 
and colleagues (2011), who demonstrated that NOX inhibition blunted exercise-induced 
oxidative stress, which was associated with prevention of exercise-induced cardiac fatigue. 
Therefore, it was hypothesized that NOX inhibition would reduce ROS production following 
exhaustive exercise. Indeed, NOX inhibition blunted ROS production, such that there were no 
significant differences in DCF fluorescence between the three APO treated groups. There are 
two approaches that can be used to mitigate the effects of ROS. The first is the prevention of 
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ROS production and the second is the scavenging of ROS by antioxidants. It is well defined in 
human and animal skeletal muscle that treatment with antioxidants prior to exercise or tetanic 
stimulation can delay time to fatigue or reduce the magnitude of fatigue (Shindoh et al., 1990; 
Ried et al., 1994; Medved et al., 2004; Moopanar & Allen, 2005). These studies provide causal 
evidence that ROS produced during exercise or tetanic contractions contribute to fatigue in 
skeletal muscle. By inhibiting NOX and preventing ROS production and cardiac fatigue it can 
be stated with confidence that ROS production contributed to the development of exercise-
induced cardiac fatigue. 
A novel finding in this thesis was that NOX inhibition prevented cardiac during β-
adrenergic stimulation. The study by Vitiello and colleagues (2011) did not report the effects of 
NOX inhibition on the LVDP response to progressive concentrations of ISO. In this thesis, there 
were no significant differences between the APO treated groups with respect to heart rate or 
coronary flow during the ISO dose response, which suggests that these variables were not 
associated with the preserved LV function following exhaustive exercise. These data suggest 
that the protective effects of NOX inhibition on LV contractility following exhaustive exercise 
were due to reduced ROS production and improved protein function within cardiomyocytes 
(discussed below). In this thesis it was impossible to determine if cardiac output was impaired 
in rats during the exhaustive exercise bout when compared to APO treated animals. Since LVDP 
was preserved in the basal state and during β-adrenergic stimulation in APO treated groups, it 
could be hypothesized that APO treated animals had preserved cardiac function in vivo and thus, 
should have been able to run for longer periods of time. However, this was not the case, as there 
were no significant differences between the run times of animals in the non-APO and APO 
treated groups. A study by Grimditch and co-workers (1981) utilized instrumented dogs to 
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demonstrate that upon exhaustion cardiac output and stroke volume were not significantly 
different than values recorded within the first 5-10 minutes of exercise. It is possible that cardiac 
fatigue only manifests after the completion of the exercise bout and is a protective mechanism 
such that it would potentially limit exercise capacity during a subsequent bout, which would 
prevent further substrate depletion (i.e. glycogen) or muscle damage. 
It is well established that acute exercise results in an increase in circulating Epi and NE 
(Chin et al., 1971; Cox et al., 1985; Scheurink et al., 1989; Conlee et al., 1991). A novel finding 
in this study was that NOX inhibition blunted the catecholamine response to exercise, such that 
the concentration of plasma Epi in the APO AC group was not significantly different than the 
APO CTL and APO 24H groups. This is the first study demonstrating that NOX inhibition can 
reduce Epi secretion. The mechanism by which NOX inhibition prevented the rise in circulating 
Epi following exhaustive exercise is not immediately clear. It has been demonstrated that 
intermittent hypoxia augmented Epi secretion from chromaffin cells. If cells were incubated with 
inhibitors of NOX or RyR prior to hypoxia, then Epi secretion was attenuated (Souvannakitti et 
al., 2010). The fact that either a NOX or RyR inhibitor was effective at reducing Epi secretion 
in that study is intriguing as evidence from this thesis suggests that activation of NOX can 
regulate RyR function. Perhaps an interaction between NOX and RyR is a conserved mechanism 
across cell types that regulates intracellular Ca2+. Psychological stress has been shown to increase 
the concentration of Epi in the plasma (Dimsdale & Moss, 1980; Gerra et al., 2001). The 
likelihood that the reduction in Epi in the APO AC group was due to a reduction in stress placed 
on the animals is minimal. All of the rats in this thesis were handled in a similar manner and the 
average time to exhaustion (i.e. stress of the exercise protocol) were not significantly different 
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between the groups. Therefore, it is possible that APO prevented activation of NOX in the 
adrenal medulla during exhaustive exercise, which reduced the secretion of Epi. 
A novel observation this thesis was that inhibition of NOX resulted in a reduction in 
coronary flow when APO treated groups were compared to non-APO treated groups. Previous 
studies using the isolated perfused mouse heart and the conscious instrumented dog have 
demonstrated that NOX inhibition using APO had no effect on coronary flow when compared 
to non-APO groups (Zhang et al., 2009; El-Awady et al., 2013). The conflicting results between 
these studies and this thesis may be methodological in nature. In this thesis, animals were 
provided APO over a three day period, whereas, the former studies perfused APO directly into 
the coronary circulation. A common feature of endothelial dysfunction is a reduction in nitric 
oxide (NO) bioavailability due to the reaction of NO with superoxide, which produces 
peroxynitrite (Levy et al., 2009). In the current thesis, inhibition of NOX decreased ROS 
production (i.e. decreased superoxide production), which would be expected to increase NO 
bioavailability, decrease CVR and increase coronary flow. However, the opposite results were 
observed; CVR was greater and coronary flow was reduced in APO treated groups when 
compared to non-APO treated groups. Thus, the mechanism responsible for the reduced coronary 
flow in the current study may not be related to ROS production and NO bioavailability in the 
coronary vasculature, but may be related to metabolic demand in the ventricular myocyte. The 
increased coupling ratio observed in APO treated animals would be expected to reduce the 
amount of ATP required to transport a given amount of Ca2+ across the SR membrane. 
Furthermore, lower SR Ca2+ leak would lead to less Ca2+-ATPase cycling during diastole, which 
would reduce ATP demand even further. Although speculative, the improved Ca2+ transport 
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efficiency and lower SR Ca2+ leak may have lowered ATP demand (i.e. lower oxygen demand), 
which resulted in a reduction in coronary flow. 
Inhibition of NOX resulted in several improvements in Ca2+ regulation. It was 
hypothesized that NOX inhibition would prevent the exercise-induced increase in SR Ca2+ leak 
that was observed in Chapter 3. As postulated, there were no significant differences in the rates 
of SR Ca2+ leak in the APO treated groups. In addition, there was a main effect of NOX inhibition 
on SR Ca2+ leak, such that leak was lower in APO treated groups when compared to non-APO 
treated groups. Evidence to support these novel findings comes from a model of dystrophic 
cardiomyopathy. Gonzalez and colleagues (2014) demonstrated that in cardiomyocytes from 
dystrophic hearts ROS production was augmented, which was associated with increased SR Ca2+ 
leak, a reduction in SR Ca2+ content and depressed contractile function. Incubation of dystrophic 
cardiomyocytes with APO restored SR Ca2+ leak and SR Ca2+ load, which improved cell 
shortening (Gonzalez et al., 2014). These data suggest that RyR is a downstream target of NOX 
dependent ROS production and the activation of NOX can regulate RyR function, which can 
impact contractile function. To further demonstrate that NOX can regulate RyR, an in vitro 
experiment was designed, whereby NADPH was added to LV homogenates, which activated 
NOX and increased ROS production and SR Ca2+ leak. When these in vitro experiments were 
repeated in the presence of APO, ROS production was blunted and SR Ca2+ leak was equal to 
control values. These results are similar to studies that utilized skeletal muscle preparations and 
demonstrated that exogenous NADPH activated NOX, increased ROS production and increased 
the open probability of RyR (Hidalgo et al., 2006; Sun et al., 2011). Taken together, exercise or 
NADPH-induced activation of NOX resulted in increased ROS production and increased SR 
Ca2+ leak through RyR2, which was prevented when NOX was inhibited by APO. 
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The inhibition of NOX resulted in augmented SERCA2a function (i.e. increased Ca2+ 
transport efficiency and apparent affinity to Ca2+), which may have contributed to the prevention 
of exercise-induced cardiac fatigue. The maximal Ca2+-ATPase activities were lower and the 
rates of Ca2+ uptake were higher in the APO treated groups when compared to the non-APO 
treated groups. Consequently, there were significantly higher coupling ratios in the APO treated 
groups. The increase in the coupling ratio was likely mediated by the increased apparent affinity 
of SERCA2a for Ca2+ and the lower rate of SR Ca2+ leak in the APO treated groups (Chamberlain 
et al., 1984; Beeler & Gable, 1994; Frank et al., 2000). Studies have shown a leftward shift in 
the Ca2+-dependent Ca2+-ATPase curve in the LV of PLN knockout mice (Luo et al., 1994; Frank 
et al., 2000). These findings have been replicated in LV samples from non-transgenic mice and 
rabbits when PLN was phosphorylated or when PLN antibody was added to the Ca2+-ATPase 
assay to mimic PLN phosphorylation (Kranias et al., 1985; Xu & Narayanan, 1999; Mahaney et 
al., 2000).  In this thesis, the ratio of pPLN to PLN was greater in the APO treated groups when 
compared the non-APO treated groups, which would explain the increased apparent affinity of 
SERCA2a for Ca2+. The mechanism responsible for the increased pPLN to PLN ratio following 
NOX inhibition was not associated with plasma Epi concentrations. PLN is phosphorylated by 
CaMKII at threonine 17. However, activation of CaMKII does not seem to be a likely 
mechanism, as this kinase is activated by elevated Ca2+ and ROS (Couchonnal & Anderson, 
2008), both of which were reduced in APO treated groups. Furthermore, activation of NOX has 
been shown to attenuate phosphatase activity (Lee et al., 2007; Shinohara et al., 2007; Jiang et 
al., 2011). Therefore, by inhibiting NOX it would be expected that phosphatase activity was 
elevated, which would have the opposite effect on pPLN compared to what was observed in this 
thesis. The functional consequence of increased coupling ratios and the apparent affinity of 
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SERCA2a for Ca2+ would be enhanced Ca2+ sequestration at low [Ca2+]f (i.e. during diastole) 
(Frank et al., 2000). This would increase SR Ca2+ load and augment the fractional release of 
Ca2+, which would result in a more forceful contraction. This may account for the protection 
against exercise-induced cardiac fatigue afforded by NOX inhibition. 
The results from this thesis suggest that exercise-induced cardiac fatigue was associated 
with increased ROS production, increased SR Ca2+ leak and activation of calpains. Due to 
technical limitations, measurements of the [Ca2+]f during exercise or in isolated perfused hearts 
were not performed in this thesis. However, based on the results from in vitro experiments, it is 
reasonable to speculate that the concentration of Ca2+ in the cytosol rose sufficiently to activate 
calpains. Thus far, this thesis has demonstrated that inhibition of NOX blunted ROS production 
and reduced SR Ca2+ leak. Therefore, the final postulate examined in this thesis stated that 
inhibition of NOX would prevent activation of calpains immediately following exhaustive 
exercise. As hypothesized there were no significant differences in calpain activity between the 
APO CTL, APO AC and APO 24H groups. These data are in agreement with previous studies 
that demonstrated that NOX inhibition using APO prevented ROS production and calpain 
activation following chemical and mechanical stress (Li et al., 2009a; McClung et al., 2009). 
Brief exposure of skeletal and cardiac muscle to elevated Ca2+ concentrations activates calpains 
and may result in EC uncoupling (Verburg et al., 2005; Verburg et al., 2009; Murphy et al., 
2013). Furthermore, there is evidence to suggest that by inhibiting calpain activity, EC coupling 
and thus force production is preserved in skeletal muscle fibres (Verburg et al., 2005; Zhang et 
al., 2008; Verburg et al., 2009). These data suggest that the reduction in calpain activity observed 
in this thesis likely prevented degradation of EC coupling proteins, which maintained EC 
coupling and thus LVDP in the APO 24H group. 
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Conclusion 
 The results from the studies that comprise this thesis demonstrate that exhaustive exercise 
decreased LVDP immediately following the exercise bout and that the depression in LVDP 
persisted for up to 24 hours post-exercise. In vitro analyses revealed that exhaustive exercise 
increased ROS production and SR Ca2+ leak in LV homogenates. The increased SR Ca2+ leak 
may explain the acute depression in LVDP, which is likely mediated through a decrease in the 
SR Ca2+ load and a decrease in the Ca2+ transient amplitude. However, ROS production and SR 
Ca2+ leak were equal to control values 24 hour post-exercise, yet LVDP remained depressed. 
Activation of calpains, possibly due to increased SR Ca2+ leak, may have contributed to the 
persistent decrease in LVDP observed 24 hours post-exercise via EC uncoupling. The exercise-
induced deficits in LV observed in this thesis share features of myocardial stunning at the whole 
organ and biochemical level. Thus, exhaustive exercise confers a pseudo-stunned phenotype on 
the rat myocardium. 
 The reduction in myocardial function, and biochemical changes following exhaustive 
exercise were prevented in animals that consumed APO, a NOX inhibitor. A potential pathway 
of biochemical events is illustrated in Figure 5.1. During exhaustive exercise NOXs were 
activated, which increased ROS production. This caused an increase in SR Ca2+ leak, which 
contributed to the acute depression of LVDP and activation of calpains. The increase in calpain 
activity contributed to the depression in LVDP that persisted for 24 hours. The activation of a 
NOX-RyR pathway (Souvannakitti et al., 2010) or NOX-RyR-calpain pathway (Li et al., 2009b) 
has been demonstrated in the myocardium and other tissues. Interestingly, by inhibiting upstream 
steps in the pathway (i.e. NOX and RyR) calpain activation and apoptosis of cardiomyocytes 
was prevented (Li et al., 2009b). By inhibiting NOXs with APO in this thesis, the downstream 
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biochemical processes in the pathway proposed in Figure 5.1 were preserved, and thus, cardiac 
fatigue did not occur. Overall, this thesis has proposed that acute, exhaustive exercise places the 
myocardium in a pseudo-stunned state and determined a potential pathway that explains some 
of the mechanisms that contribute to exercise-induced cardiac fatigue.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Proposed pathway linking the mechanisms that contribute to exercise-induced 
cardiac fatigue. The (+) sign represents activation or increased activity. Exhaustive exercise 
activates NADPH oxidase, which increases ROS production. That leads to increased SR Ca2+ 
leak and activation of calpains. These later events contribute to the acute and persistent 
depression in cardiac contractile function. Apocynin blunts exercise-induced activation of 
NADPH oxidase, which prevents downstream processes from occurring (greyed out to indicate 
no change in activity). 
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Perspective 
 The aim of this thesis was not to cast aerobic exercise in a negative light. Participation in 
a regular aerobic exercise regime results in weight loss, increased peak oxygen uptake, improved 
insulin sensitivity, reduction in serum triglycerides and cholesterol, improved glucose 
metabolism, reduction in blood pressure and an improved mental health (King et al., 1989; 
Dengel et al., 1998; Andersen et al., 1999; Ross et al., 2000). These positive effects of exercise 
far outweigh the transient decline in cardiac function following a prolonged or exhaustive bout 
of exercise. The fact that this is a transient phenomenon indicates that this may be a normal 
physiological process (discussed below). Thus, the goal of this thesis was to answer the basic 
question, what are the mechanisms that underlie exercise-induced cardiac fatigue? Since the rats 
used in this thesis were sedentary, perhaps the functional and biochemical deficits observed in 
this thesis are a normal processes that are required for physiological adaptation in the 
myocardium to the stress of regular aerobic exercise. Similar to cycles of damage, repair and 
growth in skeletal muscle in response to aerobic or resistance exercise, the activation of the 
pathway proposed in Figure 5.1 may lead to short-term deficits in cardiac function but the 
subsequent adaptation (i.e. de novo protein synthesis) following a finite recovery period may 
lead to overall improved cardiomyocyte function with repeated periods of exhaustive exercise 
and recovery (i.e. endurance training). This thesis demonstrated that inhibition of NOX 
prevented cardiac fatigue by blocking the activation of a proposed ROS-SR Ca2+ leak-calpain 
pathway. This observation was very beneficial from a basic understanding of exercise-induced 
cardiac fatigue mechanisms. However, scavenging of ROS produced during exercise has been 
shown to limit the cellular adaptations to aerobic exercise in skeletal muscle (Gomez-Cabrera et 
al., 2005; Paulsen et al., 2014). It could be hypothesized that, similar to skeletal muscle, ROS 
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produced in the LV during exhaustive exercise contributes to the development of cardiac fatigue 
and is an important signalling step in physiological adaptation.  
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Limitations 
 This thesis contained several cohorts of animals that were randomly assigned to either 
CTL, AC or 24H groups. Certain cohorts of animals were used for isolated perfused heart studies 
and other cohorts for in vitro experiments. It is difficult to say with certainty that the mechanisms 
associated with cardiac fatigue identified using in vitro assays were present during isolated 
perfused heart experiments. However, it was demonstrated that a key finding in the in vitro 
experiments, namely increased SR Ca2+ leak, was present in LV homogenates collected 
following 30 minutes of perfusion using the Langendorff technique. It is possible to assess ROS 
production and Ca2+ transients in actively beating isolated perfused hearts (Del Nido et al., 1998; 
Du et al., 2001; Kevin et al., 2003; Napankangas et a., 2012). Unfortunately, our laboratory is 
not equipped to make such measurements. The evaluation of ROS production and Ca2+ transients 
following exhaustive exercise in the isolated heart would greatly enhance the cardiac fatigue 
literature. Nonetheless, it was possible to detect increased ROS production in LV homogenates 
following exhaustive exercise and by activating NOX using NADPH. 
The training status of the rats used in this thesis may be a potential limitation. Similar to 
previously reported studies that have examined cardiac fatigue, the rats used in this thesis were 
sedentary. It is possible that the effects of exhaustive exercise are magnified in sedentary rats as 
these animals were not accustomed to such a stress to the cardiovascular system. No study has 
examined the influence of training status on the development of cardiac fatigue in rats (see Future 
Directions). Perhaps cardiac fatigue is absent following exhaustive exercise in trained rats. 
Accordingly, these collective studies offer novel insight as to the mechanism associated with 
cardiac fatigue and may serve as a starting point for training studies that investigate cardiac 
fatigue. 
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The aim of this study was to investigate the mechanisms associated with cardiac fatigue. 
Unfortunately, it is problematic to extrapolate these findings to the human literature as there are 
several species differences between rats and humans, which include but are not limited to action 
potential duration, resting heart rate, contractile protein isoform expression and the relative 
amount of Ca2+ released and sequestered by the SR (i.e. ~90% in rats and ~70% in humans) 
(Milani-Nejad & Janssen, 2014). Thus, the altered SR function observed in this thesis may not 
be associated with functional deficits in the LV of humans following exhaustive exercise. 
Logistically, it is impossible to carry out such analyses on human LV, but the findings in this 
thesis may direct future studies in larger mammals (i.e. dog, sheep or pig) that have a 
myocardium that more closely resembles humans in terms of structure and biochemical function. 
The isolated perfused heart technique is a powerful tool insofar as it allows careful 
manipulation of the constituents of the perfusate, pH, metabolic substrates and the hearts are 
devoid of neurohumoral influences. However, these factors may be a limitation in this thesis, as 
it is not known what effect exhaustive exercise had on in vivo cardiac function. The exercise-
induced reduction in LVDP may not translate into a reduction in cardiac output as neurohumoral 
factors and loading conditions can influence heart rate and stroke volume in order to maintain 
cardiac output in vivo. In the basal state there were no significant difference in heart rate in the 
CTL, AC and 24H groups. Studies have utilized pressure sensitive catheters and 
echocardiography to demonstrate that LVDP and ejection fraction measured in vivo were lower 
following exhaustive exercise (Vitiello et al., 2011; Olah et al., 2015). Furthermore, the study by 
Olah and colleagues (2015) observed a reduced stroke volume and cardiac output in animals that 
swam to exhaustion despite loading conditions and heart rates being equal to a sedentary control 
group. These data suggest that the cardiac fatigue observed in this thesis likely existed in vivo 
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and that the isolated perfused heart technique is a valid approach to assessment of cardiac fatigue 
in rat. 
As mentioned in Chapter 4, a comparison of in vitro results from groups that were treated 
with APO and groups that were not treated with APO revealed some interesting main effects of 
APO treatment. There was a temporal gap between the isolation of homogenates from non-APO 
treated animals and APO treated animals. In addition, there were no homogenates collected from 
a non-APO treated control group at the same time as all of the APO treated groups, which is a 
major limitation of this study. Several of the main effects of APO treatment may partially explain 
the mechanisms by which NOX inhibition prevented cardiac fatigue, however, these discussions 
and interpretation must be taken with a degree of caution. 
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Future Directions 
 The collection of studies in this thesis demonstrated that exhaustive exercise resulted in 
depressed cardiac contractile function that persisted for up to 24 hours post-exercise. A similar 
study observed a reduction in LVDP for up to 48 hours following an acute bout of exercise. 
Expanding on the hypothesis developed in the Perspective section, it would be of interest to 
examine the effects of repeated bouts of the same exercise stress over an extended period of time. 
One study would have rats perform exhaustive exercise such that cardiac fatigue was induced 
and present 24 hours post-exercise. At that time point one group of rats would perform an 
exercise protocol to determine if cardiac fatigue translated into impaired exercise 
capacity/performance. A second group of rats would perform the exhaustive exercise protocol 
that induced cardiac fatigue to determine if there is a negative effect of a second exhaustive 
exercise bout on LVDP. A second study would track the effects of 1, 3, 5, 10, 21, etc. bouts of 
exhaustive exercise on functional and biochemical changes in the LV (i.e. the transition from a 
sedentary to trained animal). If the hypothesis that the cellular deficits associated with cardiac 
fatigue will eventually lead to positive LV adaptations is correct, then by the xth bout of 
exhaustive exercise the magnitude of cardiac fatigue should be blunted or cardiac fatigue should 
not be present.  
 The studies in this thesis and those in the literature have used healthy, but cage sedentary 
rats to investigate the effects of acute exercise on cardiac function. Evidence in humans suggests 
that transient reductions in cardiac function occur in the post-exercise period even in highly 
trained individuals who compete in high level athletic events (i.e. marathon, Ironman triathlon). 
An ideal study would utilize sedentary, moderately trained and highly trained rats to investigate 
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the influence of training status on the development of exercise-induced cardiac fatigue. This has 
not been examined in an animal model to date. 
 A study designed to confirm the pathway presented in Figure 5.1, would utilize 
permeabilized cardiomyocytes incubated with NADPH to activate NOX in order to induce SR 
Ca2+ leak and activate calpains. Cell shortening and lengthening would be used to assess the 
effects of NOX activation on contraction and relaxation properties. Subsequent experiments 
would activate NOX in the presence of antioxidants, specific inhibitors of RyR (i.e. dantrolene) 
or specific inhibitors of calpains (i.e. leupeptin), which should in theory prevent downstream 
events from occurring based on what step in the pathway is being inhibited. For example, 
activation of NOX should increase ROS production but incubation with dantrolene would 
prevent SR Ca2+ leak through RyR, which should prevent activation of calpains.  
 An exciting study would incorporate direct measurement of Ca2+ transients and ROS 
production in isolated perfused rat hearts following exhaustive exercise. In the discussion 
throughout this thesis it was hypothesized that an increase rate in SR Ca2+ leak may lower SR 
Ca2+ load and reduce the Ca2+ transient amplitude. By monitoring the Ca2+ transient ex vivo and 
by measuring SR Ca2+ leak in vitro, this hypothesis could be substantiated.      
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Appendix A - Treadmill Acclimation Protocol 
Time 
(min) Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
0-0.5 10 m/min 10 10 10 10 10 10 
0.5-1 . . . . . . . 
1-1.5 . . . . . . . 
1.5-2 . . . . . 10 10 
2-2.5 . . . . . 11 11 
2.5-3 . . . . 10 12 12 
3-3.5 . . . . 11 13 13 
3.5-4 . . 10 10 12 14 14 
4-4.5 . . 11 11 13 15 15 
4.5-5 . 10 12 12 14 16 16 
5-5.5 . 11 13 13 15 17 17 
5.5-6 . 12 14 14 16 18 18 
6-6.5 . 13 15 15 17 19 19 
6.5-7 . 14 . 15 18 20 20 
7-7.5 . 15 . 16 19 . . 
7.5-8 . . 15 17 20 . . 
8-8.5 . . 16 18 . . . 
8.5-9 . . 17 19 . . . 
9-9.5 . . 18 20 . . . 
9.5-10 10 15 19 20 20 20 20 
 
The treadmill acclimation was performed for 7 days leading up to the exhaustive exercise bout. 
Rats began each session at 10 m/min and the speed was progressively ramped on each subsequent 
day. The time is indicated in the first column. A “.” indicates that the speed was not changed at 
the time point. 
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Appendix B – Linear Regression Analysis from Chapter 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B.1. Linear regression analysis from Chapter 4 was performed to examine the 
relationships between (A) left ventricular developed pressure (LVDP) and heart rate; (B) left 
ventricular developed pressure and run time and (C) run time and body mass. The strength of 
each relationship and probability values are indicated within each panel. 
